UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K

xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 20052006
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 000-27945

ASCENDANT SOLUTIONS, INC.
(Exact name of Registrant as specified in its charter)

Delaware
 
75-2900905
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
   
16250 Dallas Parkway, Suite 205,100, Dallas, Texas
 
75248
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 972-250-0945
 
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act: Common Stock, par value $0.0001
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
YesoNo x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
YesoNo x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.filer (as defined in Exchange Act Rule 12b-2).

Large accelerated filer o   Accelerated filer  o   Non-Accelerated filer x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o  No x
The aggregate market value of the voting stock held by nonaffiliates of the registrant, based upon the closing price for the registrant’s common stock on the OTC Bulletin Board on June 30, 2005,2006, the last trading date of registrant's most recently completed second fiscal quarter, was approximately $14,874,000.$6,239,000.

At March 21, 2006, 22,396,809April 9, 2007, 22,558,844 shares of registrant’s common stock were outstanding.
 
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive Proxy Statement to be filed within 120 days of December 31, 2006 and delivered to stockholders in connection with the Annual Meeting of Stockholders to be held May 24, 2006June 14, 2007 are incorporated by reference into Part III.






ASCENDANTASCENDANT SOLUTIONS, INC.

FORM 10-K
For the Fiscal Year Ended December 31, 20052006

Table of Contents

 
PART I.
 
Page
 
    
 
1415
    
 
2123
    
 
2123
    
 
2224
    
 
PART II.
  
 
2325
    
 
2426
    
 
2527
    
 
3640
    
 
3842
    
 
7175
    
 
7175
    
 
7176
    
 
PART III.
  
 
7277
    
 
7277
    
  
  
7278
    
 
7278
    
 
7378
    
 
PART IV.
  
 
7379
    
  
7480

-1-




PART I.

ITEMITEM 1. BUSINESS

The following discussion of our business contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth below under “Management’s Discussion and Analysis of Financial Condition and Results of Operations, Risks Related to Our Business,” Risk Factors,” and “Other Risks”, as well as elsewhere in this Annual Report on Form 10-K.

BACKGROUND

Ascendant Solutions, Inc. (“Ascendant”, we also refer to Ascendant as “we,” “us,” or “the Company”) is a diversified financial services company which is seeking to, or has invested in or acquired, healthcare, manufacturing, distribution or service companies. We also conduct various real estate activities, performingperform real estate advisory services for corporate clients, and, through an affiliate, purchase real estate assets, as a principal investor.

The following is a summary of our identifiable business segments, consolidated subsidiaries and their related business activities:
 
Business Segment
 
 
Subsidiaries
 
 
Principal Business Activity
 
HealthcareDougherty’s Holdings, Inc. and SubsidiariesHealthcare products and services provided through retail pharmacies, including specialty compounding pharmacy services and home infusion therapy centers
   
Real estate advisory services
CRESA Partners of Orange County, L.P.,
ASDS of Orange County, Inc.,
CRESA Capital Markets Group, L.P.
Tenant representation, lease management services, capital markets advisory services and strategic real estate advisory services
   
Corporate & other
Ascendant Solutions, Inc. and
ASE Investments Corporation
Corporate administration, principal real estateinvestments in Ampco Partners, Ltd., Fairways Frisco, L.P. and investments not included in other segmentsFairways 03 New Jersey, L.P.
 

 

-2-


 

 
 
During 2002, we made our first investments, and we have continued to make additional investments and acquisitions throughout 2003, 2004 and 2005. A summary of our investment and acquisition activity is shown in the table below:
 
 
Date
 
 
 Entity
 
 
Business Segment
 
 
Transaction Description
 
 
% Ownership
 
 
April 2002
 
 
Ampco Partners, Ltd
 
 
Corporate & other
 
 
Investment in a non-sparking, non-magnetic safety tool manufacturing company
 
 
10%
 
 
August 2002
 
 
VTE, L.P.
 
 
Corporate & other
 
 
Investment to acquire early stage online electronic ticket exchange company
 
 
23%
 
 
October 2002
 
 
CRESA Capital Markets Group, L.P.,
ASE Investments Corporation
 
Real estate advisory services
 
 
Investment to form real estate capital markets and strategic advisory services companies
 
 
80%
 
 
November 2003
 
 
Fairways 03 New Jersey, L.P.
 
 
Corporate & other
 
 
Investment in a single tenant office building
 
 
20%
 
 
March 2004
 
 
Dougherty’s Holdings, Inc. and Subsidiaries
 
 
Healthcare
 
 
Acquisition of specialty pharmacies and infusion therapy centers
 
 
100%
 
 
April 2004
 
 
Fairways 36864, L.P.
 
 
Corporate & other
 
 
Investment in commercial real estate properties
 
 
24.75%
 
 
May 2004
 
CRESA Partners of Orange County, L.P., ASDS of Orange County, Inc.
 
Real estate advisory services
 
 
Acquisition of tenant representation and other real estate advisory services company
 
 
99%
 
 
December 2004
 
 
Fairways Frisco, L.P.
 
 
Corporate & other
 
 
Investment in a mixed-use real estate development
 
 
14%8.87%
 

These transactions and the business activity of our business segments are discussed in more detail below under “Description of Business Segments”. Also, certain of these transactions involved related parties or affiliates as more fully described in Note 1816 of the Ascendant Consolidated Financial Statements.

-3-



Below is a summary of our investment portfolio performance by segment on a cash basis through December 31, 2005:2006:

 
Cumulative
 
Cumulative
 
Cumulative
 
 
Cumulative Cash
 
Cumulative Realized Cash
 
Cumulative Realized Cash
  
Cash
 
Realized Cash
 
Realized Cash
 
Segment
 
Investments
 
Returns
 
Return %
  
Investments
 
Returns
 
Returns %
 
                 
Healthcare $1,500,000 $814,000  54%  $1,500,000 $812,000  54%
Real Estate Advisory Services  64,000  1,020,000  1,594%   64,000  1,434,000  2,241%
Corporate & Other  1,992,000  1,868,000  94%   1,992,000  2,310,000  116%
           $3,556,000 $4,556,000  128%
 $3,556,000 $3,702,000  104% 

We face all of the risks of a business with limited capital, the special risks inherent in the acquisition or involvement in each of our particular new business opportunities, and the added risks associated with the management of diverse businesses. There can be no assurances that our current or future investments or acquisitions will produce cash results similar to those shown in the table above.

Our future acquisition criteria may include, but not necessarily be limited to, the following criteria:

·  Annual revenues of $5-50$5-100 million
·  Stable history of profitability and positive cash flow with minimum EBITDA of $1 million
·  Strong management team committed to the business
·  Leadership or proprietary position in either product line, technology, manufacturing, service offering or distribution
·  Opportunity to grow internally and/or through strategic add-on acquisitions
·  Diversified customer base and product line
·  Businesses, or situations, where we can most effectively deploy our net operating loss carryforwards

We will continue to look for acquisition opportunities, however, our current cash resources are limited and we will be required to expend significant executive time to assist the management of our acquired businesses. We will continue seeking to (1) most effectively deploy our remaining cash and debt capacity (if any) and, (2) capitalize on the experience and contacts of our officers and directors.directors, and (3) explore other acquisition and investing opportunities.

In our continued acquisition efforts, we will not limit ourselves to a particular industry. At this time, all of our business is conducted within the United States. Most likely, the target business will continue to be primarily located in the United States, although we may acquire a target business with operations and/or locations outside the United States. In seeking a target business, we will consider, without limitation, businesses (i) that offer or provide services or develop, manufacture or distribute products in the United States or abroad; or (ii) that are engaged in wholesale or retail distribution among other potential target business opportunities and/or where our tax loss carryforwards can be utilized effectively. We may also co-invest in certain real estate transactions along with Fairways Equities, LLC (“Fairways Equities”) or its principals.

We have acquired, and may acquire in the future, minority or other non-controlling investments in other companies or businesses. However, we do not intend to engage primarily in acquiring minority investments, as we prefer to control the businesses in which we invest. Specifically, we intend to conduct our activities so as to avoid being classified as an “investment company” under the Investment Company Act of 1940, and therefore avoid application of the costly and restrictive registration and other provisions of that Act. We do not believe we are currently an “investment company.”

-4-


However, if in the future more than 40% of our assets are comprised of “investment securities” (which are basically,generally, non-government securities other than securities of majority-owned and certain other controlled companies) we would, subject to certain transitional relief, be required to register as an investment company, which would involve our incurring significant registration and compliance costs under the Investment Company Act. We have obtained no formal determination nor have we requested any ruling or interpretation from the Securities and Exchange Commission as to our status or potential status under the Investment Company Act of 1940. Any violation by us of the Investment Company Act, whether intentional or inadvertent, could subject us to material adverse consequences.

Description of Business Segments

Information regarding the financial condition of each of the Company’s business segments can be found in the Company’s Consolidated Financial Statements in Item 8.

Healthcare Segment

Dougherty’s Holdings, Inc.

Description of Acquisition

On March 24, 2004, we acquired, through a newly formed wholly-owned subsidiary Dougherty’s Holdings, Inc. (“DHI”), substantially all of the assets of Park Pharmacy Corporation (the “Park Assets”) pursuant to the First Amended Plan of Reorganization under Chapter 11 of the United States Bankruptcy Code Proposed by Park Pharmacy Corporation Inc. and the Company (the "Joint Plan"(“Joint Plan”) and the Asset Purchase Agreement (the “Agreement”) entered into December 9, 2003 between Park Pharmacy and DHI. Park Pharmacy had been operating as a debtor in possession since December 2, 2002. The purchased assets included all of the cash and certain other assets of Park Pharmacy and all equity interests of the following entities (each directly or indirectly wholly-owned by Park Pharmacy): (i) Dougherty’s Pharmacy, Inc., (ii) Park Operating GP, LLC, (iii) Park LP Holdings, Inc., (iv) Park-Medicine Man GP LLC (v) Park Infusion Services, L.P., and (vi) Park-Medicine Man, L.P.

We acquired the Park Assets by investing, through DHI, an aggregate of approximately $1.5 million in cash, funded out of our working capital, and the assumption by DHI of approximately $6.3 million in debt associated with the Park Assets.

In connection with the acquisition of the Park Assets, DHI also entered into a new credit facility with Bank of Texas, the prior lender to Park Pharmacy Corporation. This new facility providesprovided for three notes, aggregating approximately $5.5 million. Each note bears interest at six percent and matures in three years. Although DHI has committed to use commercially reasonable efforts to locate a replacement lender as soon as possible, DHI is obligated to make monthly payments (consisting of both interest and principal payments, as applicable) to the bank of approximately $56,000. The newThis credit facility iswas secured by substantially all of the assets of DHI, including the stock of its operating subsidiaries. This credit facility was paid in full in February 2007.

On February 20, 2007, Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP, each a wholly-owned subsidiary of DHI, entered into a loan agreement with Amegy Bank National Association (“Amegy Bank”) for a $2,000,000 revolving line of credit and a $2,200,000 term loan. Substantially all of the proceeds from the revolving line of credit and the term loan were used to retire the outstanding balance owed to Bank of Texas, N.A. under an existing credit facility. Please see Note 10 of the Ascendant Consolidated Financial Statements contained herein.

In connection with the acquisition of the Park Assets, DHI entered into a three year supply agreement with AmerisourceBergen Drug Corporation (“AmerisourceBergen”) pursuant to which DHI and our newly acquired indirect subsidiaries agreed to purchase prescription and over-the-counter pharmaceuticals from AmerisourceBergen through March 2007. This supply agreement will also provideprovided us with pricing and payment terms that arewere improved from those previously provided by AmerisourceBergen to Park Pharmacy.

-5-



In exchange for these improved terms, DHI has agreed to acquire 85% of its prescription pharmaceuticals and substantially all of its generic pharmaceutical products from AmerisourceBergen and agreed to minimum monthly purchases of $900,000 of all products in order to obtain new favorable pricing terms. AmerisourceBergen was a creditor of the operating non-debtor subsidiaries and, in connection with the Chapter 11 bankruptcy proceeding, AmerisourceBergen agreed to accept a cash payment of approximately $1.1 million and a promissory note in the amount of approximately $750,000 payable by DHI over a period of five years, using a 15-year amortization schedule and an interest rate of six percent with the last payment being a balloon payment of the outstanding principal and accrued but unpaid interest.

-5-As of November 30, 2006, DHI entered into Amendment No. 1 (“Amendment”) to the supply agreement. The Amendment extends the supply agreement from March 24, 2007 to March 24, 2009. In addition, the Amendment (1) improves the pricing of goods purchased, (2) changes the minimum order volume from $30,000,000 to $50,000,000 over the life of the Agreement and (3) the percentage of generic drug purchases was changed from 2.50% to 6.0%. The Amendment also allows for the return of goods, in a saleable condition, within 180 days of the invoice date without a restocking fee and provides for a termination fee if DHI terminates the supply agreement before the expiration of the term of the agreement. The termination fee is a maximum of $50,000 but is reduced for each full month from December 1, 2006 until the date of termination. However, there is no termination fee if the minimum order volume has been satisfied. At December 31, 2006, DHI believes it has satisfied the minimum order volume.


TableThe Amendment also provides for a rebate in the amount of Contents$150,000 representing a 15.0% volume discount off the price of goods for the first $1,000,000 of net purchases purchased in the period after November 1, 2006 providing that DHI makes net purchases in excess of $1 million after November 1, 2006. In December 2006, DHI satisfied the net purchase requirement and received the $150,000 rebate.


The table below shows the balances of the debt assumed at the time of acquisition and as of December 31, 2005:2006:

 
Balance at
 
Principal
 
Balance at
      
Balance at
 
 
Acquisition
 
Payments
 
December 31, 2005
  
Balance at
 
Principal
 
December 31,
 
        
Acquisition
 
Payments
 
2006
 
Bank of Texas Credit Facility $5,579,000  ($ 1,120,000)$4,459,000 
          
Bank of Texas Credit Facility * $5,579,000 $(1,364,000)$4,215,000 
AmerisourceBergen Note  750,000  (57,000) 693,000   750,000  (92,000) 658,000 
Total debt assumed $6,329,000  ($ 1,177,000)$5,152,000  $6,329,000 $(1,456,000)$4,873,000 

* This facility has been replaced as of February 20, 2007 with a $2,000,000 revolving line of credit and a $2,200,000 term loan from Amegy Bank.

Description of Business

Dougherty’s Pharmacy

Dougherty’s Pharmacy is a turn-key multi-service pharmacy located in a highly prestigious area of Dallas. Centrally located, Dougherty’s continues to provide a level of service not provided by national pharmacy chain stores. We fulfill any prescription need, from the simplest to the most complex compounding prescriptions. Most national pharmacy chains do not provide complex pharmacy prescription services. We specialize in providing solutions for our customers’ pharmacy needs. The company’sDougherty’s long history began in 1929 and continues today as one of Dallas’s oldest, largest and best-known full-service pharmacies, which also include durable medical equipment and its home healthcare and other pharmacy services. We have a customer service oriented philosophy and typically do not attempt to compete solely based on price, as is the case with most of the national pharmacy chains.

-6-



Medicine Man Pharmacies

Medicine Man Pharmacies operates three community pharmacies in a market south of Houston, Texas. Medicine Man Pharmacies started business in 1966, and it focuses on offering patient pharmacy care on a very personalized and individual basis. In addition to filling prescriptions, the Medicine Man Pharmacies also offer specialized Diabetic care departments; services in nutritional and homeopathic treatment, and carry an extensive line of vitamins. Two of the Medicine Man Pharmacies stores contain compounding labs to provide specialization in prescriptions for patients that have needs other than those readily available in manufactured versions. Like Dougherty’s Pharmacy, Medicine Man Pharmacies provide a high level of customer service and solutions for customer’s pharmacy needs that are typically absent in national pharmacy chain stores.

Discontinued Operations - Park InfusionCare

Park InfusionCare is a specialty pharmacy company which specializes in full service home infusion therapy offering full nursing and pharmacy services for home infusion therapies. The infusion therapies include antibiotics, total parenteral nutrition, intravenous immunoglobulin and other intravenous therapies. The primary business referral sources include case managers from hospitals, insurance carriers as well as doctors, home health agencies and nursing homes. Park InfusionCare has three offices located in Dallas, Houston and San Antonio. Park InfusionCare’s business territory includes most of South, Central and East Texas. All three offices have infusion suites located in each office for the convenience of our clientele. The Dallas and San Antonio offices have been in business for over 10 years, whereas the Houston office began operations in January 2003.

On November 3, 2005, the Company issuedAs disclosed in a press release announcing thatCurrent Report on Form 8-K filed on May 24, 2006, the board of directors decided to retain the operations of DHI committed toPark InfusionCare, which had previously been reported as a plan to explorediscontinued operation while the Company was pursuing a potential disposition or strategic alternativestransaction for its infusion therapy business, Park InfusionCare. DHI has retainedbusiness. In connection with the servicesdecision to retain the operations of The Braff Group, a financial advisor, to assist in exploring strategic alternatives for Park InfusionCare. Neither the timing nor the benefits of a strategic transaction for Park InfusionCare, if any, canDHI entered into an employment agreement on May 18, 2006 with Scott R. Holtmyer to be determined at this time, andthe Vice President of its Park InfusionCare infusion therapy business. As a result of the board of director’s decision to retain the operations of Park InfusionCare, the Company can give no assurance that any strategic transaction will occur.

-6-

Tablehas reported the operating results of ContentsPark InfusionCare as part of continuing operations.


Real Estate Advisory Services Segment

CRESA Capital Markets Group, L.P.

In 2002, the Company formed a capital markets subsidiary, CRESA Capital Markets Group, L.P., (“Capital Markets”) and entered into a licensing and co-marketing agreement with CRESA Partners LLC, a national real estate services firm. Jim Leslie, our Chairman, also serves as an advisor to the Board of Directors of CRESA Partners, LLC. Kevin Hayes, Chairman of our consolidated subsidiary CRESA Partners of Orange County, LP, also servesserved as the Chief Executive Officer of CRESA Partners, LLC.LLC from October 2005 to September 2006.

Capital Markets provides real estate financial advisory services and strategic real estate advisory services to corporate clients on a fee basis. These services include, but are not limited to, analysis, consulting, acquisition and/or disposition of property, capital placement and acquisition, contract negotiation, and other matters related to real estate finance. Capital Markets is accounted for as a consolidated entity in our consolidated financial statements.

We own 80% of Capital Markets through our 80% ownership of ASE Investments Corporation (“ASE Investments”) and our 100 %100% ownership of Ascendant CRESA LLC, which is the 0.1% general partner in Capital Markets. ASE Investments owns the 99.9% limited partnership interest of Capital Markets. The remaining 20% of Capital Markets and ASE Investments is owned, directly or indirectly, by Brant Bryan, Cathy Sweeney and David Stringfield, who are principals in Capital Markets and shareholders in the Company.

-7-



Effective September 1, 2005, Capital Markets entered into an advisory services agreement with Fairways Equities (see below for more details on Fairways Equities) whereby Fairways Equities will provide all of the professional and administrative services required by Capital Markets. In exchange, Capital Markets will pay Fairways Equities an administrative fee of 25% of gross revenues and a compensation fee of 40% of gross revenues, as compensation to the principals working on the transaction that generated the corresponding revenues. Under the terms of the agreement, Fairways Equities assumed all of the administrative expenses, including payroll, of CRESA Capital Markets. Fairways Equities will only receive payments under the agreement if its principals close a real estate capital markets advisory transaction that generates revenue for Capital Markets. The impact of this agreement on Capital Markets is that it will have no administrative expenses or cash requirements unless it closes a revenue generating transaction. The principals in Capital Markets are also the four members of Fairways Equities. During the yearyears ended December 31, 2006 and 2005, Capital Markets paid approximately $262,000 and $233,000, respectively of compensation fees to Fairways Equities under the advisory services agreement.

CRESA Partners of Orange County, L.P.

Description of Acquisition

Effective May 1, 2004, we acquired through ASDS of Orange County, Inc. (“ASDS”) all of the issued and outstanding stock of CRESA Partners of Orange County, Inc., a California corporation f/k/a The Staubach Company - West, Inc. (“CPOC”), pursuant to the Stock Purchase Agreement dated March 23, 2004 between Kevin Hayes, the sole stockholder of CPOC (the “Seller”), and ASDS for $6.9 million, plus closing costs. CPOC is located in Newport Beach, California and provides tenant representation services to commercial and industrial users of real estate, which include strategic real estate advisory services, lease management services, facility and site acquisition and disposition advice; design, construction and development consulting; and move coordination.

Pursuant to the terms of the Stock Purchase Agreement, the purchase price was paid pursuant to the terms of a $6.9 million promissory note (the “Acquisition Note”) payable to the Seller. The Acquisition Note iswas secured by a pledge of all of the personal property of CPOC, bears interest payable monthly at the prime rate of Northern Trust Bank plus 0.50% per annum, with principal generally payable quarterly in arrears over a three year period from the excess cash flow of ASDS, as defined, and iswas guaranteed by the Company. The then outstanding principal balance of the Acquisition Note iswas payable in full on May 1, 2007.

2006.
-7-

In June 2006, ASDS entered into a credit agreement with First Republic Bank for a $5.3 million term note and CPOC entered into a $500,000 revolving line of credit. The term note is being guaranteed by CPOC. The term note and revolving line of credit are also being personally guaranteed, subject to certain limits, by certain officers and minority limited partners of CPOC. The proceeds from the term note were used to retire the outstanding balance owed to Kevin Hayes under the Acquisition Note. The Acquisition Note was retired at a discount of approximately $100,000 to its outstanding principal balance of $ 5,400,000. Please see Note 10 of the Ascendant Consolidated Financial Statements contained herein.

The purchase price iswas subject to adjustment downward (by an amount not to exceed $1.9 million) to reflect the operating results of CPOC during the four year period ending December 31, 2007 if CPOC’s revenues are less than an aggregate of $34.0 million during such period. From the date of acquisition on May 1, 2004 through December 31, 2005,2006, CPOC’s cumulative revenues were $22,034,000.$35,565,000. As a result, there will be no adjustment to the purchase price.

Following the acquisition of CPOC, ASDS contributed the assets and liabilities of CPOC to CRESA Partners of Orange County, LP (the “Operating LP”) that is owned jointly by (i) CRESA Partners-Hayes, Inc., a California corporation f/k/a The Staubach Company of California, Inc. that is the general partner of the Operating LP (the “General Partner”), (ii) ASDS, a limited partner of the Operating LP, (iii) the Seller, a limited partner of the Operating LP, and (iv) a Delaware limited liability company controlled by the management and key employees of CPOC that is a limited partner of the Operating LP (the “MGMT LLC”).

-8-



The General Partner is controlled by the management and key employees of CPOC. ASDS is entitled to receive 99% of the profits of the Operating LP until such time as ASDS has received cumulative distributions from the Operating LP equal to the Purchase Price plus a preferential return of approximately $1.7 million (total distributions equal to $8.6 million), at which time the allocation of the profits of the Operating LP shall become: 79.9% to MGMT LLC, 10% to ASDS, 10% to the Seller and 0.1% to the General Partner.

The following is a summary of distributions received by ASDS from the Operating LP and the use of those distributions:

     
Acquisition
   
 
Year Ended
 
Year Ended
 
Date to
   
 
December 31,
 
December 31,
 
December 31,
 
Total
 
 
Year Ended December 31, 2005
 
Acquisition Date to December 31, 2004
 
Total Distributions
  
2006
 
2005
 
2004
 
Distributions
 
                    
Interest payments on Acquisition Note $480,000 $211,000 $691,000  $201,000 $480,000 $211,000 $892,000 
Principal payments on Acquisition Note  718,000  - $718,000   6,082,000  718,000  -  6,800,000 
Proceeds from First Republic Bank note  (5,300,000) -  -  (5,300,000)
Interest payments on First Republic Bank note  223,000  -  -  223,000 
Principal payments on First Republic Bank note  900,000  -  -  900,000 
Total distributions received $1,198,000 $211,000 $1,409,000  $2,106,000 $1,198,000 $211,000 $3,515,000 

The table below shows the balances of the debt assumed at the time of acquisition and as of December 31, 2005:2006:

 
Balance at
 
Principal
 
Balance at
  
Balance at
 
Proceeds from
 
Principal
 
Principal
 
December 31,
 
 
Acquisition
 
Payments
 
December 31, 2005
  
Acquisition
 
Notes Payable
 
Payments
 
Discount
 
2006
 
                  
Acquisition Note $6,900,000  ($ 718,000)$6,182,000  $6,900,000 $- $(6,800,000)$(100,000)$- 
First Republic Bank term note  - 5,300,000 (900,000) - 4,400,000 
Line of credit & note payable to related party  1,000,000  (1,000,000) -   1,000,000  -  (1,000,000) -  - 
Total debt assumed $7,900,000  ($ 1,718,000)$6,182,000  $7,900,000 $5,300,000 $(8,700,000)$(100,000)$4,400,000 

In connection with the acquisition of CPOC, the Company was entitled to receive a structuring fee of $690,000, plus interest thereon, of which $230,000 was paid at closing and $230,000 was paid on May 1, 2005. The remainder of $230,000, plus interest thereon is payablewas paid on May 1, 2006. The structuring fee has been eliminated in the consolidation of the Company with CPOC and the Operating LP in the consolidated financial statements of the Company.

The results of operations of the Operating LP will be consolidated with ASDS and ultimately the Company, in accordance with FIN 46R “Consolidation of Variable Interest Entities”, until such time that ASDS has received cumulative distributions equal to the Purchase Price plus a preferential return of approximately $1.7 million (total distributions of $8.6 million). When and if the total distributions equal to $8.6 million are fully paid, our residual interest will become 10% and the principles of consolidation for financial reporting purposes will no longer be satisfied under FIN 46R or APB 18, “Equity Method for Investments in Common Stock”. Accordingly, we would no longer consolidate the results of operations of the Operating LP and we would instead record our share of income from the Operating LP as “Investment Income” in our consolidated statementstatements of operations.income.

-8-



Description of Business

CPOC provides performance based corporate real estate advisory services to corporate clients around the United States. CPOC specializes in reducing corporate costs through deployment of seasoned professionals with proven expertise in a broad range of integrated real estate services.

-9-



CPOC provides real estate services such as:

Strategic Planning - includes defining corporate goals, analysis of market and trends, demographic and labor studies, operating expense audits and formulation of strategic options
Tenant Representation - management of tenant lease acquisitions and renewals, building purchases, and negotiations on behalf of tenant clients
Business and Economic Incentives - includes identification of incentive opportunities, cost/benefit analysis, negotiation of incentives, documentation and implementation of incentive strategies and ongoing administration of incentive packages
Compliance Audits- operating expense and lease compliance audits designed to minimize tenant costs that are not in compliance with negotiated lease terms
Project Management - management of various projects including building evaluation, space use plans, architect selection, development management and cost forecasts
Financing & Capital Markets - advisory services related to sale/leaseback transactions, purchase financing, real estate debt restructuring and real estate debt sourcing
Lease Portfolio Management - provides systems to manage client lease transactions and real estate portfolios including information tracking, workflow management, document management and portfolio reporting

CPOC competes on a local and national level with other real estate services firms that provide similar services, including Trammell Crow, Cushman & Wakefield, CB Richard Ellis, Voit Commercial, Grubb & Ellis and Lee & Associates.

The table below summarizes CPOC’s transaction activity for the years ended December 31, 2006, December 31, 2005 and for the period from the date of acquisition on May 1, 2004 to December 31, 2004 and for the year ended December 31, 2005:2004:

 
Year Ended
 
Year Ended
 
Acquisition Date
 
 
December 31, 2006
 
December 31, 2005
 
to December 31, 2004
 
   
Approximate
   
Approximate
   
Approximate
 
Year Ended December 31, 2005
 
Acquisition Date to December 31, 2004
 
No. of
 
Transaction
 
No. of
 
Transaction
 
No. of
 
Transaction
 
No. of Transactions
Approximate Transaction Value
 
No. of Transactions
Approximate Transaction Value
 
Transactions
 
Value
 
Transactions
 
Value
 
Transactions
 
Value
 
Revenue $13,176,000  $8,858,000   $13,531,000  $13,176,000  $8,858,000 
Lease transactions229$432 million 200$335 million  229 $333 million 229 $432 million 200 $335 million 
Real estate sales transactions10$44 million 7$25 million  7 $10 million 10 $44 million 7 $25 million 
Project management transactions50$79 million 60$45 million  71 $85 million 50 $79 million 60 $45 million 

In March 2006, CPOC purchased a minority interest of approximately 2.7% in CRESA Partners, LLC, a national real estate services firm. The amount paid for this investment was $160,000 and is accounted for under the cost method of accounting for investments. CPOC is a licensee of CRESA Partners, LLC. Jim Leslie, the Company’s Chairman, serves as an advisor to the Board of Directors of CRESA Partners, LLC and Kevin Hayes, Chairman of CPOC, served as the Chief Executive Officer of CRESA Partners, LLC from October 2005 to September 2006.
 
Corporate and Other Segment

Our Corporate and Other Segment includes our corporate and administrative activities as well as other investments that are not included in the Healthcare or Real estate advisory servicesEstate Advisory Services segments. Our corporate and administrative activities include finance and accounting, insurance and risk management, review of investment opportunities and other advisory services to our subsidiaries and affiliates. We receive a management fee from certain of our subsidiaries in exchange for these services.

-10-



During the yearyears ended December 31, 2006 and 2005, we received approximately $343,000 and $315,000, respectively, of management fees which have been eliminated in the consolidated financial statements contained herein. We also receive periodic dividends or interest payments from one of our subsidiaries, which amounted to $112,000 in each of the years ended December 31, 2006 and 2005, andrespectively which have also been eliminated in consolidation.

Other investments which are not included in the Healthcare or Real estate advisory services segments are described below.

-9-



Ampco Partners, Ltd.

In 2002, we invested $400,000 for a 10% limited partnership interest in Ampco Partners, Ltd. (“Ampco”), a newly formed entity, which acquired the assets and intellectual property of the Ampco Safety Tools division of Ampco Metals Incorporated of Milwaukee, Wisconsin in a Chapter 11 bankruptcy proceeding. Ampco Safety Tools, founded in 1922, is a leading manufacturer of non-sparking, non-magnetic and corrosion resistant safety tools. These tools are designed to meet Occupational Safety and Health Administration and National Fire Protection Association requirements for use in locations where flammable vapors of combustible residues are present. Safety tools are used in industrial applications, primarily in manufacturing and maintenance operations. We receive quarterly distributions based upon 10% of Ampco’s reported quarterly earnings before interest, taxes, depreciation and amortization expense, or EBITDA. Our investment in Ampco is accounted for under the equity method. We recognize our proportionate share of Ampco’s net income, as “Equity in income (losses) of equity method investees” in the consolidated statements of operations.income. If we receive distributions in excess of our equity in earnings, they are accounted for as a reduction of our investment in Ampco.

In June 2006, the Company entered into a term loan agreement with Ampco for a $500,000 demand note. The proceeds from the demand note were used for general working capital purposes. The demand note bears interest at the prime rate plus 4.00% per annum.  The Company’s quarterly partnership cash distributions from Ampco are being, and will continue to be, applied to the interest and principal balances owed on the demand note. The remaining outstanding balance of the demand note is due on the earlier of demand or June 13, 2009. The demand note is secured by the Company’s limited partnership interest in Ampco

Our distributions from Ampco for the years ending December 31 are as follows, and management is not aware of any factors that would materially change such distributions going forward:follows:

 
2006
 
2005
 
2004
 
 
2005
 
2004
 
2003
        
Equity in income (losses) of equity method investees $100,000 $82,000 $66,000  $96,000 $100,000 $82,000 
Return of capital  14,000  29,000  46,000   48,000  14,000  29,000 
          
Payments on demand note  (60,000) -  - 
Total distributions received $114,000 $111,000 $112,000  $84,000 $114,000 $111,000 

Fairways Equities, LLC

During the fourth quarter of 2003, we entered into a participation agreement (the “Participation Agreement”) with Fairways Equities LLC (“Fairways”), an entity controlled by Jim Leslie, our Chairman, and Brant Bryan, Cathy Sweeney and David Stringfield who are principals of Capital Markets and shareholders of the Company (“Fairways Members”), pursuant to which we will receive up to 20% of the profits realized by Fairways in connection with certain real estate acquisitions made by Fairways. Additionally, we will have an opportunity, but not the obligation, to invest in the transactions undertaken by Fairways, through our 80% owned subsidiary, ASE Investments. Our profit participation with Fairways iswas subject to modification or termination by Fairways at the end of 2005 in the event that the aggregate level of cash flow (as defined in the Participation Agreement) generated by our acquired operating entities hasdid not reachedreach $2 million for the twelve months ended December 31, 2005. For the twelve months ended December 31, 2005, the Company did not meet this cash flow requirement andrequirement: however, there has been no action taken by the Fairways Members to terminate the Participation Agreement.

-11-



The Company is currently negotiating with the Fairways Members to modify the Participation Agreement, however, there can be no assurances that a mutually acceptable modification can be reached. We are unable to determine what real estate Fairways may acquire or the cost, type, location, or other specifics about such real estate. There can be no assurances that we will be able to generate the required cash flow to continue in the Participation Agreement after 2005,2006, or that Fairways will be able to acquire additional real estate assets, that we will choose to invest in such real estate acquisitions or that there will be profits realized by such real estate investments. We do not have an investment in Fairways, but rather a profits interest through our Participation Agreement.

Fairways 03 New Jersey, LP

During December 2003, we made a capital contribution of $145,000 to Fairways 03 New Jersey, LP (“Fairways NJ”) which, through a partnership with an institutional investor, acquired the stock of a company whose sole asset was a single tenant office building and entered into a long-term credit tenant lease with the former owner of the building.

-10-


In December 2003, subsequent to the closing of this transaction, our capital contribution of $145,000 was distributed back to us. The Company received a distribution of approximately $680,000 on December 30, 2005 from Fairways NJ, which represented the Company’s share in the profit from the sale of a single tenant commercial real estate property interest, the sole asset held by Fairways NJ. In addition to the distribution, cash of $162,000, representing the Company’s share of the total escrow, iswas being held in escrow to fund any amounts owed by Fairways NJ to the purchaser, including any amounts owed for standardthe representations &and warranties made under the sale agreement. The balance of the escrow account if any, is expected to bewas released in December 2006. Since the date of the property interest acquisition, the Company has received cumulative cash distributions of approximately $1,280,000$1,448,000 on its initial investment of $145,000 in Fairways NJ.

Fairways 36864, LP

In April 2004, we invested approximately $97,000 through ASE Investments for a 24.75% interest in Fairways 36864, LP, (whose other partners also included the Fairways Members) that participated in the development of and leaseback of single tenant commercial properties. In August and October 2004 these properties were sold and we recognized investment income of $84,000 in addition to the return of our original investment of $97,000.

Fairways Frisco, LP

On December 31, 2004, Fairways Frisco, L.P. (Fairways Frisco)(“Fairways Frisco”) acquired certain indirect interests in various partnerships (the “Frisco Square Partnerships”) that own properties (the “Properties”) in the Frisco Square mixed-use real estate development in Frisco, Texas, pursuant to a Master Agreement Regarding Frisco Square Partnerships (“Master Agreement”).Texas. Frisco Square is planned to include approximately 4 million developed square feet, including retail, offices, hotel, multi-family residences and municipal space.

The parties toUnder the Master Agreement wereterms of the amended Frisco Square Partnerships agreements, Fairways Group,Equities is the sole general partner of the Frisco Square Partnerships Cole and Mary Pat McDowell,controls all operating activities, financing activities and development activities for the remainder of the Five Star Group which is Five Star Development Co., Inc., a Texas corporation, CMP Management, LLC, a Texas limited liability company, and CMP Family Limited Partnership, a Texas limited partnership. "Frisco Square Partnerships" is a group of entities comprised of Frisco Square Ltd. ("FSLTD"), Frisco Square B1-6 F1-11, Ltd., a Texas limited partnership, Frisco Square B1-7 F1-10, Ltd., a Texas limited partnership, and Frisco Square Properties, Ltd., a Texas limited partnership. "Fairways Group" is a group of entities comprised of Fairways Frisco, Fairways B1-6 F1-11, LLC, a Texas limited liability company, Fairways B1-7 F1-10, LLC, a Texas limited liability company, and Fairways FS Properties, LLC, a Texas limited liability company.Partnerships.

As further described herein, the Company holds a limited partnership interest in Fairways Frisco. The Company is not involved in the development or management of Frisco Square,Square; rather it is solely a limited partner. The Company has invested $1,219,000 of cash into Fairways Frisco and holds a 14% limited partnership interest as of December 31, 2005. The Company was the initial contributing limited partner to Fairways Frisco and thus initially owned more than its current 14% limited partnership interest. However, as additional limited partners have made contributions, the Company’s interest has declined.2006. The Company has made no additional capital contributions subsequent to December 31, 2005. However, Fairways Frisco made two capital calls in 2006, which were not funded by the Company and thus diluted the Company’s limited partnership interest from 14% at December 31, 2005 to approximately 8.87% as of December 31, 2006. As of April 7, 2007, the general partner of the Frisco Square Partnerships indicated that they would be making a capital call of the limited partners in the amount of $4 million, the exact terms of which are currently being negotiated. The Company will not participate in this capital call. If this capital call is fully funded, the Company‘s limited partnership interest will be reduced.  



Fairways Frisco is expected to request additional capital contributions from the limited partners. At present, the Company does not intend to fund any additional capital requested from Fairways Frisco. The Company expects its limited partnership interest will be reduced further as additional limited partner contributions are received and the Company does not fund its limited partnership share of such capital contributions into Fairways Frisco. As of December 31, 2006, Fairways Frisco madeowned, either directly or indirectly, 60% of the Frisco Square Partnerships and the remaining 40% is owned by CMP Family Limited Partnership (“CMP”), which is controlled by Cole McDowell. Under the terms of the amended Frisco Square Partnerships, Fairways Frisco also has a capital call for $1.9first priority distribution preference of $5.5 million, in February 2006, which was not funded by the Company and thusit will dilute the Company’s limitedreceive its pro-rata partnership interest to approximately 11%.

-11-

Table of Contentsthe next $9.5 million of distributions from the Frisco Square Partnerships.


The table below summarizes the Frisco Square property partnerships as of December 31, 20052006 and their respective appraised values and bank debt outstanding (the appraisals were performed by an independent third-party appraiser):

   (In millions)   (In millions) 
Frisco Square Partnerships
 
Property
 
Appraised Value
 
Bank Debt
 
Net Appraised Value
 
Property
 
 Appraised Value
 
Bank Debt
 
Net Appraised Value
 
                  
Frisco Square B1-6 F1-11, Ltd. 155,000 sf apartments/retail $ 20.4 $ 17.5 $ 2.9 155,000 sf apartments/retail$22.0 $17.3 $4.7
Frisco Square B1-7 F1-10, Ltd. 61,400 sf office/retail 15.6 8.9 6.7 61,400 sf office/retail 15.1 8.9 6.3
Frisco Square Properties, Ltd. 2.1 acres/undeveloped lots 3.2 2.7 0.5 2.1 acres/undeveloped lots 3.3 2.0 1.3
Frisco Square Land, Ltd. 48.7 acres/undeveloped land 49.7 22.0 27.7 48.7 acres/undeveloped land 49.9  26.6 23.2
                
Total
   
$ 88.9
 
$ 51.1
 
$ 37.8
  
$
90.3
 
$
54.8
 
$35.5

Fairways Frisco’s share of the Net Appraised Valuenet appraised value in the table above would be approximately $29.4$30.9 million based upon the distribution terms and preferences in the Frisco Square Partnerships partnership agreements. The Company’s share of this amount would be approximately $4.0$2.5 million based on its ownership of 14%8.87% of the limited partnership interests at December 31, 2005, which would be reduced to approximately $3.3 million as a result of the February 2006 capital call which was not funded by the Company.  2006. The Net Appraised Valuenet appraised value in the table above is based on an appraisal performed by an independent third party which is provided annually to its partners by the Frisco Square Partnerships pursuant to their partnership agreements. There can be no assurance that the real property held by the Frisco Square Partnerships could be sold at the Net Appraised Value.net appraised value. The marketability and value of each property will depend upon many factors beyond our control and beyond the control of the Frisco Square Partnerships. Since investments in real property are generally illiquid, there is no assurance that there will be a market for the Frisco Square Partnerships properties. Furthermore, ourthe Company’s partnership interest in Fairways Frisco is illiquid and represents a minority interest in Fairways Frisco, which may or may not be valued according to the liquidation value of the Frisco Square Partnerships.

On April 15, 2005, the parties to the Master Agreement agreed to terminate the Master Agreement effective as of April 15, 2005. In connection with the termination of the Master Agreement,Any additional financing obtained by the Frisco Square Partnerships were amended such that Fairways Frisco owns, either directly or indirectly, 60% ofwill, in all likelihood, further dilute the Frisco Square Partnerships. The remaining 40% is owned by CMP Family Limited Partnership (“CMP”), which is controlled by Cole McDowell. CMP’s partnership interest is subject to further reduction and dilution as discussed below. Under the terms of the amended Frisco Square Partnerships, Fairways Frisco also has a first priority distribution preference of $5.5 million, and it will receive its pro-rata partnership interest of the next $9.5 million of distributions from the Frisco Square Partnerships. After $15 million of distributions have been made, Fairways Frisco’sCompany’s interest in the Cash Flow of the Frisco Square Partnerships, as defined in the partnership agreements, will become 80% and CMP’s interest will become 20%.

Furthermore, Fairways Frisco’s partnership interest in the Frisco Square Partnerships may be increased up to 85% if certain capital call and limited partner capital loan provisions are not met by CMP. If Fairways Frisco’s partnership interest in the Frisco Square Partnerships is increased in the future, the Company’s indirect interest in the Frisco Square Partnerships would also increase on a pro-rata basis with its investment in Fairways Frisco. During the year ended December 31, 2005, CMP met the capital loan provisions by providing a $400,000 cash loan as required under the partnership agreement. Subsequent to December 31, 2005, an additional $400,000 capital loan request due from CMP was funded as required.Accordingly, Fairways Frisco’s partnership interest remains at 60%.

Under the terms of the amended Frisco Square Partnerships agreements, Fairways Equities, LLC ("FEL") is now the sole general partner of the Frisco Square Partnerships and controls all operating activities, financing activities and development activities for the Frisco Square Partnerships.



Also on April 15, 2005, Fairways Frisco, through Frisco Square Land, Ltd., a newly created partnership, closed a financing transaction, the proceeds of which were used to repay the outstanding bank debt of Frisco Square, Ltd and to provide additional working capital for Fairways Frisco. Under the terms of the now terminated Master Agreement, Fairways Frisco held an option to acquire 50% of the partnership interests of Frisco Square, Ltd. Concurrently with the financing, all of the land and related development held by Frisco Square, Ltd. was transferred to Frisco Square Land, Ltd. in exchange for repayment of the bank debt, and the option to acquire 50% of the partnership interests of Frisco Square, Ltd. was cancelled. As a result of these changes, Fairways Frisco now has no interest in Frisco Square, Ltd. Fairways Frisco owns 60% of Frisco Square Land, Ltd., subject to the same increases for preference distributions and dilution to CMP if certain capital call and limited partner capital loan provisions are not met by CMP as discussed above.

The Company has not guaranteed any of the debt of the Frisco Square Partnerships or Fairways Frisco, L.P. The Company is not involved with any management, financing or other operating activities of the Frisco Square Partnerships or Fairways Frisco. However, in May 2005, the Company entered into an agreement with FEL,Fairways Equities, pursuant to which the Company is entitled to receive 25% of the fees paid to FELFairways Equities pursuant to the Fairways Frisco partnership agreement. These fees, including a monthly management fee, represent compensation to the Company for supplying resources to execute the initial transaction with the Frisco Square Partnerships in December 2004. During the yearyears ended December 31, 2006 and 2005, the Company received fees allocated from FELFairways Equities of $28,000 and $64,000, respectively under this agreement. Fairways Frisco is currently negotiating with lenders to modify or extend certain bank loans which are reflected as current liabilities at December 31, 2006.

On April 6, 2006, CMP delivered an offer to the Fairways Group to purchase 100%-13-



Please see Note 2 of the Fairways Group’s interests, pursuant to the buy/sell provisions of the various partnership agreements. The offer of $79 million, before repayment of the Fairways Group’s debts, requires the Fairways Group to respond within 60 days to the offer, electing to either accept the offer, or to buy CMP’s interests based on the same valuation. Once the Fairways Group responds, the selected buyer (either the Fairways Group or CMP) will be required to close the purchase of the other partner interest within 60 days. Pursuant to the partnership agreements, financing of the purchase may be structured with a 20% cash paymentAscendant Consolidated Financial Statements contained herein and the balance payable in four equal installments annually, with interest ataudited consolidated financial statements of Fairways Frisco, L.P. and Subsidiaries for the prime rate plus 2% payable quarterly. As of the date of this report, the Fairways Group had not responded to CMP’s offer.  The Company is not a direct party to the buy/sell provisions described above.  However, the Company’s aggregate share of this offer amount would be approximately $2.3 million over four years assuming distribution of the sale proceeds based on its ownership of 11% of the limited partnership interests subsequent to the Februaryended December 31, 2006 capital call which the Company did not fund.and 2005 filed hereto as Exhibit 99.8.

Employees

We had the following full time and part-time employees as of December 31, 2005:2006:

Business Segment
Employees
Healthcare155130
Real estate advisory services2223
Corporate and other32
Total Employees180155

In addition to our own employees, we use from time to time, and are dependent upon, various outside consultants or contractors to perform various support services including, legal and accounting. The total Healthcare segment employees above include 59 employees of Park InfusionCare, which is reported by the Company as a discontinued operation.accounting services.

Available Information

We are a reporting company under the Exchange Act and file annual, quarterly and special reports, proxy statements and other information with the United States Securities and Exchange Commission. We make our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports available on or through our website (www.ascendantsolutions.com), free of charge, as soon as reasonably practicable after we have electronically filed or furnished such materials to the Securities and Exchange Commission. These filings are also available on the Securities and Exchange Commission's web site at www.sec.gov. In addition, you may read and copy any documents we file at the Securities and Exchange Commission’s public reference room at 450 Fifth100 F Street, N.W.N.E., Washington, D.C. 20549, and at the regional offices of the Securities and Exchange Commission located at 233 Broadway, New York, New York 10279, and at 175 West Jackson Blvd., Suite 900, Chicago, Illinois 60604. You may obtain information on the operation of the Securities and Exchange Commission’s public reference room in Washington, D.C. by calling the Securities and Exchange Commission at 1-800-SEC-0330.



ITEMITEM 1A. RISKS RELATED TO OUR BUSINESSRISK FACTORS

We have limited funds and may require additional financing.  

We have very limited funds, and such funds may not be adequate to take advantage of available business opportunities or fund the ones that we have acquired. Our ultimate success may depend upon our ability to raise additional capital. We have not investigated the availability, source, or terms that might govern the acquisition of additional capital and will not do so until we determine a more definitive and specific need for additional financing. Our access to capital is more limited since our stock is no longer traded on the NASDAQ National Market, since there is limited trading activity in our stock, since we incurred significant debt as a result of our acquisitions in 2004, and since we expect to incur additional debt in order to acquire entities in the future. In addition, one of our subsidiaries has committed to use commercially reasonable efforts to replace the loan facilities associated with the acquisition of the Park Assets, which could impair our ability to locate capital for other needs. If additional capital is needed, there is no assurance that funds will be available from any source or, if available, that they can be obtained on terms acceptable to us. If not available, our operations will be limited to those that can be financed with our existing capital.  

We own subsidiaries that are highly leveraged.

Our subsidiaries are highly leveraged and, as a holding company, we depend on our subsidiaries’ revenues and cash flows to meet our obligations. Due to the high leverage, the availability of funds from these subsidiaries may be limited by contractual restrictions. Additionally, the degree to which our subsidiaries are leveraged has important consequences, including, but not limited to, the reduction in cash flow available to us for our operations and for future acquisitions, increased vulnerability to changes in economic conditions and the impairment of our ability to obtain additional financing for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes.

We may not be able to effectively integrate and manage our operating subsidiaries.

Our failure to effectively manage our recent and anticipated future growth could strain our management infrastructure and other resources and adversely affect our results of operations. We expect our recent and anticipated future growth to present management, infrastructure, systems, and other operating issues and challenges. These issues include controlling expenses, retention of employees, the diversion of management attention, the development and application of consistent internal controls and reporting processes, the integration and management of a geographically diverse group of employees, and the monitoring of third parties.

Any change in management may make it more difficult to integrate an acquired business with our existing operations. Any failure to address these issues at a pace consistent with our business could cause inefficiencies, additional operating expenses and inherent risks and financial reporting difficulties.

We are dependent upon management.

We currently have two individuals who are serving as management, including our President and CEO, and our Interim Chief Financial Officer. We are heavily dependent upon our management’s skills, talents and abilities to implement our business plan. Because investors will not be able to evaluate the merits of possible business acquisitions by us, they should critically assess the information concerning our management and Board of Directors. In addition to our own employees, we use from time to time and are dependent upon, various consultants or contractors to perform various support services including, legal and accounting.

We are dependent on a small staff to execute our business plan.

Because of the limited size of our staff, each acquisition becomes more difficult to integrate. Furthermore, it is difficult to maintain a complete segregation of duties related to the authorization, recording, processing and reporting of all transactions. In addition, our strategy of acquiring operating businesses will require our management and other personnel to devote significant amounts of time to integrating the acquired businesses with our existing operations. These efforts may temporarily distract their attention from day-to-day business and other business opportunities.



Certain of our subsidiaries account for a significant percentage of our revenues.

In 2005,2006, DHI accounted for approximately 68%74.1% of our revenue. In the future, one or more of our subsidiaries may continue to account for a significant percentage of our revenue. The reliance on any of these subsidiaries for a significant percentage of our revenue and their subsequent failure could negatively affect our results of operations.

Unforeseen costs associated with the acquisition of new businesses could reduce our profitability.

We have implemented our business strategy and made acquisitions of new businesses that may not prove to be successful. We now own an interest in six businesses, operating in different industries and we do not have experience in some of these areas. It is likely that we will encounter unanticipated difficulties and expenditures relating to our acquired businesses, including contingent liabilities, or needs for significant management attention that would otherwise be devoted to our other businesses. These costs may negatively affect our results of operations. Unforeseen costs at our recently acquired and to be acquired businesses, which have significant liabilities and commitments, could result in the inability to make required payments on indebtedness, which could result in a loss of our investments in these companies and, in the case of CPOC, require us to make payments under our guaranty.companies.

We may enter into additional leveraged transactions in connection with an acquisition opportunity.

Based on our current cash position, it is likely that if we enter into any additional acquisitions, such acquisitions will be leveraged, i.e., we may finance the acquisition of the business opportunity by borrowing against the assets of the business opportunity to be acquired, or against the projected future revenues or profits of the business opportunity. This could increase our exposure to larger losses. A business opportunity acquired through a leveraged transaction is profitable only if it generates enough revenues to cover the related debt and expenses. Failure to make payments on the debt incurred to purchase the business opportunity could result in the loss of a portion or all of the assets acquired. There is no assurance that any business opportunity acquired through a leveraged transaction will generate sufficient revenues to cover the related debt and expenses.

We are restricted on our use of net operating loss carryforwards.

At December 31, 2005,2006, we had accumulated approximately $51 million of federal net operating loss carryforwards and approximately $21$2.9 million of state net operating loss carryforwards, which may be used to offset taxable income and reduce income taxes in future years. The use of these losses to reduce future income taxes will depend on the generation of sufficient taxable income prior to the expiration of the net operating loss carryforwards.

The federal net operating loss carryforwards, if not fully utilized, will expire from 2018 to 2024.2024 and the state net operating loss carryforwards will expire from 2007 to 2009. Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”) imposes an annual limitation on the portion of our federal net operating loss carryforwards that may be used to offset taxable income. We believe that the issuance of shares of common stock pursuant to the initial public offering on November 15, 1999 caused an “ownership change” for purposes of Section 382 of the Code on such date. Consequently, we believe that utilization of the portion of our federal net operating loss carryforwards attributable to the period prior to November 16, 1999 is limited by Section 382 of the Code. The date of an “ownership change” is based upon a factual determination of the value of our stock on such date. If the “ownership change” was determined to have occurred at a date after November 15, 1999, additional federal net operating loss carryforwards would be limited by Section 382 of the Code. In addition, a second “ownership change” may occur in the future as a result of future changes in the ownership of our stock, including our issuance of stock in connection with our acquisition of a business. A second “ownership change” would result in Code Section 382 limiting our deduction of our future federal net operating loss carryforwards.

Our results of operations are difficult to predict.

Although we generated net income of $1,023,000, $65,000 and $249,000 for the years ended December 31, 2006, 2005 and 2004 respectively, we have historically incurred net operating losses. The Company experienced net losses of approximately $818,000 and $728,000 for the years ended December 31, 2003 and 2002, respectively. There can be no assurance that we will continue to achieve profitability in the future.



RISKS SPECIFIC TO OUR OPERATING SUBSIDIARIES

Dougherty’s Holdings, Inc.

We may not be able to enter into a successful transaction to sell or otherwise dispose ofsuccessfully operate our Park InfusionCare business.

On November 3, 2005, we issued a press release announcing that the board of directors of DHI committed to a plan to explore strategic alternatives for its infusion therapy business, Park InfusionCare. DHI has retainedOn May 24, 2006, the servicesboard of The Braff Groupdirectors decided to assist in exploring strategic alternatives forretain the operations of Park InfusionCare. Neither the timing nor the benefits of a strategic transaction for

The infusion markets served by Park InfusionCare if any, can be determined at this time,are highly competitive. Local, regional and national companies are currently competing in these markets and others may do so in the Company can give no assurancefuture. Some of our competitors have greater financial, technical, marketing and managerial resources than we have. This competition could result in price competition and other competitive factors that any strategic transaction will occur.could cause a decline in our revenue and profitability. We expect to continue to encounter competition in the future that could limit our ability to grow revenue and/or maintain acceptable pricing levels. In addition, the Park InfusionCare business may require additional working capital. If we are unable to successfully complete a sale ofoperate Park InfusionCare, our working capital position will be adversely affected.affected and we could experience a decline in our revenue and profitability.

Our pharmacy subsidiary is subject to extensive regulation.

Our pharmacists and pharmacies are required to be licensed by the Texas State Board of Pharmacy. The pharmacies are also registered with the federal Drug Enforcement Administration. By virtue of these license and registration requirements, the entities owned by DHI are obligated to observe certain rules and regulations, and a violation of such rules and regulations could result in fines and/or in a suspension or revocation of a license or registration. We believe that the operating entities owned by DHI currently have all the regulatory approvals necessary to conduct its business. However, we can give no assurance that they will be able to maintain compliance with existing regulations.

In recent years, an increasing number of legislative proposals have been introduced or proposed in Congress and in some state legislatures that would effect major changes in the health care system, either nationally or at the state level. We cannot predict whether any federal or state health care reform legislation will eventually be passed, and if so, the impact thereof on DHI’s financial position or results of operations. Health care reform, if implemented, could adversely affect the pricing of prescription drugs or the amount of reimbursement from governmental agencies and managed care payors, and consequently could be adverse to DHI and therefore, to us. However, to the extent health care reform expands the number of persons receiving health care benefits covering the purchase of prescription drugs, it may also result in increased purchases of such drugs and could thereby have a favorable impact on both DHI and the drug industry in general. Nevertheless, there can be no assurance that any future federal or state health care reform legislation will not adversely affect us, including our subsidiary DHI, or the retail drugstore industry generally.

In addition, a portion of DHI revenue is derived from high-end, technical pharmacy services, such as compounded prescriptions, intravenous infusion, injectables and pain management products that are not typically offered by chain drug stores, grocery pharmacies or mass merchandise pharmacies. Recently, there has been some controversy about the lack of federal regulation of these services. Additional federal and/or state regulations could also affect our business by putting additional burdens on us.

If we do not adequately respond to competitive pressures, demand for our products and services could decrease.

Our retail pharmacies operate in a highly competitive industry. The markets we serve are subject to relatively few barriers to entry. These pharmacies compete primarily on the basis of customer service, convenience of location and store design, price and product mix and selection. Some of our competitors have greater financial, technical, marketing and managerial resources than we have. Local, regional and national companies are currently competing in many of the health care markets we serve and others may do so in the future. In addition to traditional competition from independent pharmacies and other pharmacy chains, our pharmacies face competition from



discount stores, supermarkets, combination food and drugstores, mail order distributors, hospitals and HMO’s. These other formats have experienced significant growth in their market share of the prescription and over-the-counter drug business. Consolidation among our competitors, such as pharmacy benefit managers (PBM’s) and regional and national infusion pharmacy or specialty pharmacy providers could result in price competition and other competitive factors that could cause a decline in our revenue and profitability.


We expect to continue to encounter competition in the future that could limit our ability to grow revenue and/or maintain acceptable pricing levels.

Risk related to third party payors.

DHI’s revenues and profitability are affected by the continuing efforts of all third-party payors to contain or reduce the costs of health care by lowering reimbursement rates, narrowing the scope of covered services, increasing case management review of services and negotiating reduced contract pricing. Any changes in reimbursement levels from these third-party payor sources and any changes in applicable government regulations could have a material adverse effect on DHI’s revenues and profitability. Changes in the mix of patients among Medicare, Medicaid and other payor sources may also impact DHI’s revenues and profitability. There can be no assurance that DHI will continue to maintain the current payor or revenue mix.

Collectibility of accounts receivable.

DHI’s failure to maintain its controls and processes over billing and collecting, or the deterioration of the financial condition of its payors, could have a significant negative impact on its results of operations and financial condition. The collection of accounts receivable is one of DHI’s most significant challenges and requires constant focus and involvement by management and ongoing enhancements to information systems and billing center operating procedures. Further some of DHI’s payors and/or patients may experience financial difficulties, or may otherwise not pay accounts receivable when due, resulting in increased write-offs. There can be no assurance that DHI will be able to maintain its current levels of collectibility and days sales outstanding in future periods. If DHI is unable to properly bill and collect its accounts receivable, its results will be adversely affected.

We are substantially dependent on a single supplier of pharmaceutical products to sell products to us on satisfactory terms. A disruption in our relationship with this supplier could have a material adverse effect on our business.

We obtain a majority of our total merchandise, including over 90% of our pharmaceuticals, from a single supplier, AmerisourceBergen, with whom we have a long-term supply contract. Any significant disruptions in our relationship with AmerisourceBergen, or deterioration in AmerisourceBergen’s financial condition, could have a material adverse effect on us.

Failure to maintain sufficient sales to qualify for favorable pricing under our long term supply contract could increase the costs of our products.

Our long term supply agreement, as amended in November 2006, with AmerisourceBergen provides us with pricing and credit terms that are improved from those previously provided by AmerisourceBergen to Park Pharmacy Corporation.AmerisourceBergen. In exchange for these improved terms, DHI has agreed to acquire 85% of its prescription pharmaceuticals and substantially all of its generic pharmaceutical products from AmerisourceBergen and to maintain certain minimum dollar monthly purchases.

If we are unable to satisfy minimum monthly purchase requirements of $900,000, we may be required to purchase our pharmaceutical products on less favorable pricing and credit terms. For the year ended December 31, 2005,2006, we purchased over $23,159,000$23,858,000 of our pharmaceutical products from Amerisource Bergen, of which $3,484,000 relates to our Park InfusionCare subsidiary currently classified as a discontinued operation.AmerisourceBergen.

The current or future shortage in licensed pharmacists, nurses and other clinicians could adversely affect our business.

The health care industry is currently experiencing a shortage of licensed pharmacists, nurses and other health care professionals. Consequently, hiring and retaining qualified personnel will be difficult due to intense competition for



their services and employment. Any failure to hire or retain pharmacists, nurses or other health care professionals could impair our ability to expand or maintain our operations.



Certain risks are inherent in providing pharmacy services, and our insurance may not be adequate to cover any claims against us.

Pharmacies are exposed to risks inherent in the packaging and distribution of pharmaceuticals and other health care products. Although we maintain professional liability and errors and omissions liability insurance, we cannot assure you that the coverage limits under our insurance programs will be adequate to protect us against future claims, or that we will maintain this insurance on acceptable terms in the future.

CRESA Partners of Orange County, L.P.

We have numerous significant competitors, some of which may have greater financial resources than we do.

We compete across a variety of business disciplines within the commercial real estate industry, including investment management, tenant representation, corporate services, construction and development management, property management, agency leasing, valuation and mortgage banking. In general, with respect to each of our business disciplines, we cannot assure you that we will be able to continue to compete effectively or maintain our current fee arrangements or margin levels or that we will not encounter increased competition. Each of the business disciplines in which we compete is highly competitive on an international, national, regional and local level. Depending on the product or service, we face competition from other real estate service providers, institutional lenders, insurance companies, investment banking firms, investment managers and accounting firms, many of which may have greater financial resources than we do. Many of our competitors are local or regional firms. We are also subject to competition from other large national and multi-national firms.

A significant portion of our operations are concentrated in southern California and our business could be harmed if the economic downturn continues in the southern California real estate markets.

During 20052006 and 2004,2005, a significant amount of our real estate advisory services segment revenue was generated from transactions originating in California. As a result of the geographic concentrations in California, the continuation of the economic downturn in the California commercial real estate markets and in the local economies in the Orange County area could further harm our results of operations.

Our results of operations vary significantly among quarters, which makes comparison of our quarterly results difficult.

The nature of our business does not allow for ready comparison of operating results from quarter to quarter. Our transaction fees are highly dependent on transactions that do not occur ratably over the course of a year.

Our success depends upon the retention of our senior management, as well as our ability to attract and retain qualified and experienced employees.

Our continued success is highly dependent upon the efforts of our executive officers and CPOC’s existing management team. The loss of one or more of our members of the senior management team could have a material adverse effect on CPOC.

If we fail to comply with laws and regulations applicable to real estate brokerage, we may incur significant financial penalties.

Due to the nature of our operations, we are subject to numerous federal, state and local laws and regulations specific to the services performed. For example, the brokerage of real estate sales and leasing transactions requires us to maintain brokerage licenses in each state in which we operate. If we fail to maintain our licenses or conduct brokerage activities without a license, we may be required to pay fines or return commissions received or have licenses suspended. Furthermore, the laws and regulations applicable to our business also may change in ways that materially increase the cost of compliance.



We may have liabilities in connection with real estate brokerage activities.

As a licensed real estate broker, weCRESA and ourits licensed employees are subject to statutory due diligence, disclosure and standard-of-care obligations. Failure to fulfill these obligations could subject usCRESA or ourits employees to litigation from parties who purchased, sold or leased properties wethat CRESA or theyits employees brokered or managed. WeCRESA could become subject to claims by participants in real estate transactions claiming that weCRESA did not fulfill ourits statutory obligations as a broker.

RISKS RELATED TO OUR INVESTMENTS IN REAL ESTATE

The success of real estate developments is dependant on tenants to generate lease revenues.

Real estate developments are subject to the risk that, upon the expiration of leases for space located in the properties, leases may not be renewed by existing tenants, the space may not be re-leased to new tenants or the terms of renewal or releasing (including the cost of required renovations or concessions to tenants) may be less favorable than current lease terms. A tenant may experience a down-turn in its business which may cause the loss of the tenant or may weaken its financial condition, and result in the tenant’s failure to make rental payments when due, result in a reduction in percentage rent receivable with respect to retail tenants or require a restructuring that might reduce cash flow from the lease. In addition, a tenant of any of the properties may seek the protection of bankruptcy, insolvency, or similar laws, which could result in the rejection and termination of such tenant’s lease and thereby cause a reduction in our available cash flow. Although we have not experienced material losses from tenant bankruptcies, no assurance can be given that tenants will not file for bankruptcy or similar protection in the future or, if any tenants file, that they will affirm their leases or continue to make rental payments in a timely manner.

Real estate development strategies entail certain risks.

Real estate development activities entail certain risks, including:
·  the expenditure of funds on and devotion of management’s time to projects which may not come to fruition;
·  the risk that development or redevelopment costs of a project may exceed original estimates, possibly making the project uneconomic or causing the project to raise additional cash to fund such costscosts;
·  the risk that occupancy rates and rents at a completed project will be less than anticipated or that there will be vacant space at the project;
·  the risk that expenses at a completed development will be higher than anticipated; and
·  the risk that permits and other governmental approvals will not be obtained. Because of the discretionary nature of these approvals and concerns which may be raised by various governmental officials, public interest groups and other interested parties during the approval and development process, our ability to develop properties and realize income from our projects could be delayed, reduced or eliminated.
·  the Frisco Square Partnerships’ future growth and real estate development requires additional capital..
·  the risk that a significant amount of debt, which is due during 2007, will require significant additional capital if it cannot be refinanced.

Based on the status of the Frisco Square development, the Frisco Square Partnerships will need to invest significant amounts of money over the next several years and currently anticipates real estate investments to be approximately $8.0 million for calendar 2007. The Frisco Square Partnerships could finance future expenditures from any of the following sources:
·  non-recourse, sale-leaseback or other financing
·  bank borrowings;
·  private placements of debt or equity or
·  some combination of the above.
If additional capital is needed, there is no assurance that funds will be available from any source or, if available, that they can be obtained on terms acceptable to the Frisco Square Partnerships and their partners. If not available, Frisco Square’s development will be limited to that which can be financed with its existing capital.


Any additional financing obtained by the Frisco Square Partnerships will, in all likelihood, further dilute the Company’s interest in Fairways Frisco.
General economic conditions in the areas in which our properties are geographically concentrated may impact financial results.

Our real estate development investments are exposed to changes in the real estate market or in general economic conditions in Texas. Any changes may result in higher vacancy rates for commercial property and lower prevailing rents, lower sales prices or slower sales, lower absorption rates, and more tenant defaults and bankruptcies, which would negatively impact our financial performance. To the extent that weak economic conditions or other factors affect these regions more severely than other areas of the country, our financial performance could be negatively impacted.

Exposure of our assets to damage from natural occurrences such as earthquakes, and weather conditions that affect the progress of construction may impact financial results.

Natural disasters, such as earthquakes, floods or fires, or unexpected climactic conditions, such as unusually heavy or prolonged rain, may have an adverse impact on our ability to develop our properties and realize income from our projects.



Illiquidity of real estate and reinvestment risk may reduce economic returns to investors.

Real estate investments are relatively illiquid and, therefore, our ability to vary our portfolio quickly in response to changes in economic or other conditions is limited. Further, certain significant expenditures, including property taxes, maintenance costs, mortgage payments, insurance costs and related charges must be made throughout the period of ownership of real property regardless of whether the real property is producing any income.

OTHER RISKS

We are controlled by our principal stockholders, officers and directors.  

Our principal stockholders, officers and directors, and affiliates beneficially own approximately 53%55% of our Common Stock. As a result, such persons may have the ability to control and direct our affairs and business. Such concentration of ownership may also have the effect of delaying, deferring or preventing a change in control.

We have certain transactionsrelationships with related parties.

We have relationships or transactions with related parties or affiliates of ours. Please see Note 1816 of the Ascendant Consolidated Financial Statements contained herein.

Our stock is not listed on The NASDAQ National Market.

Our stock is quoted and traded on the OTCBB. The OTCBB is a regulated quotation service that displays real-time quotes, last-sale prices, and volume information inof OTC securities. An OTC security is not listed or traded on NASDAQ or a national securities exchange, and NASDAQ has no business relationship with the issuers quoted in the OTCBB. Issuers of all securities quoted on the OTCBB are subject to periodic filing requirements with the Securities and Exchange Commission or other regulatory authority. Even with OTCBB eligibility and trading, fewer investors have access to trade our common stock, which will limit our ability to raise capital through the sale of our securities.

In addition, our common stock is subject to penny stock regulations, which could cause fewer brokers and market makers to execute trades in our common stock. This is likely to hamper our common stock trading with sufficient volume to provide liquidity and could cause our stock price to further decrease.



The penny stock regulations require that broker-dealers who recommend penny stocks to persons other than institutional accredited investors must make a special suitability determination for the purchaser, receive the purchaser’s written consent to the transaction prior to the sale and provide the purchaser with risk disclosure documents which identify risks associated with investing in penny stocks. These requirements have historically resulted in reducing the level of trading activity in securities that become subject to the penny stock rules. Holders of our common stock may find it more difficult to sell their shares of common stock, which is expected to have an adverse effect on the market price of the common stock.

We may be subject to litigation in the future.

We may be subject to future litigation or claims in the normal course of business, with or without merit. These claims may result in substantial costs and divert management’s attention and resources, which may seriously harm our business, prospects, financial condition and results of operations and may also harm our reputation, all of which may have a material adverse effect on our ability to pursue various strategic and financial alternatives as well as have a material adverse effect on our stock price. We may be unable to pay expenses or liabilities that may arise out of any possible legal claims.

ITEM 1B. UNRESOLVED STAFF COMMENTS

Not applicable



ITEMITEM 2. PROPERTIES

The physical properties used by the Company and its significant business segments are summarized below:

Approximate
Business Segment
Property Type
Owned/Leased
Approximate Sq Ft.Square Feet
HealthcareCorporate offices, retail pharmacies and infusion therapy centersLeased36,54443,698
Real estate advisory servicesCorporate officesLeased22,173
Corporate and otherCorporate officesLeased5,069-

The Healthcare segment properties above include 17,079 square feet used by Park InfusionCare, which is reported by the Company as a discontinued operation.

Mr. James C. Leslie, the Company’s Chairman, controls, and Mr. Will Cureton, one of our directors, is indirectly a limited partner in the entity that owns the building located in Dallas, Texas in which the corporate office space is sub-leased by Ascendant and DHI. Also, through August 2005, Capital Markets paid rent for office space in the same building to an entity controlled by Mr. Leslie. We consider all of these leases to be at or below market terms for comparable space in the same building. During the years ended December 31,

Beginning on March 16, 2005 2004 and 2003,ending on October 13, 2006, Ascendant and Capital Markets paid rent of approximately $26,000, $67,200 and $45,000 directly to an entity controlled by Mr. Leslie. The remaining rent expense paid by Ascendant and DHI is paid under sublease agreements withsubleased space from an unrelated third party and approximates $13,000 monthly. We also incurfor approximately $7,000 per month. In October 2006, Ascendant began sharing office space with DHI. During the year ended December 31, 2006, DHI subleased space from an unrelated third party for $6,000 per month. In addition, Ascendant incurred certain shared office costs with an entity controlled by Mr. Leslie, which gives rise to reimbursements from us to that entity. These costs were approximately $9,000 in 2006.

During the year ended December 31, 2005 and 2004, Ascendant and Capital Markets paid aggregate rent of approximately $26,000 and $67,200 directly to an entity controlled by Mr. Leslie. The remaining rent expense paid by Ascendant and DHI was paid under sublease agreements with an unrelated third party for approximately $13,000 monthly. We also incurred certain shared office costs with an entity controlled by Mr. Leslie, which gave rise to reimbursements from us to that entity. These costs were approximately $24,300 $22,800 and $3,400$22,800 in 2005 2004 and 2003,2004, respectively.

In addition, we have other relationships or transactions with other related parties or affiliates of ours. Please see Note 1816 to the Ascendant Consolidated Financial Statements contained herein.

ITEMITEM 3. LEGAL PROCEEDINGS

OnIn January 29, 2004, Bishopsgate Corp. and T.E. Millard filed a lawsuit in the 192nd District Court of Dallas County, Texas against us, our officers and directors, and Park Pharmacy’s officers and directors claiming that we breached obligations to fund Bishopsgate’s proposed purchase of the Park Assets.

Mr. Millard filed a Chapter 13 bankruptcy case in Dallas, Texas on August 15, 2003. Millard’s Chapter 13 bankruptcy case was converted to a Chapter 7 liquidation bankruptcy case on December 20, 2004. Upon the conversion of the bankruptcy case, Daniel J. Sherman was appointed Chapter 7 Trustee. In August 2005, the Company, its officers and directors and Park Pharmacy’s officers and directors entered into a compromise and settlement agreement, which was approved by the bankruptcy court, whereby the defendants collectively paid $80,000court. Please see Note 15 to the bankruptcy Trustee in settlement of all claims. The Company’s insurance carrier provided the fundsAscendant Consolidated Financial Statements contained herein for the Company’s portion of the settlement amount, which was $55,000. In exchange for the settlement, and in satisfaction of the counterclaims filed against Millard and Bishopsgate Corp, the Company received all of the stock of Bishopsgate Corp. The stock has not been assigned any value in the Company’s financial statements and it is held by a newly-formed entity, DM-ASD Holding, Co.additional details.

Between January 23, 2001 and February 21, 2001, five putative class action lawsuits were filed in the United States District Court for the Northern District of Texas against us, certain of our directors, and a limited partnership of which a director is a partner. The five lawsuits assert causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, for an unspecified amount of damages on behalf of a putative class of individuals who purchased our common stock between various periods ranging from November 11, 1999 to January 24, 2000. The lawsuits claim that we and the individual defendants made misstatements and omissions concerning our products and customers. 



In April 2001, the Court consolidated the lawsuits, and on July 26, 2002, plaintiffs filed a Consolidated Amended Complaint (“CAC”). We filed a motion to dismiss the CAC on or about September 9, 2002. On July 22, 2003, the Court granted in part and denied in part defendants’ motion to dismiss. On September 2, 2003, defendants filed an answer to the CAC. Plaintiffs then commenced discovery. On September 12, 2003, plaintiffs filed a motion for class certification, and on February 17, 2004, we filed our opposition. On July 1, 2004, the Court denied plaintiffs’ motion for certification. On September 8, 2004, the Fifth Circuit granted plaintiffs’ petition for permission to appeal the denial of class certification. On August 23, 2005, the Fifth Circuit affirmed the district court’s denial of class certification, The Company settled the lead plaintiffs’ remaining individual claims for a confidential amount, which was paid by the Company’s directors'directors’ and officers'officers’ insurance carrier.



Accordingly, the district court entered a final judgment dismissing the claims with prejudice in February 2006. Please see Note 15 to the Ascendant Consolidated Financial Statements contained herein for additional details.

In April 2006, we were notified by the Internal Revenue Service (“IRS”) that our federal income tax return for the 2004 tax year had been selected for review. In addition, in September 2006 we were notified by the IRS that the federal partnership income tax return of CPOC for the 2004 tax year had been selected for review. The IRS is currently conducting its reviews. At this time, we can make no representations or give any guidance regarding the potential outcome of this review and the impact, if any, it may have on February 24, 2006.our financial position. However, we are not aware of any potential issues that may cause adjustment to our filed tax returns.
In September 2006, the Chapter 7 trustee for the bankruptcy estate of Quantum North America, Inc. sought to enforce two default judgments against us for alleged preferential and fraudulent transfers to the Company's predecessor, ASD Systems, Inc. in the aggregate amount of approximately $150,000, plus interest and attorneys fees. The transfers at issue occurred in 2000. The adversary proceedings filed in the bankruptcy case were styled: David Gottlieb Trustee v. ASD Systems, Inc.; Adv. Nos. 1:02-ap-02131-GM and 1:02-ap-01948. We took the position that the judgments were void based on defective service and neither Ascendant nor ASD were afforded the opportunity to defend the claims. We also disputed the underlying claims and were prepared to fully defend the Trustee's suit once the judgments were set aside. After presenting the Trustee with our defenses, we were able to settle the claims for a nominal payment of $5,000. We have a settlement in principle with the Trustee which is pending approval by the Bankruptcy Court. 

We are also occasionally involved in other claims and proceedings, which are incidental to our business. We cannot determine what, if any, material affect these matters will have on our future financial position and results of operations.

ITEMITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS 

None.



PART II.

ITEMITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

MARKET PRICES; RECORD HOLDERS AND DIVIDENDS

Our stock is quoted and traded on the OTC Bulletin Board (“OTCBB”). The OTCBB is a regulated quotation service that displays real-time quotes, last-sale prices, and volume information inof over-the-counter (“OTC”) securities. An OTC security is not listed or traded on NASDAQ or a national securities exchange, and NASDAQ has no business relationship with the issuers quoted in the OTCBB. Issuers of all securities quoted on the OTCBB are subject to periodic filing requirements with the Securities and Exchange Commission or other regulatory authority. OTCBB requirements include, among other things, a broker-dealer acting as a market maker willing to enter a quote for the securities and requires us to remain current in our periodic filings under the Securities Exchange Act of 1934, as amended. Even with OTCBB eligibility and trading, delistingour having been delisted adversely affects the ability or willingness of investors to purchase our common stock, which, in turn, severely affects the market liquidity of our securities.

FollowingThe following is a summary of our stock’s quarterly market price ranges for the two most recent fiscal years. The price quotations noted herein represent prices between dealers, without retail mark-ups, mark-downs or commissions and may not represent actual transactions.


  
Fiscal year 2004: HighLow
Fiscal year 2005:
 
High
 
Low
 
First quarter* $1.95$0.30 $1.43 $0.85 
Second quarter* 1.700.71  1.77  1.20 
Third quarter* 1.650.85  1.40  0.70 
Fourth quarter*
 
1.35
 
0.75
 
  0.93  0.51 
       
Fiscal year 2005:  
Fiscal year 2006:
     
First quarter* $1.43$0.85 $0.85 $0.47 
Second quarter* 1.771.20  0.80  0.51 
Third quarter* 1.400.70  0.62  0.33 
Fourth quarter*
 
0.93
 
0.51
 
  0.60  0.25 

*These quotations represent high and low bid prices for our stock as reported by the OTCBB and Pink Sheets.

On March 31, 2006,30, 2007, the last reported sale price of our common stock on the OTCBB was $0.70$0.33 per share.

At March 31, 2006,30, 2007, there were approximately 2,7001,800 registered and beneficial holders of record of our common stock.

The aggregate market value of the voting stock held by nonaffiliates of the registrant,Company, based upon the closing price for the registrant’sour common stock on the OTC Bulletin Board on June 30, 2005,2006, the last trading date of registrant'sour most recently completed second fiscal quarter was approximately $14,874,000.$6,239,000.

We have not paid any cash dividends on our common stock and do not anticipate declaring dividends in the foreseeable future. Our current policy is to retain earnings, if any, to finance potential acquisitions and fund operations. The future payment of dividends will depend on the results of operations, financial condition, capital expenditure plans and other factors that we deem relevant and will be at the sole discretion of our Board of Directors.

-23--25-


ITEMEM 6. SELECTED CONSOLIDATED FINANCIAL DATA

The following selected consolidated financial data should be read in conjunction with the consolidated financial statements, the notes to such statements and the information under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in this Annual Report on Form 10-K, including the discussion therein of changes in our business under “Overview.” The consolidated statements of operationsincome data and the consolidated balance sheet data are derived from our audited consolidated financial statements.
 
(in thousands, except per share data)
 
 
(in thousands, except per share data)
  
December 31,
 
 
2005
 
2004
 
2003
 
2002
 
2001
  
2006
 
2005
 
2004
 
2003
 
2002
 
Statements of Operations Data:
                           
Revenues $43,788 $31,625 $505 $- $2,284  $55,417 $52,967 $39,291 $505 $- 
Cost of revenues  30,164  21,572  -  -  2,242   36,452  34,722  25,055  -  - 
Gross profit  13,624  10,053  505  -  42   18,965  18,245  14,236  505  - 
            
Operating expenses:                        
Selling, general and administrative expenses  12,093 9,431 1,540 998 10,068   16,230 16,991 13,112 1,540 998 
Impairment charges  - - 112 - 5,892   - - - 112 - 
Depreciation and amortization  611  443  63  18  2,158   713  652  494  63  18 
Total operating expenses  12,704  9,874  1,715  1,016  18,118   16,943  17,643  13,606  1,715  1,016 
Operating income (loss)  920  179  (1,210) (1,016) (18,076)  2,022  602  630  (1,210) (1,016)
Gain (loss) on disposal of assets  (1) (32) - 1 95 
Loss on disposal of assets  - (1) (32) - 1 
Equity in income (losses) of equity method investees  675 374 85 19 -   (356) 675 374 85 19 
Other income  73 19      155 73 19 - - 
Interest income (expense), net  (658) (405) 30 59 364   (758) (763) (520) 30 59 
Minority interest  (50) (56) 277 209 -   (65) (50) (56) 277 209 
Income tax provision  (241) (166) -  -  -   (205) (241) (166) -  - 
Income (loss) from continuing operations  718 (87) (818) (728) (17,617)  793 295 249 (818) (728)
Income (loss) from discontinued operations  (653) 336  -  -  -   230  (230) -  -  - 
Net income (loss) $65 $249 $(818)$(728)$(17,617) $1,023 $65 $249 $(818)$(728)
                        
Net income (loss) attributable to common shareholders $65 $249 $(818)$(728)$(17,617) $1,023 $65 $249 $(818)$(728)
            
Basic net income (loss) per share from:                        
Continuing operations $0.03 * $(0.04)$(0.03)$(0.83) $0.04 $0.01 $0.01 $(0.04)$(0.03)
Discontinued operations $(0.03)$0.02 $- $- $-  $0.01 $(0.01)$- $- $- 
 $0.00 $0.01 $(0.04)$(0.03)$(0.83) $0.05  * $0.01 $(0.04)$(0.03)
Diluted net income (loss) per share                        
Continuing operations $0.03 * $(0.04)$0.03 $0.83  $0.04 $0.01 $0.01 $(0.04)$0.03 
Discontinued operations $(0.03)$0.02 $- $- $-  $0.01 $(0.01)$- $- $- 
 $0.00 $0.01 $(0.04)$(0.03)$(0.83) $0.05  * $0.01 $(0.04)$(0.03)
* Less than $0.01 per share                        
Average common shares outstanding, basic  22,007  21,804  21,557  21,231  21,231   22,410  22,007  21,804  21,557  21,231 
Average common shares outstanding, diluted  22,878  22,389  21,557  21,231  21,231   22,676  22,878  22,389  21,557  21,231 
         
  
2005
  
2004
  
2003
  
2002
  
2001
 
December 31,
  
2006
  
2005
  
2004
  
2003
  
2002
 
Balance Sheet Data
                        
Cash and cash equivalents $3,216 $1,867 $2,006 $2,950 $4,204  $2,686 $3,221 $1,868 $2,006 $2,950 
Working capital  3,539 4,320 2,120 3,063 4,000   (86) 4,508 6,196 2,120 3,063 
Assets held available for sale  2,207 2,626    
Total assets  21,998 20,753 2,841 3,673 4,361   21,039 21,998 20,753 2,841 3,673 
Liabilities related to assets held available for sale  2,897 2,271 - - - 
Long-term debt (including current maturities)  10,235 10,634 - - -   9,930 11,924 12,616 - - 
Stockholders' equity  3,073 2,879 2,523 3,306 4,011   4,235 3,073 2,879 2,523 3,306 
-24--26-


ITEMITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
The following discussion and analysis should be read in conjunction with “Selected Consolidated Financial Data” and our consolidated financial statements and notes thereto included elsewhere in this report. Except for the historical information contained herein, certain statements used in this Form 10-K are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements about our financial condition, prospects, operations and business are generally accompanied by words such as “anticipates,” “expects,” “estimates,” “believes,” “intends,” “plans” or similar expressions. These forward-looking statements are subject to numerous risks, uncertainties and other factors, some of which are beyond our control that could cause actual results to differ materially from those forecasted or anticipated in such forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to, those discussed below under “Risks“Risk Factors -- Risks Related to Our Business,” “Risks“Risk Factors -- Risks Specific to Operating Subsidiaries,” and “Other“Risk Factors -- Other Risks.” These risks and uncertainties include, but are not limited to, (a) the following general risks: our limited funds and risks of not obtaining additional funds, certain of our subsidiaries are highly leveraged, potential difficulties in integrating and managing our subsidiaries, our dependence upon management, our dependence upon a small staff, certain subsidiaries accounting for a significant percentage of revenue, unforeseen acquisition costs, the potential for future leveraged acquisitions, restrictions on the use of net operating loss carryforwards, and the difficulty in predicting operations; (b) the following risks to Dougherty’s Holdings, Inc.: potential problems that may arise in sellingoperating the Park InfusionCare business, extensive regulation of the pharmacy business, the competitive nature of the retail pharmacy industry, third party payor attempts to reduce reimbursement rates, difficulty in collecting accounts receivable, dependence upon a single pharmaceutical products supplier, price increases as a result of our potential failure to maintain sufficient pharmaceutical sales, shortages in qualified employees, and liability risks inherent in the pharmaceutical industry; (c) the following risks to CRESA Partners of Orange County, L.P.: the size of our competitors, our concentration on the southern California real estate market, the variance of financial results among quarters, the inability to retain senior management and/or attract and retain qualified employees, the regulatory and compliance requirements of the real estate brokerage industry and the risks of failing to comply with such requirements, and the potential liabilities that arise from our real estate brokerage activities; (d) the following risks to our investments in real estate: our dependence on tenants for lease revenues, the risks inherent in real estate development activities, the ability of the Frisco Square Partnerships to obtain financing on acceptable terms, the general economic conditions of areas in which we focus our real estate development activities, the risks of natural disasters, and the illiquidity of real estate investments;investment; and (e) the following other risks: a majority of our common stock is beneficially owned by our principal stockholders, officers and directors, relationships and transactions with related parties, our stock is not traded on NASDAQ or a national securities exchange, effect of penny stock regulations, and litigation.

Because such forward-looking statements are subject to risks, uncertainties and assumptions, you are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s view only as of the date the forward-looking statement is made. Our forward-looking statements are based on the current expectations of management, and we undertake no obligation to update publicly any forward-looking statement for any reason, even if new information becomes available or other events occur in the future. The cautionary statements made in this report should be read as being applicable to all related forward-looking statements, wherever they appear in this report.

OVERVIEW

Our company has undergone a series of fundamental changes in the past threefour years, and as a result, our management believes that year-to-year comparisons of our past results are not meaningful as a basis for evaluating our future prospects.

DuringBetween 2002 -and 2005, we made investments and/or acquisitions, which are more fully described herein in Item 1, Business of Part 1 and in the Notes to the Ascendant Consolidated Financial Statements also included herein.

There is no assurance that we will be able to successfully operate these acquired businesses or that we will be able to successfully acquire or develop continue to add one or more additional business enterprises in the future.

-27-



We expect our future operating results to fluctuate. Factors that are likely to cause these fluctuations include:

·  the matters discussed under the section titled “Risks Related to our Business” and “Risks Specific to Operating Subsidiaries” below;
·  our ability to profitably operate our acquisitions of the Park Assets and CPOCbusinesses we acquired and to pay the principal and interest on the significant debt incurred to make these acquisitions;
·  our ability to sellsuccessfully operate the Park InfusionCare as further discussed herein;business;
·  our success with the investments in, and operations of, Ampco, Capital Markets, Fairways Frisco and our participation in other Fairways transactions, if any;
·  our ability to successfully defend outstanding litigation;
·  fluctuations in general interest rates;
·  the availability and cost of capital to us;
·  the existence and amount of unforeseen acquisition costs; and
·  our ability to locate and successfully acquire or develop one or more additional business enterprises.

-25-



 
Key measures used by the Company’s management to evaluate business segment performance include revenue, cost of sales, gross profit, investment income and EBITDA. EBITDA is calculated as net income before deducting interest, taxes, depreciation and amortization. Although EBITDA is not a measure of actual cash flow because it does not consider changes in assets and liabilities that may impact cash balances, the Company believes it is a useful metric to evaluate operating performance and has therefore included such measures in the discussion of operating results below.
 
Discontinued Operations

In September 2005,As disclosed in a Current Report on Form 8-K filed on May 24, 2006, the Company determined that it would exitboard of directors decided to retain the home infusion therapy business, which operated as partoperations of its healthcare segment under the name Park InfusionCare. This will allow DHI to devote undivided focus on its primary business, independent specialty retail pharmacies. In connection therewith, the Company retained The Braff Group, a financial advisor, to assist in marketing Park InfusionCare, for sale. The financial advisor is currently in discussions with various interested buyers. The Company can provide no assurance that it will be able to find a buyer for Park InfusionCare, or to the extent a buyer is found, that a transaction on terms acceptable or favorable to the Company will be consummated. The Company has accounted for Park InfusionCarewhich had previously been reported as a discontinued operation sincewhile the third quarterCompany was pursuing a potential disposition or strategic transaction for its infusion therapy business. In connection with the decision to retain the operations of 2005.

ComparisonPark InfusionCare, DHI entered into an employment agreement on May 18, 2006 with Scott R. Holtmyer to be the Vice President of Discontinued Operations Results forits Park InfusionCare infusion therapy business. As a result of the Year Ended December 31, 2005board of director’s decision to retain the Year Ended December 31, 2004

  
Years Ended December 31,
 
  
2005
 
2004
 
      
Income (loss) from discontinued operations:     
Infusion therapy revenue $9,071,000 $7,666,000 
Cost of sales  4,558,000  3,483,000 
Gross profit  4,513,000  4,183,000 
        
Selling, general and administrative expenses  4,898,000  3,680,000 
Depreciation and amortization  41,000  51,000 
Interest expense, net  105,000  116,000 
Other income  108,000  - 
Charges related to discontinuance  230,000  - 
Income (loss) from discontinued operations $(653,000)$336,000 

The results foroperations of Park InfusionCare, the year ended December 31, 2004 reflectCompany has reported the operating results of Park InfusionCare from the dateas part of acquisition on March 24, 2004continuing operations. The Company had previously recorded an estimated charge of $230,000 for employee retention costs directly related to December 31, 2004, whereas the 2005 results are comprised of the full twelve months ending December 31, 2005.any potential disposition or strategic transaction for Park InfusionCare.

The gross profit as a percentage of revenue declined from 54.6% in 2004 to 49.8% in 2005. The decline in gross profit percentage is due primarily to increases in wholesale drug prices and a change in the mix of revenue to lower margin therapies. The decline in interest expense is due to a decrease in the revolving bank debt allocated to Park InfusionCare due to a decline in its overall borrowing base.

Charges related to discontinuance represent an accrual for retention bonuses to be paid to key employees upon the sale of Park InfusionCare. As of December 31, 2005, none of these accrued amounts has been paid. Other income in 2005 represents amounts received from third party payors which were not billed as infusion therapy revenue.

-26--28-



RESULTS OF CONTINUING OPERATIONS 

(Amounts exclude discontinued operations        Comparison of the Year Ended December 31, 2006 to the Year Ended December 31, 2005 (000’s omitted).
  
Twelve Months Ended December 31, 2006
 
  
Healthcare
 
Real Estate Advisory Services
 
  
2006
 
2005
 
$ Change
 
2006
 
2005
 
$ Change
 
Revenue $41,062 $39,136 $1,926 $14,355 $13,831 $524 
Cost of Sales  28,048  26,517  1,531  8,404  8,205  199 
Gross Profit  13,014  12,619  395  5,951  5,626  325 
Operating expenses  12,292  13,143  (851) 3,448  3,343  105 
Equity in income (losses) of equity method investees  -  -  -  -  -  - 
Other income  8  9  (1) 100  -  100 
Interest income (expense), net  (330) (330) -  (400) (444) 44 
Gain (loss) on sale of equipment  -  -  -  -  (1) 1 
Minority interests  -  -  -  (48) (37) (11)
Income tax provision  -  -  -  (199) (209) 10 
Discontinued operations  230  (230) 460  -  -  - 
Net income
 
$
630
 
$
(1,075
)
$
1,705
 
$
1,956
 
$
1,592
 
$
364
 
Plus:
                   
Interest (income) expense, net $330 $330 $- $400 $444 $(44)
Income tax provision  -  -  -  199  209  (10)
Depreciation & Amortization  391  332  59  297  304  (7)
Discontinued operations  (230) 230  (460) -  -  - 
EBITDA from continuing operations
 
$
1,121
 
$
(183
)
$
1,304
 
$
2,852
 
$
2,549
 
$
303
 
  
Twelve Months Ended December 31, 2006
 
  
Corporate & Other
 
Consolidated
 
  
2006
 
2005
 
$ Change
 
2006
 
2005
 
$ Change
 
              
Revenue $- $- $- $55,417 $52,967 $2,450 
Cost of Sales  -  -  -  36,452  34,722  1,730 
Gross Profit  -  -  -  18,965  18,245  720 
Operating expenses  1,203  1,157  46  16,943  17,643  (700)
Equity in income (losses) of equity method investees  (356) 675  (1,031) (356) 675  (1,031)
Other income  47  64  (17) 155  73  82 
Interest income (expense), net  (28) 11  (39) (758) (763) 5 
Gain (loss) on sale of equipment  -  -  -  -  (1) 1 
Minority interests  (17) (13) (4) (65) (50) (15)
Income tax provision  (6) (32) 26  (205) (241) 36 
Discontinued operations  -  -  -  230  (230) 460 
Net income
 
$
(1,563
)
$
(452
)
$
(1,111
)
$
1,023
 
$
65
 
$
958
 
Plus:
                   
Interest (income) expense, net $28 $(11)$39 $758 $763 $(5)
Income tax provision  6  32  (26) 205  241  (36)
Depreciation & Amortization  25  16  9  713  652  61 
Discontinued operations  -  -  -  (230) 230  (460)
EBITDA from continuing operations
 
$
(1,504
)
$
(415
)
$
(1,089
)
$
2,469
 
$
1,951
 
$
518
 
-29-

Healthcare
Revenue
Total revenues increased $1,926,000 during the year ended December 31, 2006 to $41,062,000. This represents a 4.9% increase over revenue of $39,136,000 in 2005. The increase includes a 4.2% increase in the number of retail pharmacy prescriptions filled and increased sales of front end merchandise. The increase in revenue of $3,804,000, or 12.7% at Dougherty’s Pharmacy and Medicine Man pharmacies (the “Retail Pharmacies”), is offset by a decrease of $1,878,000, or 20.5%, at Park InfusionCare. The decrease in infusion revenue is due to a decrease in the number of patient therapies and the lingering impact on ongoing business from the Company’s prior announcement in November 2005 of the plans to seek a strategic transaction or potential disposition.

Cost of Sales
Cost of sales increased $1,531,000 for the year ended December 31, 2006 to $28,048,000, or 68.3% of revenue. Cost of sales was $26,517,000 or 67.8% of sales in 2005. The overall increase in cost of sales is primarily due to higher retail pharmacy sales at lower gross margins, caused principally by lower reimbursement rates by third party insurance companies. The increased cost of sales of 13.1% at the retail pharmacies was offset, in part, by the 29.4% decrease in cost of sales at Park InfusionCare which is due to a change in revenue mix to higher margin therapies. Costs of sales includes all periods presented)direct costs related to the sale of products.

Operating Expenses
Operating expenses decreased $851,000 for the year ended December 31, 2006 to $12,292,000 from $13,143,000 in 2005. Operating expenses represented 29.9% of revenue in 2006 as compared to 33.6% of revenue in 2005. The decrease in healthcare operating expenses is due primarily to a reduced headcount and other operating expenses at

Park InfusionCare of $515,000 which is a reduction of 10.4% as compared to 2005. In addition, overhead expenses at the DHI corporate office were reduced by $636,000, or 39.5%, as a result of reduced headcount and other cost reduction initiatives initiated in 2006. The overall decrease in operating expenses as a percentage of revenue is due primarily to a reduction of headcount net of increases attributable to increased pharmacy revenues.

Interest Income (Expense), Net
Interest expense, net is comprised of interest expense related to the debt assumed as part of the acquisition of the Park Assets by DHI. Interest expense, net was $330,000 for the year ended December 31, 2006, which was unchanged from the year ended December 31, 2005. Interest expense on DHI’s revolving bank debt is fixed at six percent per annum.

Earnings Before Interest, Taxes, Depreciation and Amortization
EBITDA increased by $1,304,000 to EBITDA of $1,121,000 in for the year ended December 31, 2006 from an EBITDA loss of ($183,000) in 2005. This overall increase is due primarily to an overall decrease in operating expense of $851,000 due to reduced headcount and other operating expenses. EBITDA at the Retail Pharmacies increased 43% in 2006 to $2,144,000 from $1,499,000 in the year ended 2005. During 2006, the EBITDA loss at Park InfusionCare was decreased by $25,000 to an EBITDA loss of ($253,000) in 2006 from an EBITDA loss of ($278,000) in 2005, a decrease of 9%.

Real estate advisory services

Revenue
Revenue increased $524,000 from $13,831,000 in 2005 to $14,355,000 during the year ended December 31, 2006. The following are included in real estate advisory services revenue for the year ended December 31, 2006 (i) fee revenue earned by CPOC of $13,510,000 and (ii) fee revenue earned by Capital Markets of $815,000. The overall increase is due primarily to an increase of $365,000 in revenue earned by CPOC which is due to an increase in commissions received for tenant representation services during 2006.

Cost of Revenue

Cost of revenue was $8,404,000 for the year ended December 31, 2006, representing 58.5% of revenue. By comparison, cost of revenue was $8,205,000 or 59.3% of revenue in 2005. The overall increase in cost of revenue is due to increased commission and referral fee costs. The decrease in the cost of revenue percentage is due to a decrease in broker commissions paid as a percentage of total revenue. Cost of revenue includes all direct costs, including license fees and broker commissions, incurred in connection with a real estate advisory transaction. Brokerage commissions can vary depending on the transaction terms and whether brokers have reached certain commission targets.

Operating Expenses
Operating Expenses increased $105,000 from $3,343,000 in 2005 to $3,448,000 for the year ended December 31, 2006. This overall increase includes an increase of $116,000 in selling, general and administrative expenses at Capital Markets due to increase professional bonuses due to greater transaction revenues. Under the management agreement which was implemented in 2005, Capital Markets only incurs expenses when revenues are earned from a real estate advisory transaction closing.

-30-

Interest Income (Expense), Net
Interest expense, net is comprised of interest expense related to the debt related to the CPOC acquisition. Interest expense, net was $400,000 in 2006 as compared to $444,000 for the year ended December 31, 2005. The overall decrease of $44,000 is primarily due to the reduction of the principal balance of $1,782,000 during 2006. The overall decrease is reduced by an increase in the prime rate from 7.25% at December 31, 2005 to 8.25% at December 31, 2006. The CPOC acquisition note payable bears interest at the Bank of America prime rate minus 0.25%.
Earnings Before Interest, Taxes, Depreciation and Amortization
EBITDA increased 11.9% to $2,852,000 in 2006 from $2,549,000 in 2005. This overall increase includes an increase in revenue of $524,000 and a corresponding increase in gross profit of $325,000. The increase also includes a $100,000 gain as a result of a discount on the restructuring of the Acquisition Debt.

Corporate and other

Operating Expenses
Operating expenses for the year ended December 31, 2006 were $1,203,000, or an increase of $46,000 over operating expenses of $1,157,000 for the year ended December 31, 2005. The increase is primarily a result of increased payroll and professional fees in the normal course of business. Operating expenses of $1,203,000 includes payroll and benefits of $418,000; legal expense of $78,000; insurance expense of $120,000; audit and accounting expense of $165,000; SEC, transfer agent and other professional fees of $128,000; director fees and stock compensation expense of $110,000 and other selling, general and administrative expenses of $184,000.

Equity in Income (Losses) of Equity Method Investees
Equity in income (losses) of equity method investees decreased $1,031,000 from $675,000 during the year ended December 31, 2005 to ($356,000) for the year ended December 31, 2006. Equity in income (losses) of equity method investees represents our pro-rata portion, based on our limited partnership interests, of the income (losses) of Ampco Partners, Ltd., Fairways 03 New Jersey, L.P. and Fairways Frisco, LP as follows:

  
December 31,
 
December 31,
 
  
2006
 
2005
 
      
Ampco Partners, Ltd. $96,000 $100,000 
Fairways 03 New Jersey, LP  6,000  1,112,000 
Fairways Frisco, L.P.  (458,000) (537,000)
  $(356,000)$675,000 

The equity in earnings of Fairways NJ of $1,112,000 is comprised of earnings from its interest in the leasing of a single tenant commercial building and a gain on the sale of that building in 2005. Of this total, $951,000 was received is cash distributions in 2005. The Company received a distribution of approximately $680,000 on December 30, 2005 from Fairways NJ, which represented the Company’s share in the profit from the sale of a single tenant commercial real estate property interest, the sole asset held by Fairways NJ. In addition to the distribution, cash of $162,000, representing the Company’s share of the total escrow, was held in escrow to fund any amounts owed by Fairways NJ to the purchaser, including any amounts owed for standard representations and warranties under the sale agreement. The balance of the escrow account and interest income of $168,000 was received in December 2006.

The equity in losses of Fairways Frisco of $458,000 and $537,000 represents our share of the net loss of Fairways Frisco for the years ended December 31, 2006 and 2005, respectively. These amounts are non-cash adjustments to our operating results and we have no obligation to fund the operating losses or debts of Fairways Frisco.

Other Income
Other income was $47,000 in 2006 as compared to $64,000 in 2005. This represents receipts from Fairways Equities under an agreement whereby the Company receives 25% of certain fees earned by Fairways Equities. During 2006 Fairways Equities earned fewer fees than in 2005.

Income tax provision
Income tax provision decreased $26,000 from $32,000 in 2005 to $6,000 in 2006 as a result of lower taxable income in 2006. The income tax provision represents federal alternative minimum taxes owed by the Company. The Company’s net operating loss carryforwards are limited to usage of 90% of alternative minimum taxable income, and therefore it will be required to pay alternative minimum tax on 10% of its alternative minimum taxable income at a statutory tax rate of 20%.


-31-


Comparison of the Year Ended December 31, 2005 to the Year Ended December 31, 2004 (000’s omitted).
 
Years Ended December 31,
 
 
Healthcare
 
Real Estate Advisory Services
 
     
Dollar
     
Dollar
  
Years Ended December 31,
 
 
2005
 
2004
 
Change
 
2005
 
2004
 
Change
  
Healthcare
 
Real Estate Advisory Services
 
              
2005
 
2004
 
$ Change
 
2005
 
2004
 
$ Change
 
Revenue $29,957 $21,866 $8,091 $13,831 $9,759 $4,072  $39,136 $29,532 $9,604 $13,831 $9,759 $4,072 
Cost of Sales  21,959 16,185 5,774 8,205 5,387 2,818   26,517  19,668  6,849  8,205  5,387  2,818 
Gross Profit  7,998  5,681  2,317  5,626  4,372  1,254   12,619  9,864  2,755  5,626  4,372  1,254 
Operating expenses  8,204 6,136 2,068 3,343 2,479 864   13,143 9,868 3,275 3,343 2,479 864 
Equity in income (losses) of equity method investees  - - - - - -   - - - -   - 
Other income  9 19 (10) - - -   9 19 (10) -   - 
Interest income (expense), net  (225) (182) (43) (444) (247) (197)  (330) (297) (33) (444) (247) (197)
Gain (loss) on sale of equipment  - (17) 17 (1) (15) 14   - (17) 17 (1) (15) 14 
Minority interests  - - - (37) (29) (8)  - - - (37) (29) (8)
Income tax provision  -  -  -  (209) (166) (43)  - - - (209) (166) (43)
Income from continuing operations
 
$
(422
)
$
(635
)
$
213
 
$
1,592
 
$
1,436
 
$
156
 
Discontinued operations  (230) -  (230) -  -  - 
Net income
 
$
(1,075
)
$
(299
)
$
(776
)
$
1,592
 
$
1,436
 
$
156
 
Plus:
                            
Interest (income) expense, net $225 $182 $43 $444 $247 $197  $330 $297 $33 $444 $247 $197 
Income tax provision  - - - 209 166 43   - - - 209 166 43 
Depreciation & Amortization  291  220  71  304  216  88   332 271 61 304 216 88 
Discontinued operations  230  -  230  -  -  - 
EBITDA from continuing operations
 
$
94
 
$
(233
)
$
327
 
$
2,549
 
$
2,065
 
$
484
  
$
(183
)
$
269
 
$
(452
)
$
2,549
 
$
2,065
 
$
484
 
              
  
Years Ended December 31,
 
  
Corporate & Other
 
Consolidated
 
      
Dollar
     
Dollar
 
  
2005
 
2004
 
Change
 
2005
 
2004
 
Change
 
              
Revenue $- $- $- $43,788 $31,625 $12,163 
Cost of Sales  -  -  -  30,164  21,572  8,592 
Gross Profit  -  -  -  13,624  10,053  3,571 
Operating expenses  1,157  1,259  (102) 12,704  9,874  2,830 
Equity in income (losses) of equity method investees  675  374  301  675  374  301 
Other income  64  -  64  73  19  54 
Interest income (expense), net  11  24  (13) (658) (405) (253)
Gain (loss) on sale of equipment  -  -  -  (1) (32) 31 
Minority interests  (13) (27) 14  (50) (56) 6 
Income tax provision  (32) -  (32) (241) (166) (75)
Income from continuing operations
 
$
(452
)
$
(888
)
$
436
 
$
718
 
$
(87
)
$
805
 
Plus:
                   
Interest (income) expense, net $(11)$(24)$13 $658 $405 $253 
Income tax provision  32  -  32  241  166  75 
Depreciation & Amortization  16  7  9  611  443  168 
EBITDA from continuing operations
 
$
(415
)
$
(905
)
$
490
 
$
2,228
 
$
927
 
$
1,301
 

  
Years Ended December 31,
 
  
Corporate & Other
 
Consolidated
 
  
2005
 
2004
 
$ Change
 
2005
 
2004
 
$ Change
 
Revenue $- $- $- $52,967 $39,291 $13,676 
Cost of Sales  -  -  -  34,722  25,055  9,667 
Gross Profit  -  -  -  18,245  14,236  4,009 
Operating expenses  1,157  1,259  (102) 17,643  13,606  4,037 
Equity in income (losses) of equity method investees  675  374  301  675  374  301 
Other income  64  -  64  73  19  54 
Interest income (expense), net  11  24  (13) (763) (520) (243)
Gain (loss) on sale of equipment  -  -  -  (1) (32) 31 
Minority interests  (13) (27) 14  (50) (56) 6 
Income tax provision  (32) -  (32) (241) (166) (75)
Discontinued operations  -  -  -  (230) -  (230)
Net income
 
$
(452
)
$
(888
)
$
436
 
$
65
 
$
249
 
$
(184
)
Plus:
                   
Interest (income) expense, net $(11)$(24)$13 $763 $520 $243 
Income tax provision  32  -  32  241  166  75 
Depreciation & Amortization  16  7  9  652  494  158 
Discontinued operations  -  -  -  230  -  230 
EBITDA from continuing operations
 
$
(415
)
$
(905
)
$
490
 
$
1,951
 
$
1,429
 
$
522
 
-27--32-



 
Healthcare

Revenue
Revenue increased $8,091,000$9,604,000 during the year ended December 31, 2005 to $29,957,000.$39,136,000 from $29,532,000 in 2004. The increase is due to increased pharmacy sales at Dougherty’s Pharmacy in 2005 as a result of increased pricing for prescription drug sales as well as increased front end merchandise sales subsequent to the remodeling of Dougherty’s Pharmacy. The increase is also due to the fact that 2004 results are reflected for the period from the date of acquisition on March 24, 2004 to December 31, 2004, as compared to a full twelve months in 2005.

Cost of Sales
Cost of sales was $21,959,000$26,517,000 for the year ended December 31, 2005, representing 73.3%68% of revenue. Cost of sales was 74.0%$19,668,000 or 66.6% of sales in 2004. The overall increase is also due primarily to the inclusion of DHI’s cost of sales for the period from the date of acquisition on March 24, 2004 to December 31, 2004 as compared to a full twelve months in 2005. The increase is cost of sales as a percentage of revenue is primarily due to an increase in infusion care wholesale drug prices and a change in the mix of revenue to lower margin therapies. This increase in infusion care cost of sales is somewhat offset by the decline in retail pharmacy cost of sales as a percentage of revenue in 20052006 is due to an increased mix of generic prescriptions as compared to brand name drugs, along with improved merchandising and purchasing in the front end of the pharmacies. Dougherty’s Pharmacy was remodeled in 2005, which contributed to increased sales of front end merchandise, which carry a higher gross margin than prescription drug sales. Cost of sales includes all direct costs related to the sale of products in pharmacies. The increase of $5,774,000 in cost of sales for the year ended December 31, 2005 is due primarily to the inclusion of DHI’s cost of sales for the period from the date of acquisition on March 25, 2004 to December 31, 2004 as compared to a full twelve months in 2005.

Operating Expenses
Operating expenses increased $2,068,000$3,275,000 for the year ended December 31, 2005 to $8,204,000.$13,143,000 as compared to operating expenses of $9,868,000 in 2004. Operating expenses represented 27.4%33.6% of revenue in 2005 as compared to 28.1%33.4% of revenue in 2004. The decreaseincrease in operating expenses as a percentage of revenue is due primarily to increased pharmacy revenues combined with smaller increases in fixed operating expenses. The overall dollar increase in operating expenses is due primarily to the inclusion of DHI’s operating expenses, including amortization of Patient Prescriptions, for the period from the date of acquisition on March 25,24, 2004 to December 31, 2004 as compared to a full twelve months in 2005.

Interest Income (Expense), Net
Interest expense, net is comprised of interest expense related to the debt assumed as part of the acquisition of the Park Assets by DHI. Interest expense, net was $182,000$297,000 for the year ended December 31, 2004, as compared to $225,000$330,000 for the year ended December 31, 2005. Interest expense on DHI’s revolving bank debt is fixed at six percent per annum. For the year ended December 31, 2005, interest expense, net increased due to inclusion of the DHI results for the period from the date of acquisition on March 25,24, 2004 to December 31, 2004 as compared to a full twelve months in 2005.

Earnings Before Interest, Taxes, Depreciation and Amortization
DHI experienced an EBITDA loss of $(183,000) during 2005 as compared to EBITDA of $269,000 during 2004. EBITDA at the Retail Pharmacies increased 36.9% in 2005 to $1,499,000 from $946,000 in the year ended 2004. This EBITDA loss was primarily a result of an EBITDA loss of ($278,000) at Park InfusionCare as a result of the decline in revenue and a change in the mix of revenue to lower margin therapies. The decrease in infusion revenue is due to a decrease in the number of patient therapies and the lingering impact on ongoing business from the Company’s prior announcement in November 2005 of the plans to seek a strategic transaction or potential disposition.

Real estate advisory services

Revenue
Revenue increased $4,072,000 from $ 9,759,000 in 2004 to $13,831,000 during the year ended December 31, 2005. The following are included in real estate advisory services revenue for the year ended December 31, 2005 (i) fee revenue earned by CPOC of $13,176,000 and (ii) fee revenue earned by CRESA Capital Markets of $655,000. The increase over 2004 revenue is due primarily to the inclusion of CPOC’s revenue for the period from the date of acquisition on May 1, 2004 to December 31, 2004 as compared to a full twelve months in 2005.

-33-



Cost of Revenue
Cost of revenue was $8,205,000 for the year ended December 31, 2005, representing 59.3% of revenue. Cost of revenue was $5,387,000 or 55.2% of revenue in 2004. The overall increase in cost of revenue as a percentage of revenue is due to increased commission and referral fee costs. Cost of revenue includes all direct costs, including broker commissions, incurred in connection with a real estate advisory transaction. The increase of $2,818,000 in cost of revenue for the year ended December 31, 20042005 is due primarily to the inclusion of CPOC’s cost of revenue for the period from the date of acquisition on May 1, 2004 to December 31, 2004 as compared to a full twelve months in 2005.


-28-


Operating Expenses
Operating expenses increased $864,000 from $2,479,000 in 2004 to $3,343,000 for the year ended December 31, 2005. This increase includes a decrease of $151,000 in selling, general and administrative expenses at Capital Markets due to decreased professional bonuses due to lower transaction revenues. The increase also includes an increase of $926,000 for CPOC due to the inclusion of CPOC’s operating expenses for the period from the date of acquisition on May 1, 2004 to December 31, 2004 as compared to a full twelve months in 2005.

Interest Income (Expense), Net
Interest expense, net is comprised of interest expense related to the debt assumed as part of the CPOC acquisition. Interest expense, net was $444,000 in 2005 as compared to $247,000 for the year ended December 31, 2004. The increase is partially due to an increase in the prime rate from 5.25% at December 31, 2004 to 7.25% at December 31, 2005. The CPOC acquisition note payable bears interest at the Northern Trust Bank was at prime rate plus 0.50%. The remainder of the increase in interest expense is due to the inclusion of CPOC’s interest expense for the period from the date of acquisition on May 1, 2004 to December 31, 2004 as compared to a full twelve months in 2005.

Earnings Before Interest, Taxes, Depreciation and Amortization
EBITDA increased 23.4% to $2,549,000 in 2005 from $2,065,000 in 2004. This increase is due principally to an increase in gross profit of $1,254,000 which is partially offset by an increase in operating expenses of $864,000.

Corporate and other

Operating Expenses
Operating expenses for the year ended December 31, 2005 were $1,157,000, or a decrease of $102,000 overfrom operating expenses of $1,259,000 for the year ended December 31, 2004. The decrease is primarily a result of decreased costs for legal and accounting due to the additional activity generated by our acquisitions of the Park Assets and CPOC in 2004. Operating expenses of $1,157,000 includes payroll and benefits of $515,000; legal expense of $111,000; insurance expense of $178,000; audit and accounting expense of $83,000; SEC, transfer agent and other professional fees of $89,000; and other selling, general and administrative expenses of $181,000.

Equity in Income (Losses) of Equity Method Investees
Equity in income (losses) of equity method investees increased $301,000 from $374,000 during the year ended December 31, 2004 to $675,000 for the year ended December 31, 2005. Equity in income (losses) of equity method investees represents our pro-rata portion, based on our limited partnership interests, of the income (losses) of Ampco Partners, Ltd., Fairways 03 New Jersey, L.P., Fairways 36864, L.P. and Fairways Frisco, LP as follows:

 
Years Ended December 31,
  
December 31,
 
December 31,
 
 
2005
 
2004
  
2005
 
2004
 
          
Ampco Partners, Ltd. $100,000 $82,000  $100,000 $82,000 
Fairways 03 New Jersey, LP  1,112,000  208,000   1,112,000  208,000 
Fairways 36864, L.P.  -  84,000   -  84,000 
Fairways Frisco, L.P.  (537,000) -   (537,000) - 
 $675,000 $374,000  $675,000 $374,000 


-34-


The equity in earnings of Fairways NJ of $1,112,000 is comprised of earnings from its interest in the leasing of a single tenant commercial building and a gain on the sale of that building in 2005. Of this total, $951,000 was received is cash distributions in 2005. The remaining amount is expected to be received in cash as described below. The Company received a distribution of approximately $680,000 on December 30, 2005 from Fairways NJ, which represented the Company’s share in the profit from the sale of a single tenant commercial real estate property interest, the sole asset held by Fairways NJ. In addition to the distribution, cash of $162,000, representing the Company’s share of the total escrow, is being held in escrow to fund any amounts owed by Fairways NJ to the purchaser, including any amounts owed for standard representations & warranties under the sale agreement. The balance of the escrow account if any, is expected to be releasedwas received in December 2006.

The equity in losses of Fairways Frisco of $537,000 represents our share of the net loss of Fairways Frisco for the year ended December 31, 2005. We made our initial investment in Fairways Frisco on December 31, 2004, and accordingly no equity in income (losses) of Fairways Frisco was recorded in 2004. This amount is a non-cash adjustment to our operating results and we have no obligation to fund the operating losses or debts of Fairways Frisco.

-29-



The equity in income of Fairways 36864, L.P. of $84,000 for the year ended December 31, 20042005 was due to a gain on the sale of two single tenant commercial properties in which we had an investment through ASE Investments. This investment is no longer outstanding. See Item I, “Business” of Part I for more information.

Other Income
Other income in 2005 represents the receipt of $64,000 from Fairways Equities, LLC under an agreement whereby the Company receives 25% of certain fees earned by FEL.Fairway Equities.

Income tax provision
Income tax provision of $32,000 in 2005 represents federal alternative minimum taxes owed by the Company. Based on the Company’s differences in income in various legal entities and its temporary differences between taxable income and book income, there was no income tax provision recorded for 2004. The Company’s net operating loss carryforwards are limited to usage of 90% of alternative minimum taxable income, and therefore it will be required to pay alternative minimum tax on 10% of its alternative minimum taxable income at a statutory tax rate of 20%.


-30-


Comparison of the Year Ended December 31, 2004 to the Year Ended December 31, 2003 (000’s omitted).
  
Years Ended December 31,
 
  
Healthcare
 
Real Estate Advisory Services
 
      
Dollar
     
Dollar
 
  
2004
 
2003
 
Change
 
2004
 
2003
 
Change
 
              
Revenue $21,866 $- $21,866 $9,759 $505 $9,254 
Cost of Sales  16,185  -  16,185  5,387  -  5,387 
Gross Profit  5,681  -  5,681  4,372  505  3,867 
Operating expenses  6,136  -  6,136  2,479  506  1,973 
Equity in income (losses) of equity method investees  -  -  -  -     - 
Other income  19  -  19  -     - 
Interest income (expense), net  (182) -  (182) (247) (3) (244)
Gain (loss) on sale of equipment  (17) -  (17) (15) -  (15)
Minority interests  -  -  -  (29) 1  (30)
Income tax provision  -  -  -  (166) -  (166)
Income from continuing operations
 
$
(635
)
$
-
 
$
(635
)
$
1,436
 
$
(3
)
$
1,439
 
Plus:
                   
Interest (income) expense, net $182 $- $182 $247 $3 $244 
Income tax provision  -  -  -  166  -  166 
Depreciation & Amortization  220  -  220  216  2  214 
                    
EBITDA from continuing operations
 
$
(233
)
$
-
 
$
(233
)
$
2,065
 
$
2
 
$
2,063
 

  
Years Ended December 31,
 
  
Corporate & Other
 
Consolidated
 
      
Dollar
     
Dollar
 
  
2004
 
2003
 
Change
 
2004
 
2003
 
Change
 
              
Revenue $- $- $- $31,625 $505 $31,120 
Cost of Sales  -  -  -  21,572  -  21,572 
Gross Profit  -  -  -  10,053  505  9,548 
Operating expenses  1,259  1,209  50  9,874  1,715  8,159 
Equity in income (losses) of equity method investees  374  85  289  374  85  289 
Other income  -  -  -  19  -  19 
Interest income (expense), net  24  33  (9) (405) 30  (435)
Gain (loss) on sale of equipment  -  -  -  (32) -  (32)
Minority interests  (27) 276  (303) (56) 277  (333)
Income tax provision  -  -  -  (166) -  (166)
Income from continuing operations
 
$
(888
)
$
(815
)
$
(73
)
$
(87
)
$
(818
)
$
731
 
Plus:
                   
Interest (income) expense, net $(24)$(33)$9 $405  ($30)$435 
Income tax provision  -  -  -  166  -  166 
Depreciation & Amortization  7  61  (54) 443  63  380 
                    
EBITDA from continuing operations
 
$
(905
)
$
(787
)
$
(118
)
$
927
 
$
(785
)
$
1,712
 


-31-



Healthcare

Revenue
Revenue increased $21,866,000 during the year ended December 31, 2004. The increase over 2003 revenue is due primarily to the inclusion of DHI’s revenue since March 25, 2004.

Cost of Sales
Cost of sales was $16,185,000 for the year ended December 31, 2004, representing 74% of revenue. Cost of sales includes all direct costs related to the sale of products in pharmacies. The increase of $16,185,000 in cost of sales for the year ended December 31, 2004 is due primarily to the inclusion of DHI’s cost of sales since March 25, 2004.

Operating Expenses
Operating Expenses increased $6,136,000 for the year ended December 31, 2004. This increase is comprised of an increase of $5,916,000 in selling, general and administrative expenses and an increase of $220,000 in depreciation and amortization. Depreciation and amortization includes $136,000 of amortization for intangible assets recorded in connection with the acquisition of the Park Assets. The increase in operating expenses is due primarily to the inclusion of DHI’s operating expenses, including amortization of Patient Prescriptions, since March 25, 2004.

Other Income
Other income increased $19,000 for the year ended December 31, 2004 due to the inclusion of DHI’s results since March 25, 2004.

Interest Income (Expense), Net
Interest expense, net is comprised of interest expense related to the debt assumed as part of the acquisition of the Park Assets by DHI. Interest expense, net was $182,000 for the year ended December 31, 2004. For the year ended December 31, 2004, interest expense, net increased $182,000 due to inclusion of the DHI results since March 25, 2004.

Real estate advisory services

Revenue
Revenue increased $9,254,000 from $ 505,000 to $9,759,000 during the year ended December 31, 2004. The following are included in real estate advisory services revenue (i) fee revenue earned by CPOC of $8,858,000 and (ii) fee revenue earned by CRESA Capital Markets of $901,000. The increase over 2003 revenue is due primarily to the inclusion of CPOC’s revenue since May 1, 2004.

Cost of Revenue
Cost of revenue was $5,388,000 for the year ended December 31, 2004, representing 55.2% of revenue. Cost of revenue includes all direct costs, including broker commissions, incurred in connection with a real estate advisory transaction. The increase of $5,388,000 in cost of revenue for the year ended December 31, 2004 is due primarily to the inclusion of CPOC’s cost of revenue since May 1, 2004.

Operating Expenses
Operating Expenses increased $1,973,000 from $506,000 to $2,479,000 for the year ended December 31, 2004. This increase includes an increase of $118,000 in selling, general and administrative expenses at Capital Markets due to increased payroll expenses from the addition of professional staff. The increase also includes an increase of $111,000 for depreciation expense at CPOC. The remaining increase in operating expenses is due to the inclusion of CPOC’s selling, general and administrative expenses since May 1, 2004 and increases in staff payroll for CRESA Capital Markets.

Interest Income (Expense), Net
Interest expense, net is comprised of interest expense related to the debt assumed as part of the CPOC acquisition. Interest expense, net was $247,000 for the year ended December 31, 2004. For the year ended December 31, 2004, interest expense, net increased $244,000 due to interest expense of $211,000 on the acquisition note payable to Kevin Hayes and interest expense of $33,000 on other debt assumed in the acquisition of CPOC.

-32-



Corporate and other

Operating Expenses
Operating expenses for the year ended December 31, 2004 were $1,259,000, or an increase of $50,000 over the year ended December 31, 2003. The increase is primarily a result of increased costs for legal, accounting, insurance and salaries due to the additional business activity generated by our acquisitions of the Park Assets and CPOC. Operating expenses of $1,258,000 includes payroll and benefits of $327,000; legal expense of $241,000; insurance expense of $ 182,000; audit and accounting expense of $170,000; SEC, transfer agent and other professional fees of $120,000; non-cash stock compensation expense of $40,000; and other selling, general and administrative expenses of $178,000.

Equity in Income (Losses) of Equity Method Investees
Equity in income (losses) of equity method investees increased $289,000 to $374,000 during the year ended December 31, 2004. The increase is a result of income received from our investment in Fairways 03 New Jersey LP of $208,000 during the year ended December 31, 2004. Equity in income (losses) of equity method investees also includes $82,000 of income recorded from our pro rata share of Ampco’s earnings for the year ended December 31, 2004. Equity in income (losses) of equity method investees also increased $84,000 for the year ended December 31, 2004 due to a gain on the sale of two single tenant commercial properties in which we had an investment through ASE Investments. See Item I, “Business” of Part I for more information.

Interest Income (Expense), Net
Interest income (expense), net decreased from $33,000 to $24,000 during the year ended December 31, 2004 due to decreased interest earned on lower excess cash balances as compared to the year ended December 31, 2003.

LIQUIDITY AND CAPITAL RESOURCES

As of December 31, 2005,2006, we had working capital deficit of approximately $3.5$0.1 million as compared to working capital of approximately $4.3$4.5 million at December 31, 2004.2005. The decrease includes a $1,045,000$4.6 million decrease in working capital relatedis due to an increase in the current portion of notes payable of approximately $3.8 million due to the discontinued operationschange in classification of Park InfusionCare. The decrease is offsetthe Bank of Texas notes payable, in our Healthcare segment, from a long-term liability to a current liability. In addition, the First Republic Bank note payable, in our Real Estate segment, increased the current portion of notes payable by positive changes in$1.2 million.

On February 20, 2007, Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP, each a wholly-owned subsidiary of DHI, entered into a loan agreement with Amegy Bank for a $2,000,000 revolving line of credit and a $2,200,000 term loan. Substantially all of the proceeds from the revolving line of credit and the term loan were used to retire the outstanding balance owed to Bank of Texas, N.A. under an existing credit facility. As a result, under the payments terms of the Amegy Bank revolving line of credit and term loan, we improved the working capital from the real estate advisory services segment and distributions received from the Company’s investment in Fairways NJ.position by approximately $3.7 million.

As of December 31, 2005,2006, we had cash and cash equivalents of approximately $3.2$2.7 million compared to approximately $1.9$3.2 million as of December 31, 2004.2005.

Our future capital needs are uncertain. Although management projects positive cash flow after debt service based on anticipated operations of our acquired businesses, there can be no assurances that this will occur. If the Company does not generate the necessary cash flow, the Company will need additional financing in the future to fund operations. We do not know whether additional financing will be available when needed, or that, if available, we will obtain financing on terms favorable to stockholders.

-35-



Cash from Financing Activities

Dougherty’s Holdings, Inc.
During the yearyears ended December 31, 2006 and 2005, DHI made principal payments on its notes payable of $556,000,$1,170,000 and it$718,000, respectively. DHI also made no$755,000 of new borrowings under its bank credit facility.facility and the insurance premium finance notes payable during the year ended December 31, 2006 whereas no new borrowings were made during the year ended December 31, 2005.

ASDS of Orange County, Inc.

During the first six months of 2006, ASDS made principal payments of $882,000 on its Acquisition Note Payable to Kevin Hayes. In June 2006, ASDS entered into a credit agreement with First Republic Bank for a $5.3 million term note. The proceeds from the term note were used to retire the outstanding balance owed to Kevin Hayes under the Acquisition Note. The Acquisition Note was retired at a discount of approximately $100,000 to its outstanding principal balance of $5,400,000. During the last six months of the year, ASDS paid $900,000 on the First Republic Bank term note. Please see Note 10 of the Ascendant Consolidated Financial Statements contained herein.

During the year ended December 31, 2005, ASDS of Orange County, Inc. (“ASDS”) made principal payments of $718,000 on its Acquisition Note Payable to Kevin Hayes. There were no new borrowings during the year ended December 31, 2005 by either ASDS or CPOC.

In connection with the acquisition of CPOC, the Company was entitled to receive a structuring fee of $690,000, plus interest thereon, of which $230,000 was paid at closing and $230,000 was paid on May 1, 2005. The remainder of $230,000, plus interest thereon is payablewas paid on May 1, 2006. The structuring fee has been eliminated in the consolidation of the Company with CPOC and the Operating LP in the consolidated financial statements of the Company.

-33-



Cash Flow

During the year ended December 31, 20052006 we had positivea decline in cash flow of approximately $1,349,000.$535,000. Cash flow provided from operating activities for the year ended December 31, 20052006 was $4,308,000,$1,091,000 while cash used in investing activities was $1,671,000$70,000 and cash used in financing activities was $1,288,000.$1,556,000. The cash used in investing activities was primarily for purchases of property &and equipment and investments inof $177,000 less net distributions from limited partners of $107,000 which includes the Fairways Frisco.NJ distribution. The cash used in financing activities was primarily related to payments on the acquisition debt for DHI and CPOC.

Through December 31, 2005,2006, we have invested approximately $1.22 million in Fairways Frisco. In September 2005, the Company borrowed $225,000 from a bank and used the proceeds to increase its investment in Fairways Frisco. This unsecured bank note payable was repaid in full in January 2006. The Frisco Square Partnerships and Fairways Frisco will require additional funding in order to complete development of the planned project. We are not obligated to invest any additional funds if Fairways Frisco makes a capital call for additional cash, although we may choose to do so depending on our available funds. However, if we do not participate in additional capital calls, our limited partnership interest will be diluted.

In December 2005, the Company received a cash distribution of approximately $680,000 from Fairways NJ, which represented the Company’s share in the profit from the sale of a single tenant commercial real estate property interest, the sole asset held by Fairways NJ. In addition to the distribution, cash of $162,000, representing the Company’s share of the total escrow, is beingwas held in escrow to fund any amounts owed by Fairways NJ to the purchaser, including any amounts owed for standard representations & warranties under the sale agreement. The balance of the escrow account, if any, is expected to be releasedincluding interest income, totaling approximately $168,000 was received in December 2006.

Our future capital needs are uncertain. Although management projects positive cash flow after debt service based on anticipated operations of our acquired businesses, there can be no assurances that this will occur. If the Company does not generate the necessary cash flow, the Company will need additional financing in the future to fund operations.

-36-



Additionally, if we were to make additional acquisitions, we would likely need additional capital to fund all, or a portion, of those acquisitions. We do not know whether additional financing will be available when needed, or that, if available, we will obtain financing on terms favorable to stockholders.

Tax Loss Carryforwards

At December 31, 2005,2006, we had approximately $54$51 million of federal net operating loss carryforwards andavailable to offset future taxable income, which, if not utilized, will fully expire from 2018 to 2024. In addition, we had approximately $21$2.9 million of state net operating loss carryforwards available to offset future taxable income, which, if not utilized, will fully expire from 20182007 to 2024.2009. We believe that the issuance of shares of our common stock pursuant to our initial public offering on November 15, 1999 caused an “ownership change” for purposes of Section 382 of the Internal Revenue Code of 1986, as amended. Consequently, we believe that the portion of our federal net operating loss carryforwards attributable to the period prior to November 16, 1999 is subject to an annual limitation pursuant to Section 382. Our total deferred tax assets have been fully reserved as a result of the uncertainty of future taxable income. Accordingly, no tax benefit has been recognized in the periods presented.

State Income Taxes

In May 2006, the State of Texas replaced the current franchise tax system with a new Texas Margin Tax (“TMT”). The TMT is a 1% gross receipts tax based on the Company’s taxable margin, as defined by the new law. However, for taxable entities primarily engaged in retail and wholesale trade, the rate is 0.5% of taxable margin. The Company has evaluated the impact of the TMT on our consolidated financial position, results of operations or cash flows and has concluded that the TMT does not appear it will have a material impact on its results of operations.

Off Balance Sheet Arrangements

As discussed in Part I of this Form 10-K, the Company has guaranteed the Acquisition Note in the amount of $6.9 million. The Acquisition Note iswas payable from the excess cash flows of ASDS over a three year period. During the period from May 1, 2004 until December 31, 2005,June 2006, principal payments of $718,000we made paid on the Acquisition Note. In June 2006, ASDS entered into a credit agreement with First Republic Bank for a $5.3 million term note. The proceeds from the term note were paid onused to retire the outstanding balance owed to Kevin Hayes under the Acquisition Note. There were no payments required under the terms of the Company’s guarantee.

In January 2005, the Company agreed to provide a limited indemnification to its partners in the Fairways NJ investment for any losses those partners may incur under their personal guaranties of the partnership’s bank indebtedness. The Company’s partners in this investment are the Fairways Members. The Company’s indemnification to these 4four partners is limited to $520,000 in the aggregate, which is its 20% pro rata partnership interest of the $2.6 million in bank debt that was guaranteed by the individuals. In December 2005, this bank debt was paid in full by Fairways NJ and the personal guarantees, as well as the Company’s indemnification, were cancelled.

-34-



Disclosures About Contractual Obligations and Commercial Commitments

In connection with the acquisition of the Park Assets in 2004, DHI entered into a three year supply agreement with AmerisourceBergen Drug Corporation pursuant to which DHI and its subsidiaries agreed to purchase prescription and over-the-counter pharmaceuticals from AmerisourceBergen through March 2007. This supply agreement will also provideprovided us with pricing and payment terms that are improved from those previously provided by AmerisourceBergen to Park Pharmacy. In exchange for these improved terms, DHI has agreed to acquire 85% of its prescription pharmaceuticals and substantially all of its generic pharmaceutical products from AmerisourceBergen and agreed to minimum monthly purchases of $900,000 of all products in order to obtain new favorable pricing terms. For the years ended December 31, 2006 and 2005 and the period from the date of acquisition through December 31, 2004, DHI purchased over $23,858,000, $23,159,000 and $17,250,000, respectively, of its pharmaceutical products from AmerisourceBergen.

-37-



In December 2006, DHI entered into Amendment No. 1 (“Amendment”) to the supply agreement. The Amendment extends the supply agreement from March 24, 2007 to March 24, 2009. In addition, the Amendment (1) improves the pricing for goods purchased, (2) changes the minimum order volume from $30,000,000 to $50,000,000 over the life of the agreement and (3) the percentage of generic drug purchases was changed from 2.50% to 6.0%. The Amendment also allows for the return of goods, in a saleable condition, within 180 days of the invoice date without a restocking fee and provides for a termination fee if DHI terminates the supply agreement before the expiration of the term of the agreement. The termination fee is a maximum of $50,000 but is reduced for each full month from December 1, 2006 until the date of termination. However, there is no termination fee if the minimum order volume has been satisfied. At December 31, 2006, DHI believes it has satisfied the minimum order volume.

The Amendment also provides for a rebate in the amount of $150,000 representing a 15.0% volume discount off the price of goods for the first $1,000,000 of net purchases purchased in the period after November 1, 2006 providing that DHI makes net purchases in excess of $1 million after November 1, 2006. In December 2006, DHI satisfied the net purchase requirement and received the $150,000 rebate.

A summary of our contractual commitments under debt and lease agreements and other contractual obligations at December 31, 20052006 and the effect such obligations are expected to have on liquidity and cash flow in future periods appears below. This is all forward-looking information and is subject to the risks and qualifications set forth at the beginning of Item 7.

Contractual Obligations
      
As of December 31, 2005
 
Payments due by Period ($-000's omitted)
 
As of December 31, 2006
 
Payments due by Period ($-000's omitted)
 
 Less than 1-3 3-5 More than    Less than 1-3 3-5 More than   
 1 year Years Years 5 years Total  1 year Years Years 5 years Total 
                      
Lease Obligations $1,198,000 2,975,000 831,000 2,292,000 $7,296,000  $1,260,000 $2,147,000 $1,127,000 $2,007,000 $6,541,000 
Notes Payable  650,000  9,585,000  -  - $10,235,000   6,106,000  3,824,000  -  -  9,930,000 
            
Total $1,848,000 $12,560,000 $831,000 $2,292,000 $17,531,000  $7,366,000 $5,971,000 $1,127,000 $2,007,000 $16,471,000 

On February 20, 2007, Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP, each a wholly-owned subsidiary of DHI, entered into a loan agreement with Amegy Bank for a $2,000,000 revolving line of credit and a $2,200,000 term loan. Substantially all of the proceeds from the revolving line of credit and the term loan were used to retire the outstanding balance owed to Bank of Texas, N.A. under an existing credit facility. As a result of this new loan agreement, on February 20, 2007 the note payable payments due in less than one year decreased by approximately $3,757,000 since the new debt payments terms extend the maturity of the revolving line of credit and term loan payments into future years. Please see Note 10 of the Ascendant Consolidated Financial Statements contained herein.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to long-term investments. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.   We believe the following accounting policies and the related judgments and estimates affect the preparation of our consolidated financial statements.

-38-


 
Revenue Recognition
Healthcare revenues are reported at the estimated net realizable amounts expected to be received from individuals, third-party payors, institutional healthcare providers and others. We recognize revenue from the sale of pharmaceutical products and retail merchandise as transactions occur and product is delivered to the customer. Revenue from product sales is recognized at the point of sale and service revenue is recognized at the time services are provided.

CPOC’s primary revenue is from brokerage commissions earned from project leasing and tenant representation transactions. Brokerage commission revenue is generally recorded upon execution of a lease contract, unless additional activities are required to earn the commission pursuant to a specific brokerage commission agreement. Participation interests in rental income are recognized over the life of the lease. Other revenue is recognized as the following consulting services are provided: facility and site acquisition and disposition, lease management, design, construction and development consulting, move coordination and strategic real estate advisory services. Participation interests in rental income are recognized over the life of the lease.


-35-


Long-Term Investments  
Our long-term investments are accounted for using the equity method of accounting for investments and none represent investments in publicly traded companies. The equity method is used as we do not have a majority interest and do not have significant influence over the operations of the respective companies. We also use the equity method for investments in real estate limited partnerships where we own more than 3% to 5% of the limited partnership interests. Accordingly, we record our proportionate share of the income or losses generated by our equity method investees in the income statement. If we receive distributions in excess of our equity in earnings, they are recorded as a reduction of our investment.

The fair value of our long-term investments is dependent upon the performance of the companies in which we have invested, as well as volatility inherent in the external markets for these investments. The fair value of our ownership interests in, and advances to, privately held companies is generally determined based on overall market conditions, availability of capital as well as the value at which independent third parties have invested in similar private equity transactions. We evaluate, on an on-going basis, the carrying value of our ownership interests in and advances to the companies in which we have invested for possible impairment based on achievement of business plan objectives, the financial condition and prospects of the company and other relevant factors, including overall market conditions. Such factors may be financial or non-financial in nature.

If as a result of the review of this information, we believe our investment should be reduced to a fair value below its cost, the reduction would be charged to “loss on investments” on the statements of operations.income. Although we believe our estimates reasonably reflect the fair value of our investments, our key assumptions regarding future results of operations and other factors may not reflect those of an active market, in which case the carrying values may have been materially different than the amounts reported.

Recent Accounting Pronouncements.
In January 2003, the Financial Accounting Standards Board issued FASB interpretation No. 46R (“FIN 46R”), Consolidation of Variable Interest Entities. FIN 46R clarifies the application of Accounting Research Bulletin No. 51, Consolidated Financial Statements to certain entities in which the equity investors do not have either a controlling interest or sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46R is effective for variable interest entities in which we hold a variable interest. FIN 46R will not have an impact on our financial condition or results of operations. The Company has applied the provisions of FIN 46R to its acquisition of CPOC. As a result, CPOC is treated as a consolidated subsidiary in the Company’s consolidated financial statements.

In December 2004, the Financial Accounting Standards Board issued FASB Statement No. 123R (Revised 2004), Share-Based Payment. (“Statement 123R”), which required that the compensation cost relating to share-based payment transactions such as options, restricted share plans, performance based awards, share appreciation rights and employee share purchase plans be recognized in financial statements.

Statement 123R replaces FASB Statement No. 123, Accounting for Stock-Based Compensation and supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees. Statement 123, as originally issued in 1995, established as preferable a fair-value-based method of accounting for share-based payment transactions with employees. However, that statement permitted entities the option of continuing to apply the guidance in Opinion 25, as long as the footnotes to the financial statements disclosed what net income would have been had the preferable fair-value-based method been used.

The Company currently expenses the cost of restricted shares issued to employees and directors over the service vesting period associated with the restricted shares.

-39-



The Company currently has no options outstanding which are not vested. The unrecognized compensation cost related to these options is not material and as a result, the implementation of Statement 123R willdid not have a material impact on the Company’s Stock Based Compensation.

The Company accounts for its employee stock options and stock based awards under the fair value provisions of Statement 123R, which was adopted effective January 1, 2006, whereby stock-based compensation is measured at the grant date based on the value of the awards and is recognized as expense over the requisite service period

(usually the vesting period). See Note 12 for additional information about the Company’s Stock Based Compensation.

In May 2006, the State of Texas replaced the current franchise tax system with a new Texas Margin Tax (“TMT”). The TMT is a 1% gross receipts tax based on the Company’s taxable margin, as defined by the new law. However, for taxable entities primarily engaged in retail and wholesale trade, the rate is 0.5% of taxable margin. The Company has evaluated the impact of the TMT on our consolidated financial position, results of operations or cash flows and has concluded that the TMT does not appear it will have a material impact on our results of operations.

In June 2006, the FASB issued Interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes, effective for fiscal years beginning after December 15, 2006, with early adoption permitted. FIN 48 clarifies the accounting for uncertainty in income taxes recognized in accordance with FASB Statement No. 109, Accounting for Income Taxes, by providing a recognition threshold and measurement guidance for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. We have evaluated the impact of the adoption of this interpretation on our consolidated financial position, results of operations or cash flows and have concluded that it does not appear it will have a material impact on our results of operations.

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”), which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement applies under other accounting pronouncements that require or permit fair value measurements, the FASB having previously concluded in those accounting pronouncements that fair value is the relevant measurement attribute. Accordingly, this Statement does not require any new fair value measurements. SFAS 157 is effective for fiscal years beginning after December 15, 2007. We are currently evaluating the impact, if any; the adoption of SFAS 157 will have on our consolidated financial position, results of operations or cash flows.

In September 2006, the Securities and Exchange Commission ("SEC") staff issued Staff Accounting Bulletin No. 108 ("SAB 108"), "Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements." SAB 108 was issued to provide consistency in how registrants quantify financial statement misstatements. The Company is required to and will initially apply SAB 108 in connection with the preparation of its annual financial statements for the year ending December 31, 2006. The Company does not expect the application of SAB 108 to have a material effect on its financial position and results of operations.

ITEMITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We currently do not engage in commodity futures trading or hedging activities and do not enter into derivative financial instrument transactions for trading or other speculative purposes. We also do not currently engage in transactions in foreign currencies or in interest rate swap transactions that could expose us to market risk.

We are exposed to market risk from changes in interest rates with respect to the credit agreements entered into by our subsidiaries to the extent that the pricing of these agreements is floating.

At December 31, 2006, we were exposed to interest rate risk under the First Republic Bank note payable which bears interest payable monthly at the prime rate of Bank of America minus 0.25% per annum and the $440,000 demand note payable to Ampco Partners, Ltd., which bears interest at the Bank of Texas prime rate plus 4.00%.

-36--40-


We are exposed to interest rate risk as the guarantor of ASDS’s Acquisition Note, which bears interest payable monthly at the prime rate of Northern Trust Bank plus 0.50% per annum. At December 31, 2005, we were also exposed to interest rate risk under the $225,000 term note payable to Comerica Bank, which bears interest at the Comerica Bank prime rate plus 1.00%. However, this note payable to Comerica Bank was paid in full in January 2006.
If the effective interest rate under the Acquisition NoteFirst Republic Bank note and the Comerica Bank termAmpco Partners, Ltd demand note were to increase by 100 basis points (1.00%), our annual financing expense would increase by approximately $68,000,$44,000, based on the average balances outstanding during the year ended December 31, 2005.2006. A 100 basis pointspoint (1.00%) increase in market interest rates would decrease the fair value of our fixed rate debt by approximately $69,000.$23,000. We did not experience a material impact from interest rate risk during the year ended December 31, 2005, respectively.2006.

On February 20, 2007, Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP, each a wholly-owned subsidiary of DHI, entered into a loan agreement with Amegy Bank for a $2,000,000 revolving line of credit and a $2,200,000 term loan. Please see Note 10 of the Ascendant Consolidated Financial Statements contained herein. Outstanding advances under the revolving line of credit will bear interest at the Amegy Bank prime rate and the term loan bears interest at the Amegy Bank’s prime rate plus 0.25%. As a result, we are now exposed to interest rate risk under the Amegy Bank credit facility.

In addition, our ability to finance future acquisitions through debt transactions may be impacted if we are unable to obtain appropriate debt financing at acceptable rates. We are exposed to market risk from changes in interest rates through our investing activities.activities, if any. Our investment portfolio consists primarily of investments in high-grade commercial bank money market accounts. At December 31, 2006, we had no investing activities.

The following table summarizes the financial instruments held by us at December 31, 2005,2006, which are sensitive to changes in interest rates. At December 31, 2005,2006, approximately 63%49% of our debt was subject to changes in market interest rates and was sensitive to those changes. Scheduled principal cash flows for debt outstanding at December 31, 20052006 for the twelve monthsyears ending December 31 are as follows:

 Fixed Rate Variable Total  Fixed Rate Variable Total 
              
2006 $425,000 $225,000 $650,000 
2007  2,994,000  6,182,000  9,176,000  $4,466,000 $1,640,000 $6,106,000 
2008  32,000  -  32,000   43,000  1,200,000  1,243,000 
2009  377,000  -  377,000   581,000  2,000,000  2,581,000 
Thereafter  -  -  -   -  -  - 
 $3,828,000 $6,407,000 $10,235,000  $5,090,000 $4,840,000 $9,930,000 

On February 20, 2007, Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP, each a wholly-owned subsidiary of DHI, entered into a loan agreement with Amegy Bank for a $2,000,000 revolving line of credit and a $2,200,000 term loan. Substantially all of the proceeds from the revolving line of credit and the term loan were used to retire the outstanding balance owed to Bank of Texas, N.A. under an existing credit facility. As a result of this new loan agreement, on February 20, 2007 payments on fixed rate debt due in 2007 decreased by approximately $3,757,000 since the new debt payments terms extend the maturity of the revolving line of credit and term loan payments into future years. Also, due to this new loan agreement, $4,215,000 of the fixed rate debt in 2007 became variable rate debt. Consequently, as of February 20, 2007, approximately 91% of our debt is now subject to changes in market interest rates and is sensitive to those changes. Please see Note 10 of the Ascendant Consolidated Financial Statements contained herein.
 

 

-37--41-



 

 
 
ITEM 8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
 
 
Page
ASCENDANT SOLUTIONS, INC.
 
  
Reports
3943
  
4144
  
4245
  
4346
  
4447
  
4649
  

The financial statements of Park Pharmacy Corporation as of March 24, 2004 and June 30, 2003 and for the period from July 1, 2003 to March 24, 2004 and the years ended June 30, 2003 and 2002 are incorporated herein by reference to Item 8 of Part II of the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2004.

-38--42-


ReportReport of Independent Registered Public Accounting Firm





Board of Directors and Stockholders
Ascendant Solutions, Inc.


We have audited the accompanying consolidated balance sheets of Ascendant Solutions, Inc. and subsidiaries as of December 31, 20052006 and 2004,2005, and the related consolidated statements of operations,income, stockholders’ equity and cash flows for each of the three the years then ended.in the period ended December 31, 2006. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company has determined it is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Ascendant Solutions, Inc. and subsidiaries as of December 31, 2005 and 2004, and the consolidated results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

/s/ HEIN & ASSOCIATES LLP

Dallas, Texas
March 6, 2006

-39-



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors and Stockholders
Ascendant Solutions, Inc.
Dallas, Texas

We have audited the accompanying consolidated statements of operations, stockholders’ equity and cash flows of Ascendant Solutions, Inc. (the “Company”) for the year ended December 31, 2003. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit providesaudits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the results of operations, stockholders’ equity and cash flowsconsolidated financial position of Ascendant Solutions, Inc. and subsidiaries as of December 31, 2003,2006 and 2005, and the consolidated results of their operations and their consolidated cash flows for each of the year thenthree years in the period ended December 31, 2006, in conformity with accounting principlesUnited States generally accepted in the United States of America.accounting principles.


 
/s/ BDO Seidman,HEIN & ASSOCIATES LLP

Dallas, Texas
March 26, 2004

-40-



ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED BALANCE SHEETS
 
(000's omitted, except share amounts)
 
      
  
December 31,
 
December 31,
 
  
2005
 
2004
 
      
ASSETS
 
      
Cash and cash equivalents $3,216 $1,867 
Trade accounts receivable, net  3,492  4,129 
Other receivables  165  156 
Receivable from affiliates  85  71 
Inventories  2,569  2,201 
Prepaid expenses  451  502 
Assets held available for sale  2,207  2,626 
Total current assets  12,185  11,552 
Property and equipment, net  909  629 
Goodwill  7,299  7,299 
Other intangible assets  426  758 
Equity method investments  1,086  410 
Other assets  93  105 
Total assets
 
$
21,998
 
$
20,753
 
        
LIABILITIES AND STOCKHOLDERS' EQUITY
        
Accounts payable $2,583 $1,407 
Accrued liabilities  2,516  3,098 
Notes payable, current  650  456 
Liabilities related to assets held available for sale  2,897  2,271 
Total current liabilities  8,646  7,232 
Notes payable, long-term  9,585  10,178 
Minority interests  694  464 
Total liabilities
  
18,925
  
17,874
 
Commitments and contingencies (Notes 11 & 17)       
        
Stockholders' equity:       
Common stock, $0.0001 par value; 50,000,000 shares authorized; 22,180,900 and 21,933,400 shares issued and outstanding at December 31, 2005 and 2004, respectively  2  2 
Additional paid-in capital  60,078  59,961 
Deferred compensation  (66) (78)
Accumulated deficit  (56,941) (57,006)
Total stockholders' equity
  
3,073
  
2,879
 
Total liabilities and stockholders' equity
 
$
21,998
 
$
20,753
 
        
See accompanying notes to the Consolidated Financial Statements
April 11, 2007



-41-



ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF OPERATIONS
 
(000's omitted, except share and per share amounts)
 
        
  
Years Ended December 31,
 
  
2005
 
2004
 
2003
 
Revenue:          
Healthcare $29,957 $21,866 $- 
Real estate advisory services  13,831  9,759  505 
   43,788  31,625  505 
Cost of sales:          
Healthcare  21,959  16,185  - 
Real estate advisory services  8,205  5,387  - 
   30,164  21,572  - 
Gross profit  13,624  10,053  505 
           
Operating expenses:          
Selling, general and administrative expenses  12,012  9,373  1,540 
Non-cash stock compensation  81  58  - 
Impairment charges  -  -  112 
Depreciation and amortization  611  443  63 
Total operating expenses  12,704  9,874  1,715 
Operating income (loss)  920  179  (1,210)
Equity in income of equity method investees  675  374  66 
Other income  73  19  19 
Interest income (expense), net  (658) (405) 30 
Loss on sale of property and equipment  (1) (32) - 
Income (loss) before minority interest and income tax provision  1,009  135  (1,095)
Minority interest  50  56  (277)
Income tax provision  241  166  - 
Income (loss) from continuing operations  718  (87) (818)
Income (loss) from discontinued operations  (653) 336  - 
Net income (loss) $65 $249 $(818)
           
Basic net income (loss) per share          
Continuing operations $0.03  * $(0.04)
Discontinued operations $(0.03)$0.02 $- 
  $0.00 $0.01 $(0.04)
Diluted net income (loss) per share          
Continuing operations $0.03  * $(0.04)
Discontinued operations $(0.03)$0.02 $- 
  $0.00 $0.01 $(0.04)
* Less than $0.01 per share          
           
Average common shares outstanding, basic  22,006,733  21,803,817  21,557,150 
Average common shares outstanding, diluted  22,877,704  22,389,267  21,557,150 
           
See accompanying notes to the Consolidated Financial Statements.


-42-



ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
 
(000's omitted, except share amounts)
 
              
              
  
Common Stock
 
Additional
     
Total
 
  
Class A
 
Paid-in
 
Deferred
 
Accumulated
 
Stockholders'
 
  
Shares
 
Amount
 
Capital
 
Compensation
 
Deficit
 
Equity
 
              
Balance at January 1, 2003
  
21,230,900
 
$
2
 
$
59,822
 
$
(81
)
$
(56,437
)
$
3,306
 
Issuance of restricted stock to officers  435,000  -  -  -  -  - 
Amortization of deferred compensation  -  -  -  35  -  35 
Net loss  -  -  -  -  (818) (818)
Balance at December 31, 2003
  
21,665,900
 
$
2
 
$
59,822
 
$
(46
)
$
(57,255
)
$
2,523
 
Exercise of stock options  200,000  -  49  -  -  49 
Non-cash stock option compensation  -  -  18  -  -  18 
Issuance of restricted stock to officers & directors  67,500  -  72  (72) -  - 
Amortization of deferred compensation  -  -  -  40  -  40 
Net income  -  -  -  -  249  249 
Balance at December 31, 2004
  
21,933,400
 
$
2
 
$
59,961
 
$
(78
)
$
(57,006
)
$
2,879
 
Exercise of stock options  200,000  -  48  -  -  48 
Issuance of restricted stock to directors  47,500  -  69  (69) -  - 
Amortization of deferred compensation  -  -  -  81  -  81 
Net income  -  -  -  -  65  65 
Balance at December 31, 2005
  
22,180,900
 
$
2
 
$
60,078
 
$
(66
)
$
(56,941
)
$
3,073
 

See accompanying notes to the Consolidated Financial Statements.


-43-



ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(000's omitted)
 
  
  
Years Ended December 31,
 
  
2005
 
2004
 
2003
 
Operating Activities
       
           
Net income (loss) $65 $249 $(818)
Adjustments to reconcile net income (loss) to net cash          
provided by (used in) operating activities:          
Provision for doubtful accounts  143  161  - 
Depreciation and amortization  611  443  63 
Deferred compensation amortization  81  41  35 
Non-cash equity in losses (income) of equity method investees          
Fairways Frisco, LP  537  -  - 
Fairways 03 New Jersey, LP  (162) -  - 
Non-cash stock option compensation  -  18  - 
Loss on sale of property and equipment  1  41  - 
Impairment charges  -  -  112 
Minority interest  50  56  (277)
Loss (income) from discontinued operations  653  (336) - 
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable  494  (274) (3)
Inventories  (368) (188) - 
Prepaid expenses and other assets  40  (52) 13 
Accounts payable  1,176  (59) (21)
Accrued liabilities  (582) 178  10 
           
Net cash provided by (used in) continuing operations  2,739  278  (886)
Net cash provided by discontinued operations  1,569  1,481  - 
Net cash provided by (used in) operating activities  4,308  1,759  (886)
           
Investing Activities
          
           
Return of capital distributions  13  30�� 46 
Proceeds from sale of property and equipment  -  38  - 
Deferred acquisition costs  -  310  (310)
Net cash acquired in acquisitions  -  1,614  - 
Purchases of property and equipment  (560) (160) (32)
Distributions to limited partners  (50) (31) - 
Investment in limited partnerships  (1,065) (155) (146)
Return of investment in limited partnerships  -  -  145 
Payment of acquisition liabilities  -  (1,350) - 
           
Net cash provided by (used in) continuing operations  (1,662) 296  (297)
Net cash used in discontinued operations  (9) (15) - 
Net cash provided by (used in) investing activities  (1,671) 281  (297)

ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED BALANCE SHEETS
 
(000's omitted, except par value and share amounts)
 
      
  
December 31,
 
December 31,
 
  
2006
 
2005
 
      
ASSETS
 
      
Cash and cash equivalents $2,686 $3,221 
Trade accounts receivable, net  5,339  5,108 
Other receivables  387  171 
Receivable from affiliates  66  85 
Inventories, net  2,832  2,827 
Prepaid expenses  637  452 
Total current assets  11,947  11,864 
Property and equipment, net  1,019  1,222 
Goodwill  7,299  7,299 
Other intangible assets  95  426 
Equity method investments  419  1,086 
Other assets  260  101 
Total assets
 
$
21,039
 
$
21,998
 
        
LIABILITIES AND STOCKHOLDERS' EQUITY
        
Accounts payable $2,293 $3,455 
Accrued liabilities  3,634  2,852 
Notes payable, current  6,106  1,049 
Total current liabilities  12,033  7,356 
Notes payable, long-term  3,824  10,875 
Minority interests  947  694 
Total liabilities
  
16,804
  
18,925
 
Commitments and contingencies (Notes 10 and 15)       
        
Stockholders' equity:       
Common stock, $0.0001 par value; 50,000,000 shares authorized; 22,508,170 and 22,180,900 shares issued and outstanding at December 31, 2006 and 2005, respectively  2  2 
Additional paid-in capital  60,176  60,078 
Deferred compensation  (25) (66)
Accumulated deficit  (55,918) (56,941)
Total stockholders' equity
  
4,235
  
3,073
 
Total liabilities and stockholders' equity
 
$
21,039
 
$
21,998
 
        
See accompanying notes to the Consolidated Financial Statements


-44-




ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF CASH FLOWS, Continued
 
(000's omitted)
 
  
  
  
Years Ended December 31,
 
  
2005
 
2004
 
2003
 
Financing Activities
          
           
Proceeds from exercise of common stock purchase options  48  49  - 
Proceeds from sale of limited partnership interests  230  230  239 
Payments on notes payable  (1,287) (1,058) - 
Proceeds from notes payable  341  -  - 
           
Net cash provided by (used in) continuing operations  (668) (779) 239 
Net cash used in discontinued operations  (620) (1,400) - 
Net cash (used in) provided by financing activities  (1,288) (2,179) 239 
           
Net increase (decrease) in cash and cash equivalents  1,349  (139) (944)
Cash and cash equivalents at beginning of year  1,867  2,006  2,950 
           
Cash and cash equivalents at end of year $3,216 $1,867 $2,006 
           
Supplemental Cash Flow Information
          
Cash paid for income taxes $502 $- $- 
Cash paid for interest on notes payable $728 $497 $- 
           
See accompanying notes to the Consolidated Financial Statements.
ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF INCOME
 
(000's omitted, except share and per share amounts)
 
        
  
Years Ended December 31,
 
  
2006
 
2005
 
2004
 
Revenue:         
Healthcare $41,062 $39,136 $29,532 
Real estate advisory services  14,355  13,831  9,759 
   55,417  52,967  39,291 
Cost of sales:          
Healthcare  28,048  26,517  19,668 
Real estate advisory services  8,404  8,205  5,387 
   36,452  34,722  25,055 
Gross profit  18,965  18,245  14,236 
           
Operating expenses:          
Selling, general and administrative expenses  16,190  16,910  13,054 
Non-cash stock compensation  40  81  58 
Depreciation and amortization  713  652  494 
Total operating expenses  16,943  17,643  13,606 
Operating income  2,022  602  630 
Equity in income of equity method investees  (356) 675  374 
Other income  155  73  19 
Interest income (expense), net  (758) (763) (520)
Loss on sale of property and equipment  -  (1) (32)
Income before minority interest and income tax provision  1,063  586  471 
Minority interest  65  50  56 
Income tax provision  205  241  166 
Income from continuing operations  793  295  249 
Income (loss) from discontinued operations  230  (230) - 
           
Net income $1,023 $65 $249 
           
Basic net income (loss) per share          
Continuing operations $0.04 $0.01 $0.01 
Discontinued operations $0.01 $(0.01)$- 
  $0.05  * $0.01 
Diluted net income (loss) per share          
Continuing operations $0.04 $0.01 $0.01 
Discontinued operations $0.01 $(0.01)$- 
  $0.05  * $0.01 
* Less than $0.01 per share          
           
Average common shares outstanding, basic  22,409,814  22,006,733  21,803,817 
Average common shares outstanding, diluted  22,675,722  22,877,704  22,389,267 
See accompanying notes to the Consolidated Financial Statements.


-45-



ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
 
(000's omitted, except share amounts)
 
              
              
  
Common Stock
 
Additional
     
Total
 
  
Class A
 
Paid-in
 
Deferred
 
Accumulated
 
Stockholders'
 
  
Shares
 
Amount
 
Capital
 
Compensation
 
Deficit
 
Equity
 
              
Balance at December 31, 2003
  
21,665,900
 
$
2
 
$
59,822
 
$
(46
)
$
(57,255
)
$
2,523
 
Exercise of stock options  200,000  -  49  -  -  49 
Non-cash stock option compensation  -  -  18  -  -  18 
Issuance of restricted stock to officers & directors  67,500  -  72  (72) -  - 
Amortization of deferred compensation  -  -  -  40  -  40 
Net income  -  -  -  -  249  249 
Balance at December 31, 2004
  
21,933,400
 
$
2
 
$
59,961
 
$
(78
)
$
(57,006
)
$
2,879
 
Exercise of stock options  200,000  -  48  -  -  48 
Issuance of restricted stock to directors  47,500  -  69  (69) -  - 
Amortization of deferred compensation  -  -  -  81  -  81 
Net income  -  -  -  -  65  65 
Balance at December 31, 2005
  
22,180,900
 
$
2
 
$
60,078
 
$
(66
)
$
(56,941
)
$
3,073
 
Exercise of stock options  200,000  -  48  -  -  48 
Issuance of restricted stock to directors  127,270  -  50  (15) -  35 
Amortization of deferred compensation  -  -  -  56  -  56 
Net income  -  -  -  -  1,023  1,023 
Balance at December 31, 2006
  
22,508,170
 
$
2
 
$
60,176
 
$
(25
)
$
(55,918
)
$
4,235
 
                    
See accompanying notes to the Consolidated Financial Statements.


ASCENDANT SOLUTIONS, INC.-46-



ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(000's omitted)
 
  
  
Years Ended December 31,
 
  
2006
 
2005
 
2004
 
Operating Activities
       
        
Net income $1,023 $65 $249 
Adjustments to reconcile net income to net cash          
provided by operating activities:          
Provision for doubtful accounts  451  374  260 
Depreciation and amortization  713  652  494 
Deferred compensation amortization  56  81  40 
Issuance of stock in lieu of directors fees  35  -  18 
Non-cash equity in losses (income) of equity method investees          
Fairways Frisco, LP  458  537  - 
Fairways 03 New Jersey, LP  -  (162) - 
Income from early extinguishment of debt  (100) -  - 
Loss on sale of property and equipment  -  1  32 
Minority interest  65  50  56 
Discontinued operations  -  -  - 
Changes in operating assets and liabilities, net of effects from acquisitions:          
Accounts receivable  (682) 868  922 
Inventories  (5) (329) (165)
Prepaid expenses and other assets  (543) 46  (103)
Accounts payable  (1,162) 1,822  16 
Accrued liabilities  782  (309) 140 
Net cash provided by operating activities  1,091  3,696  1,959 
           
Investing Activities
          
           
Distributions from limited partnerships  149  13  29 
Proceeds from sale of property and equipment  -  -  42 
Deferred acquisition costs  -  -  310 
Net cash acquired in acquisitions  -  -  1,537 
Purchases of property and equipment  (177) (569) (172)
Distributions to limited partners  (42) (50) (31)
Investment in limited partnerships  -  (1,065) (155)
Payment of acquisition liabilities  -  -  (1,350)
Purchase cost of acquisitions, net of cash acquired  -  -  (857)
Net cash used in investing activities  (70) (1,671) (647)


-47-



ASCENDANT SOLUTIONS, INC.
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(000's omitted)
 
  
  
Years Ended December 31,
 
  
2006
 
2005
 
2004
 
Financing Activities
       
        
Proceeds from exercise of common stock options  48  48  49 
Proceeds from sale of limited partnership interests  230  230  230 
Payments on notes payable  (8,472) (1,291) (1,729)
Proceeds from notes payable  6,638  341  - 
Net cash used in financing activities  (1,556) (672) (1,450)
           
Net increase (decrease) in cash and cash equivalents  (535) 1,353  (138)
Cash and cash equivalents at beginning of year  3,221  1,868  2,006 
           
Cash and cash equivalents at end of year $2,686 $3,221 $1,868 
           
Supplemental Cash Flow Information
          
Cash paid for income taxes $205 $502 $- 
Cash paid for interest on notes payable $740 $728 $497 
Noncash financing activities:
         
Partnership distributions applied to note payable $60 $- $- 
Property and equipment acquired under capital leases $- $258 $- 
           
See accompanying notes to the Consolidated Financial Statements.






-48-

Ascendant Solutions, Inc.
Notes to Consolidated Financial Statements



 
1.
OrganizationOrganization and Significant Accounting Policies
 
Description of Business
 
Ascendant Solutions, Inc. (“Ascendant” or “the Company”) is a diversified financial services company which is seeking to or has invested in or acquired healthcare, manufacturing, distribution or service companies. The Company also conducts various real estate activities, performing real estate advisory services for corporate clients, and, through an affiliate, purchase real estate assets, as a principal investor.
 
The following is a summary of the Company’s identifiable business segments, consolidated subsidiaries and their related business activities:
 
Business Segment
Subsidiaries
Principal Business Activity
HealthcareDougherty’s Holdings, Inc. and SubsidiariesHealthcare products and services provided through retail pharmacies , including specialty compounding pharmacy services and home infusion therapy centers
   
Real estate advisory services
CRESA Partners of Orange County, L.P., ASDS of Orange County, Inc.,
CRESA Capital Markets Group, L.P.
Tenant representation, lease management services, capital markets advisory services and strategic real estate advisory services
   
Corporate & other
Ascendant Solutions, Inc. and
ASE Investments Corporation
Corporate administration, investments not included in other segmentsAmpco Partners, Ltd., Fairways Frisco, L.P. and Fairways 03 New Jersey, L.P.

Through early 2001, the Company had been engaged in providing call center, order management and fulfillment services, portions of which were sold or otherwise wound down by July 1, 2001. From July 1, 2001 and continuing through December 31, 2002, the Company had no revenue producing contracts or operations. In December 2001, the Company revised its strategic direction to seek acquisition possibilities throughout the United States or enter into other business endeavors.

-46--49-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



During 2002, the Company made its first investments, and it has continued to make additional investments and acquisitions throughout 2003, 2004 and 2005. A summary of the Company’s investment and acquisition activity is shown in the table below:

Date
Entity
Business Segment
Transaction Description
% Ownership
April 2002Ampco Partners, LtdCorporate & otherInvestment in a non-sparking, non-magnetic safety tool manufacturing company10%
     
August 2002VTE, L.P.Corporate & otherInvestment to acquire early stage online electronic ticket exchange company23%
     
October 2002
CRESA Capital Markets Group, L.P.,
ASE Investments Corporation
Real estate advisory servicesInvestment to form real estate capital markets and strategic advisory services companies80%
     
November 2003Fairways 03 New Jersey, L.P.Corporate & otherInvestment in a single tenant office building20%
     
March 2004Dougherty’s Holdings, Inc. and SubsidiariesHealthcareAcquisition of specialty pharmacies and therapy infusion centers100%
     
April 2004Fairways 36864, L.P.Corporate & otherInvestment in commercial real estate properties24.75%
     
May 2004
CRESA Partners of Orange County, L.P.,
ASDS of Orange County, Inc.
Real estate advisory servicesAcquisition of tenant representation and other real estate advisory services company99%
     
December 2004Fairways Frisco, L.P.Corporate & otherInvestment in a mixed-use real estate development14%
8.87%1

1 The Company was the initial limited partner in Fairways Frisco, L.P. (“Fairways Frisco”), which obtained a 50% ownership interest in the Frisco Square Partnerships on December 31, 2004. Fairways Frisco L.P. subsequently sold additional limited partnership interests and the Company as of September 2006 now owns approximately 8.87% of Fairways Frisco, L.P.

Certain of these transactions involved related parties or affiliates as more fully described in Notes 2 and 1816 of these consolidated financial statements.

The Company will continue to look for acquisition opportunities, however, its current cash resources are limited and it will be required to expend significant executive time to assist the management of its acquired businesses. The Company will continue seeking to (1) most effectively deploy its remaining cash and debt capacity (if any) and (2) capitalize on the experience and contacts of its officers and directors.directors and (3) explore other acquisition and investing opportunities.

-50-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Significant Accounting Policies  

Basis of Presentation  
The consolidated financial statements include the accounts of Ascendant and all subsidiaries for which the Company owns greater than 50% of the voting equity interests or has significant influence over operations. All intercompany balances and transactions have been eliminated. The limited partnership interests for the consolidated subsidiaries and related minority interests are included on the balance sheet as Minority Interests.  

-47-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



The results of operations of CRESA Partners of Orange County, LP (“CPOC”) have been consolidated with ASDS of Orange County, Inc. (“ASDS”) and ultimately the Company, in accordance with FIN 46R “Consolidation of Variable Interest Entities”, until such time that ASDS has received cumulative distributions equal to $6.9 million (the Purchase Price) plus a preferential return of approximately $1.7 million (total distributions of $8.6 million). As of December 31, 2006, the Company has received distributions totaling approximately $3,515,000. When and if the total distributions equal to $8.6 million are fully paid, the Company’s residual interest will become 10% (through ASDS) and the principles of consolidation for financial reporting purposes will no longer be satisfied under FIN 46R or APB 18, “Equity Method for Investments in Common Stock”. Accordingly, the Company would no longer consolidate the results of operations of CPOC and would instead record its share of income from CPOC as “Equity in income of equity method investees” in the consolidated statementstatements of operations.income.

Use of Estimates  
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported consolidated financial statements and accompanying notes, including allowance for doubtful accounts, inventory reserves and recoverability &and valuation of equity method investments. Actual results could differ from those estimates.  

Cash and Cash Equivalents  
The Company classifies all highly liquid investments with original maturities of three months or less as cash equivalents. Cash equivalents are stated at cost, which approximates fair value.  

Concentration of Credit Risk
The Company’s credit risk relates primarily to its trade accounts receivables and its receivables from affiliates, along with cash deposits maintained at financial institutions in excess of federally insured limits. Management performs continuing evaluations of debtors’ financial condition and provides an allowance for uncollectible accounts as determined necessary. See Note 43 for additional information regarding the Company’s trade accounts receivable, allowance for doubtful accounts and significant customer relationships.

Property and Equipment  
Property and equipment is carried at cost. Depreciation and amortization are provided over the estimated useful lives of the assets (generally three to seven years) using the straight-line method. Leasehold improvements are amortized on a straight-line basis over the lesser of the respective lease term or estimated useful life of the asset.  See Note 76 for additional information regarding property and equipment.

Inventories
Inventories consists of healthcare product finished goods held for resale, valued at the lower of cost, using the first-in, first-out method, or market. The Company provides an estimated reserve against inventory for excess, slow moving and obsolete inventory as well as inventory whose carrying value is in excess of its net realizable value. See Note 54 for additional information regarding inventories.

-51-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Long-Lived Assets  
The Company evaluates the carrying value of its long-lived assets by comparing the undiscounted cash flows over the remaining useful life of the long-lived assets with the assets’ carrying value. If this comparison indicates that the carrying value will not be recoverable, the carrying value of the long-lived assets will be reduced accordingly based on a discounted cash flow analysis. During the year ended December 31, 2003, the Company recorded anNo impairment provision of approximately $112,000 related to VTE’s investment of certain computer software and hardware. No impairment was recorded in 20052006 or 2004.2005.


-48-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


Equity Method Investments 
Equity method investments represent investments in limited partnerships accounted for using the equity method of accounting for investments, and none represent investments in publicly traded companies. The equity method is used as the Company does not have a majority interest and does not have significant influence over the operations of the respective companies. The Company also uses the equity method for investments in real estate limited partnerships where it owns more than 3% to 5% of the limited partnership interests. Accordingly, the Company records its proportionate share of the income or losses generated by equity method investees in the consolidated statements of operations.income. If the Company receives distributions in excess of its equity in earnings, they are recorded as a reduction of its investment.

Revenue Recognition  
Healthcare revenues are reported at the estimated net realizable amounts expected to be received from individuals, third-party payors, institutional healthcare providers and others. The Company recognizes revenue from the sale of pharmaceutical products and retail merchandise as transactions occur and product is delivered to the customer. Revenue from product sales is recognized at the point of sale and service revenue is recognized at the time services are provided.

CPOC’s primaryReal estate advisory services revenue is from brokerage commissions earned from project leasing and tenant representation transactions. Brokerage commission revenue is generally recorded upon execution of a lease contract, unless additional activities are required to earn the commission pursuant to a specific brokerage commission agreement. Participation interests in rental income are recognized over the life of the lease. Other revenue is recognized as the following consulting services are provided: facility and site acquisition and disposition, lease management, design, construction and development consulting, move coordination and strategic real estate advisory services. Participation interests in rental income are recognized over the life of the lease.

Income Taxes  
The Company’s income taxes are presented utilizing an asset and liability approach, and deferred taxes are determined based on the estimated future tax effects of differences between the financial statement and tax bases of assets and liabilities given the provisions of the enacted tax laws. Valuation allowances are established for deferred tax assets where management believes it is more likely than not that the deferred tax asset will not be realized.

Net Income (Loss) Per Share
Basic and diluted net income (loss) per share is computed based on the net income (loss) applicable to common stockholders divided by the weighted average number of shares of common stock outstanding during each period. Potentially dilutive securities consisting of warrants and stock options were not included in the calculation for the year ended December 31, 2003 as their effect is anti-dilutive. The number of potentially dilutive securities excluded from the computation of diluted net loss per share was approximately 270,000 for the year ended December 31, 2003. The number of dilutive shares resulting from assumed conversion of stock options and warrants are determined by using the treasury stock method.  See Note 1614 for more information regarding the calculation of net income (loss) per share.

Impairment of goodwill and other intangible assets
The Company has adopted a policy of recording an impairment loss on goodwill and other intangible assets when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amount. Goodwill and other intangible assets are assessed for impairment on at least an annual basis by management.

Recent Accounting Pronouncements
In December 2003, the FASB revised FASB interpretation No. 46R (“FIN 46R”), Consolidation of Variable Interest Entities. FIN 46R clarifies the application of Accounting Research Bulletin No. 51, Consolidated Financial Statements to certain entities in which the equity investors do not have either a controlling interest or sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties.

-49--52-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


FIN 46R is effective for variable interest entities in which we hold a variable interest. FIN 46R will not have an impact on our financial condition or results of operations. The Company has applied the provisions of FIN 46R to its acquisition of CPOC. As a result, CPOC is treated as a consolidated subsidiary in the Company’s consolidated financial statements.

Recent Accounting Pronouncements
In December 2004, the Financial Accounting Standards Board issued FASB Statement No. 123R (Revised 2004), Share-Based Payment. (“Statement 123R”), which requires that the compensation cost relating to share-based payment transactions such as options, restricted share plans, performance based awards, share appreciation rights and employee share purchase plans be recognized at fair value in financial statements.

Statement 123R replaces FASB Statement No. 123, Accounting for Stock-Based Compensation and supersedes APB Opinion No. 25, Accounting for Stock Issued to Employees. Statement 123, as originally issued in 1995, established as preferable a fair-value-based method of accounting for share-based payment transactions with employees. However, that statement permitted entities the option of continuing to apply the guidance in Opinion 25, as long as the footnotes to the financial statements disclosed what net income would have been had the preferable fair-value-based method been used.

The Company currently expenses the cost of restricted shares issued to employees and directors over the service vesting period associated with the restricted shares. The Company currently has no options outstanding which are not vested. The unrecognized compensation cost related to these options is not material and as a result, the implementation of Statement 123R willdid not have a material impact on its results of operations.

The Company accounts for its employee stock options and stock based awards under the fair value provisions of Statement 123R, which was adopted effective January 1, 2006, whereby stock-based compensation is measured at the grant date based on the value of the awards and is recognized as expense over the requisite service period (usually the vesting period). See Note 12 for additional information about the Company’s Stock Based Compensation.

In May 2006, the State of Texas replaced the current franchise tax system with a new Texas Margin Tax (“TMT”). The TMT is a 1% gross receipts tax based on the Company’s taxable margin, as defined by the new law. However, for taxable entities primarily engaged in retail and wholesale trade, the rate is 0.5% of taxable margin. The Company has evaluated the impact of the TMT on our consolidated financial position, results of operations or cash flows and has concluded that the TMT does not appear it will have a material impact on its results of operations.

In June 2006, the FASB issued Interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes, effective for fiscal years beginning after December 15, 2006, with early adoption permitted. FIN 48 clarifies the accounting for uncertainty in income taxes recognized in accordance with FASB Statement No. 109, Accounting for Income Taxes, by providing a recognition threshold and measurement guidance for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company has evaluated the impact of the adoption of this interpretation on its consolidated financial position, results of operations or cash flows and has concluded that it does not appear that FIN 48 will have a material impact on its results of operations.

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”), which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement applies under other accounting pronouncements that require or permit fair value measurements, the FASB having previously concluded in those accounting pronouncements that fair value is the relevant measurement attribute. Accordingly, this Statement does not require any new fair value measurements. SFAS 157 is effective for fiscal years beginning after December 15, 2007. The Company is currently evaluating the impact, if any; the adoption of SFAS 157 will have on its consolidated financial position, results of operations or cash flows.

In September 2006, the Securities and Exchange Commission ("SEC") staff issued Staff Accounting Bulletin No. 108 ("SAB 108"), "Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements." SAB 108 was issued to provide consistency in how registrants quantify financial statement misstatements. The Company is required to and will initially apply SAB 108 in connection with the preparation of its annual financial statements for the year ending December 31, 2006.

-53-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


The Company does not expect the application of SAB 108 to have a material effect on its financial position and results of operations.

Stock Based Compensation  
The Company accounts for its employee stock options and stock based awards utilizing the intrinsic value method, whereby, if the exercise price of an employee’s stock option equals or exceeds the market price of the underlying stock on the date of the grant, no compensation expense is recognized. The Company currently applies APB Opinion No. 25 and related interpretations in accounting for its Long-Term Incentive Plan (the “Plan”). Had compensation cost been recognized consistent with SFAS No. 123, the Company’s net income (loss) attributable to common stockholders and net income (loss) per share would have been adjusted to the pro forma amounts indicated below for the years ended December 31, 2005, 2004 and 2003:

  
2005
 
2004
 
2003
 
Net income (loss) attributable to common stockholders as reported $65,000 $249,000 $(818,000)
           
Total stock-based employee compensation included in reported net income (loss), net of related tax effects  -  18,000  - 
Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects  (10,000) (88,000) (35,000)
           
Pro forma net income (loss) $55,000 $179,000 $(853,000)
           
Net income (loss) per share:          
Basic - as reported $0.00 $0.01 $(0.04)
Basic - pro forma $0.00 $0.01 $(0.04)
Diluted - as reported $0.00 $0.01 $(0.04)
Diluted - pro forma $0.00 $0.01 $(0.04)


-50-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


The Company used the Black-Scholes option-pricing model to determine under the fair value provisions of grants made during 2002. The following weighted average assumptions were applied in determiningStatement 123R, which was adopted effective January 1, 2006, whereby stock based compensation is measured at the pro forma compensation cost: risk free interest rate - 4.69%, expected option life in years - 6.00, expected stock price volatility - 1.837grant date based on the value of awards and expected dividend yield - 0.00%is recognized as expense over the requisite service period (usually the vesting period). See Note 1412 for additional information on stock options.based compensation.

Fair Value of Financial Instruments  
The Company’s financial instruments include cash, accounts receivable and accounts payable that are carried at cost, which approximates fair value because of the short maturity of these instruments. The fair value of notes payable approximates carrying value as interest rates approximate market rates. The fair value of equity method investments is not readily determinable without undo cost.

Reclassifications
Certain prior year balances have been reclassified to conform to the current year presentation.
Discontinued Operations

As disclosed in a Current Report on Form 8-K filed on May 24, 2006, the board of directors decided to retain the operations of Park InfusionCare, which had previously been reported as a discontinued operation while the Company was pursuing a potential disposition or strategic transaction for its infusion therapy business. As a result of the board of director’s decision to retain the operations of Park InfusionCare, the Company has reported the operating results of Park InfusionCare as part of continuing operations. The Company had previously recorded an estimated charge of $230,000 for employee retention costs directly related to any potential disposition or strategic transaction for Park InfusionCare. As no such transaction was consummated, none of these retention costs were paid and the Company has recorded a reversal of this accrual as part of results from discontinued operations in the accompanying consolidated statements of income for the year ended December 31, 2006. All other Park InfusionCare amounts in this Form 10-K for the years ended December 31, 2006 and 2005 have been reported as part of continuing operations. 

2. Significant Equity Investments

Fairways 03 New Jersey, LP

During December 2003, the Company made a capital contribution of $145,000 to Fairways 03 New Jersey, LP (“Fairways NJ”) which, through a partnership with an institutional investor, acquired the stock of a company whose sole asset was a single tenant office building and entered into a long-term credit tenant lease with the former owner of the building. In December 2003, subsequent to the closing of this transaction, the Company’s capital contribution of $145,000 was distributed back. The Company received a distribution of approximately $680,000 on December 30, 2005 from Fairways NJ, which represented the Company’s share in the profit from the sale of a single tenant commercial real estate property interest, the sole asset held by Fairways NJ. In addition to the distribution, cash of $162,000, representing the Company’s share of the total escrow, iswas being held in escrow to fund any amounts owed by Fairways NJ to the purchaser, including any amounts owed for standard representations &and warranties under the sale agreement. The balance of the escrow account, if any, is expected to be releasedincluding interest income, totaling approximately $168,000 was received in December 2006. Since the date of the property interest acquisition, the Company has received cumulative cash distributions of approximately $1,280,000$1,448,000 on its initial investment of $145,000 in Fairways NJ.

-54-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Fairways Frisco Partnerships

On December 31, 2004, Fairways Frisco, L.P. (Fairways Frisco)(“Fairways Frisco”) acquired certain indirect interests in various partnerships (the “Frisco Square Partnerships”) that own properties (the “Properties”) in the Frisco Square mixed-use real estate development in Frisco, Texas, pursuant to a Master Agreement Regarding Frisco Square Partnerships (“Master Agreement”).Texas. Frisco Square is planned to include approximately 4 million developed square feet, including retail, offices, hotel, multi-family residences and municipal space.

The parties toUnder the Master Agreement wereterms of the amended Frisco Square Partnerships agreements, Fairways Group,Equities is the sole general partner of the Frisco Square Partnerships Cole and Mary Pat McDowell,controls all operating activities, financing activities and development activities for the remainder of the Five Star Group which is Five Star Development Co., Inc., a Texas corporation, CMP Management, LLC, a Texas limited liability company, and CMP Family Limited Partnership, a Texas limited partnership. "Frisco Square Partnerships" is a group of entities comprised of Frisco Square Ltd. ("FSLTD"), Frisco Square B1-6 F1-11, Ltd., a Texas limited partnership, Frisco Square B1-7 F1-10, Ltd., a Texas limited partnership, and Frisco Square Properties, Ltd., a Texas limited partnership. "Fairways Group" is a group of entities comprised of Fairways Frisco, Fairways B1-6 F1-11, LLC, a Texas limited liability company, Fairways B1-7 F1-10, LLC, a Texas limited liability company, and Fairways FS Properties, LLC, a Texas limited liability company.Partnerships.

As further described herein, the Company holds a limited partnership interest in Fairways Frisco. The Company is not involved in the development or management of Frisco Square,Square; rather it is solely a limited partner.

-51-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


The Company has invested $1,219,000 of cash into Fairways Frisco and holds a 14% limited partnership interest as of December 31, 2005.2006. The Company has made no additional capital contributions subsequent to December 31, 2005. However, Fairways Frisco made two capital calls in 2006, which were not funded by the Company and thus diluted the Company’s limited partnership interest from 14% at December 31, 2005 to approximately 8.87% as of December 31, 2006. As of April 7, 2007, the general partner of the Frisco Square Partnerships indicated that they would be making a capital call of the limited partners in the amount of $4 million, the exact terms of which are currently being negotiated. The Company will not participate in this capital call. If this capital call is fully funded, the Company‘s limited partnership interest will be reduced.

Fairways Frisco is expected to request additional capital contributions from the limited partners. At present, the Company does not intend to fund any additional capital requested from Fairways Frisco. The Company expects its limited partnership interest will be reduced further as additional limited partner contributions are received and the Company does not fund its limited partnership share of such capital contributions into Fairways Frisco.

On April 15, 2005, the parties to the Master Agreement agreed to terminate the Master Agreement effective asAs of April 15, 2005. In connection with the termination of the Master Agreement, the Frisco Square Partnerships were amended such thatDecember 31, 2006, Fairways Frisco owns,owned, either directly or indirectly, 60% of the Frisco Square Partnerships. ThePartnerships and the remaining 40% is owned by CMP Family Limited Partnership (“CMP”), which is controlled by Cole McDowell. CMP’s partnership interest iswas subject to further reduction and dilution as discussed below. Under the terms of the amended Frisco Square Partnerships, Fairways Frisco also has a first priority distribution preference of $5.5 million, and it will receive its pro-rata partnership interest of the next $9.5 million of distributions from the Frisco Square Partnerships. After $15 million of distributions have been made, Fairways Frisco’s interest in the Cash Flow of the Frisco Square Partnerships, as defined in the partnership agreements, will become 80% and CMP’s interest will become 20%.

Furthermore, Fairways Frisco’s partnership interest in the Frisco Square Partnerships may be increased up to 85% if certain capital call and limited partner capital loan provisions are not met by CMP. If Fairways Frisco’s partnership interest in the Frisco Square Partnerships is increased in the future, the Company’s indirect interest in the Frisco Square Partnerships would also increase on a pro-rata basis with its investment in Fairways Frisco. During the year ended December 31, 2005, CMP met the capital loan provisions by providing a $400,000 cash loan as required under the partnership agreement. Subsequent to December 31, 2005, an additional $400,000 capital loan request due from CMP was funded as required.Accordingly, Fairways Frisco’s partnership interest remains at 60%.

Under the terms of the amended Frisco Square Partnerships agreements, Fairways Equities, LLC (FEL) is now the sole general partner of the Frisco Square Partnerships and controls all operating activities, financing activities and development activities for the Frisco Square Partnerships.

Also on April 15, 2005, Fairways Frisco, through Frisco Square Land, Ltd., a newly created partnership, closed a financing transaction, the proceeds of which were used to repay the outstanding bank debt of Frisco Square, Ltd and to provide additional working capital for Fairways Frisco. Under the terms of the now terminated Master Agreement, Fairways Frisco held an option to acquire 50% of the partnership interests of Frisco Square, Ltd. Concurrently with the financing, all of the land and related development held by Frisco Square, Ltd. was transferred to Frisco Square Land, Ltd. in exchange for repayment of the bank debt, and the option to acquire 50% of the partnership interests of Frisco Square, Ltd. was cancelled. As a result of these changes, Fairways Frisco now has no interest in Frisco Square, Ltd. Fairways Frisco owns 60% of Frisco Square Land, Ltd., subject to the same increases for preference distributions and dilution to CMP if certain capital call and limited partnerNo further capital loan provisions are provided in the partnership agreements, and CMP’s interest is dependent upon it ability to fund future capital calls. In the event CMP does not metfund a capital call requested by CMP as discussed above.the general partner, and provided the Partnership funds CMP’s unfunded amounts, CMP’s interest will be diluted according to the partnership agreements.

The Company has not guaranteed any of the debt of the Frisco Square Partnerships or Fairways Frisco, L.P..L.P. The Company is not involved with any management, financing or other operating activities of the Frisco Square Partnerships or Fairways Frisco. However, in May 2005, the Company entered into an agreement with FEL,Fairways Equities, pursuant to which the Company is entitled to receive 25% of the fees paid to FELFairways Equities pursuant to the Fairways Frisco partnership agreement. These fees, including a monthly management fee, represent compensation to the Company for supplying resources to execute the initial transaction with the Frisco Square Partnerships in December 2004. During the yearyears ended December 31, 2006 and 2005, the Company received fees allocated from FELFairways Equities of $28,000 and $64,000, respectively under this agreement.


-52--55-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


3.
Discontinued Operations

In September 2005, the Company determined that it would exit the home infusion therapy business, which operated as part of its healthcare segment under the name Park InfusionCare. This will allow DHI to devote undivided focus on its primary business, independent specialty retail pharmacies. In connection therewith, the Company retained The Braff Group, a financial advisor, to assist in marketing Park InfusionCare for sale. The financial advisor
Fairways Frisco is currently in discussionsnegotiating with various interested buyers. The Company can provide no assurance that it will be ablelenders to find a buyer for Park InfusionCare,modify or to the extent a buyer is found, that a transaction on terms acceptable or favorable to the Company will be consummated.

The Company began accounting for Park InfusionCareextend certain bank loans which are reflected as a discontinued operation in the third quarter of 2005. The following is a summary of the assets held available for sale and the related liabilities as of December 31, 2005 and 2004:

  
December 31,
 
December 31,
 
  
2005
 
2004
 
      
Assets Held Available for Sale:       
Cash $5,000 $1,000 
Accounts Receivable, net  1,622,000  2,226,000 
Inventory, net  258,000  297,000 
Property and equipment, net  313,000  87,000 
Other Assets  9,000  15,000 
  $2,207,000 $2,626,000 
Liabilities Related to Assets Held Available for Sale:       
Accounts Payable $872,000 $227,000 
Accrued Liabilities  336,000  63,000 
Notes Payable  1,689,000  1,981,000 
  $2,897,000 $2,271,000 

Notes payable in both periods above includes an allocated amount of DHI’s notes payable to Bank of Texas which is based on a borrowing base equal to 84% of eligible accounts receivable and 50% of eligible inventory, as further defined in the agreement with Bank of Texas. If the Company is successful in its attempt to sell Park InfusionCare, DHI will pay down the Bank of Texas notes payable in accordance with these borrowing base requirements. Notes payable above also includes capital leases for equipment specifically used by Park InfusionCare.

Accruedcurrent liabilities at December 31, 2005 above include an accrual of $230,000 for retention bonuses to be paid to employees of Park InfusionCare upon consummation of a sale transaction. In order to provide continuity of operations and staff, DHI has agreed to pay bonuses to various employees who continue to perform their duties through the date of the sale transaction. This accrued liability is an estimated amount and no amounts have been paid under this retention bonus plan.


-53-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


The following results of Park InfusionCare have been presented as income (loss) from discontinued operations in the accompanying consolidated statements of operations:

  
Years Ended December 31,
 
  
2005
 
2004
 
      
Income (loss) from discontinued operations:     
Infusion therapy revenue $9,071,000 $7,666,000 
Cost of sales  4,558,000  3,483,000 
Gross profit  4,513,000  4,183,000 
        
Selling, general and administrative expenses  4,898,000  3,680,000 
Depreciation and amortization  41,000  51,000 
Interest expense, net  105,000  116,000 
Other income  108,000  - 
Charges related to discontinuance  230,000  - 
Income (loss) from discontinued operations $(653,000)$336,000 
2006.

 
4.3.
Trade Accounts Receivable

  
December 31,
 
December 31,
 
  
2005
 
2004
 
Healthcare:
     
Trade accounts receivable $1,893,000 $1,790,000 
Less - allowance for doubtful accounts  (227,000) (72,000)
   1,666,000  1,718,000 
Real Estate Advisory Services:
       
Trade accounts receivable  1,826,000  2,411,000 
Less - allowance for doubtful accounts  -  - 
   1,826,000  2,411,000 
  $3,492,000 $4,129,000 
Trade accounts receivable consist of the following:

  
December 31,
 
December 31,
 
  
2006
 
2005
 
Healthcare:
     
Trade accounts receivable $3,268,000 $3,878,000 
Less - allowance for doubtful accounts  (318,000) (596,000)
   2,950,000  3,282,000 
Real Estate Advisory Services:
       
Trade accounts receivable  2,389,000  1,826,000 
Less - allowance for doubtful accounts  -  - 
   2,389,000  1,826,000 
        
  $5,339,000 $5,108,000 

Healthcare trade accounts receivable consists primarily of amounts receivable from third-party payerspayors (insurance companies and governmental agencies) under various medical reimbursement programs, institutional healthcare providers, individuals and others and are not collateralized. Certain receivables are recorded at estimated net realizable amounts. Amounts that may be received under medical reimbursement programs are affected by changes in payment criteria and are subject to legislative actions. Healthcare reduces its accounts receivable are reduced by an allowance for the amounts deemed to be uncollectible. In general, anAn allowance is established for all retail pharmacy accounts aged in excess of 60 daysdays. In general, an allowance of 4% of all infusion therapy accounts is established.established when the receivable is recorded and it is increased to 80% for all accounts aged in excess of 180 days. Accounts that management has ultimately determined to be uncollectible are written off against the allowance.

Healthcare accounts receivable from Medicare and Medicaid combined were approximately 16.1%13.3% and 18.4%16.1% of total accounts receivable at December 31, 20052006 and 2004,2005, respectively. Additionally, at December 31, 2005, DHIHealthcare had accounts receivable outstanding from one insurance company of approximately 13.1% of total Healthcare accounts receivable. No other single customer or third-party payer accounted for more than 10% of DHI’sHealthcare’s accounts receivable at December 31, 2006 or 2005, orrespectively. In addition, during the years ended December 31, 2006 and 2005 and for the period from May 1, 2004 respectively.(date of acquisition) to December 31, 2004, the Healthcare operations did not derive revenue in excess of ten percent from any single customer.


-54-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


The Company’s real estate advisory services operations grants credit to customers of various sizes and provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable. For the year ended December 31, 2006 the Company’s real estate advisory services operations derived revenues in excess of ten percent from one customer totaling approximately $4,739,000 or 33% of revenues. For the year ended December 31, 2005 the Company’s real estate advisory services operations derived revenues in excess of ten percent from two customers totaling approximately $5,264,000 or 39.9% of revenues and $1,592,000 or 12.1% of revenues, respectively. For the period from May 1, 2004 (date of acquisition) to December 31, 2004, the Company’s real estate advisory services operations derived revenues in excess of ten percent from one customer totaling approximately $3,479,000 or 39% of its total revenue.

5.  
-56-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



4. Inventories

Inventories consist of the following:

 
December 31
 
December 31
 
 
December 31
 
December 31
  
2006
 
2005
 
 
2005
 
2004
      
Inventory-retail pharmacy $1,849,000 $1,498,000  $1,650,000 $1,849,000 
Inventory-infusion/homecare  162,000  183,000   537,000  448,000 
Inventory-general retail  568,000  578,000   665,000  568,000 
Less: Inventory reserves  (10,000) (58,000)  (20,000) (38,000)
 $2,569,000 $2,201,000  $2,832,000 $2,827,000 

6.5.  
Prepaid Expenses

Prepaid expenses consist of the following:

 
December 31,
 
December 31,
  
December 31,
 
December 31,
 
 
2005
 
2004
  
2006
 
2005
 
          
Prepaid insurance $168,000 $279,000  $179,000 $168,000 
Deferred tenant representation costs  94,000  200,000   364,000  94,000 
Prepaid marketing costs  13,000  -   13,000  13,000 
Prepaid rent  62,000  -   -  62,000 
Other prepaid expenses  114,000  23,000   81,000  115,000 
 $451,000 $502,000  $637,000 $452,000 

The Company’s real estate advisory services operations defer direct costs associated with its tenant representation services until such time a lease is signed between the tenant and landlord. Upon execution of a signed lease, the Company expenses 50% of these direct costs associated with the transactions, with the balance being paid by the individual broker through a reduction in the commission earned. The Company regularly reviews these direct costs and expenses such costs related to canceled or unlikely to be completed transactions.

-55-

7.6.  
Property and Equipment, Net

Property and equipment, net consist of the following:

       
 
Estimated
 
December 31,
 
December 31,
  
Estimated
 
December 31,
 
December 31,
 
 
Useful Lives
 
2005
 
2004
  
Useful Lives
 
2006
 
2005
 
              
Computer equipment and software  3 to 5 years $493,000 $280,000   3 to 5 years $657,000 $539,000 
Furniture, fixtures and equipment  5 to 7 years  332,000  274,000   5 to 7 years  684,000  652,000 
Leasehold improvements  Life of Lease  569,000  283,000   Life of Lease  609,000  607,000 
Automotive equipment  5 years  12,000  - 
     1,394,000  837,000      1,962,000  1,798,000 
Less accumulated depreciation and amortization     (485,000) (208,000)     (943,000) (576,000)
    $909,000 $629,000     $1,019,000 $1,222,000 


-57-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Depreciation expense was $279,000, $206,000$382,000, $320,000 and $63,000$257,000 for the years ended December 31, 2006, 2005 2004 and 2003,2004, respectively.

8.7.  
Goodwill and Other Intangible Assets

Goodwill and other intangible assets consist of the following:

 
December 31,
 
December 31,
  
December 31,
 
December 31,
 
 
2005
 
2004
  
2006
 
2005
 
          
Goodwill $7,299,000 $7,299,000  $7,299,000 $7,299,000 
Other intangible assets:              
Patient Prescriptions  544,000  544,000   544,000  544,000 
Non-compete Agreements  450,000  450,000   450,000  450,000 
Less - accumulated amortization  (568,000) (236,000)  (899,000) (568,000)
 $426,000 $758,000  $95,000 $426,000 

The acquisitions of the Park Assets and CPOC in 2004 were accounted for using the purchase method of accounting and the purchase prices were allocated as follows:

  
Park Assets
 
CPOC
 
      
Net cash acquired $1,396,000 $141,000 
Trade accounts receivable  5,044,000  2,604,000 
Inventory  2,281,000  - 
Furniture, fixtures and equipment  547,000  312,000 
Other assets  166,000  297,000 
Patient prescriptions  544,000  - 
Goodwill  -  7,299,000 
Non-compete agreements  -  450,000 
Accounts payable and accrued liabilities  (2,983,000) (2,910,000)
Line of credit payable under secured $800,000 bank credit facility  -  (500,000)
Note payable to related party  -  (500,000)
Notes payable under equipment financing obligations  (23,000) (93,000)
Allocated purchase price $6,972,000 $7,100,000 


-56-

Tableto identifiable assets, including intangible assets, and liabilities at their fair market value at the date of Contentsacquisition. As a result of the purchase price allocation, the acquisition of CPOC resulted in goodwill totaling $7,299,000.
ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



The excess of the purchase price over the net tangible assets acquired have been allocated to (i) patient prescriptions for the Park Assets acquisition which are being amortized over 3 years and (ii) to non-compete agreements and goodwill for the CPOC acquisition. In connection with the CPOC acquisition, the Company obtained non-compete agreements from nine of CPOC’s management and key employees, including Kevin Hayes, CPOC’s Chairman. The non-compete agreements are being amortized over their contractual life of 3 years, which amounted to $150,000 and $100,000 for the yearyears ended December 31, 20052006 and 2005. In addition, amortization expense on the non-compete agreements for the period from the acquisition date of May 1, 2004 through December 31, 2004 respectively.was $100,000. The Company made these acquisitions in 2004 for investment purposes.

The estimated scheduled amortization of other intangible assets for the twelve months ending December 31 areis as follows:
 
Patient
 
Non-compete
  
Patient
 
Non-compete
   
 
Prescriptions
 
Agreements
  
Prescriptions
 
Agreements
 
Total
 
            
2006 $181,000 $150,000 
2007  45,000  50,000  $45,000 $50,000 $95,000 
Thereafter  -  -   -  -  - 
 $226,000 $200,000  $45,000 $50,000 $95,000 


-58-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



9.8.  
Equity Method Investments

Equity method investments consist of the following:

 
Ownership
 
Original
 
December 31,
 
December 31,
  
Ownership
 
Original
 
December 31,
 
December 31,
 
  
Investment
 
2005
 
2004
   % 
Investment
 
2006
 
2005
 
                  
Ampco Partners, Ltd.  10% $400,000 $242,000 $256,000   10%$400,000 $194,000 $242,000 
Fairways 03 New Jersey, LP  20%  145,000  162,000  -   20% 145,000  -  162,000 
Fairways Frisco, LP  14%  1,219,000  682,000  154,000   8.87% 1,219,000  225,000  682,000 
    $1,764,000 $1,086,000 $410,000     $1,764,000 $419,000 $1,086,000 

The Company’s investment in Fairways Frisco includes its cumulative cash investment of $1,219,000 and its equity in the losses of Fairways Frisco for the year ended December 31, 2006 and 2005 of ($458,000) and ($537,000). respectively. The Company received no distributions from Fairways Frisco during the yearyears ended December 31, 2005.2006 and 2005, respectively.

The Company received a distribution of approximately $680,000 on December 30, 2005 from Fairways NJ, which represented the Company’s share in the profit from the sale of a single tenant commercial real estate property interest, the sole asset held by Fairways NJ. In addition to the distribution, cash of approximately $162,000, representing the Company’s share of the total escrow, is being held in escrow to fund any amounts owed by Fairways NJ to the purchaser, including any amounts owed for standard representations and warranties under the sale agreement. The balance of the escrow account, if any, is expected to be releasedincluding interest income, of approximately $168,000 was received in December 2006.

-57-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Equity in incomeearnings (losses) of equity method investees included in the consolidated statements of operationsincome consists of the following:

 
Years Ended December 31,
  
December 31,
 
December 31,
 
December 31,
 
 
2005
 
2004
 
2003
  
2006
 
2005
 
2004
 
              
Ampco Partners, Ltd. $100,000 $82,000 $66,000  $96,000 $100,000 $82,000 
Fairways 03 New Jersey, LP  1,112,000  208,000  -   6,000  1,112,000  208,000 
Fairways 36864, LP  -  84,000  - 
Fairways Frisco, LP  (537,000) -  - 
Fairways 36864, L.P.  -  -  84,000 
Fairways Frisco, L.P.  (458,000) (537,000) - 
 $675,000 $374,000 $66,000  $(356,000)$675,000 $374,000 

10.9.  
Accrued Liabilities

Accrued liabilities consist of the following:

  
December 31,
 
December 31,
 
  
2005
 
2004
 
      
Accrued real estate commissions & fees $1,790,000 $2,060,000 
Accrued payroll and related  382,000  487,000 
Accrued expenses  137,000  210,000 
Accrued rent  169,000  116,000 
Accrued property, franchise and sales taxes  38,000  44,000 
Accrued state income taxes payable  -  181,000 
  $2,516,000 $3,098,000 


-58-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



11.  
Notes Payable
  
December 31,
 
December 31,
 
  
2006
 
2005
 
      
Accrued real estate commissions and fees $2,802,000 $1,790,000 
Accrued payroll and related costs  395,000  651,000 
Accrued expenses - other  174,000  204,000 
Accrued rent  174,000  169,000 
Accrued property, state and sales taxes  89,000  38,000 
  $3,634,000 $2,852,000 

Notes payable consist of the following:
  
December 31,
 
December 31,
 
  
2005
 
2004
 
Bank of Texas Credit Facility, secured by substantially all healthcare assets
       
Term note A in the principal amount of $1,000,000, interest at 6% per annum payable monthly, principal due in full in March 2007. $528,000 $688,000 
Term note B in the principal amount of $4,000,000, interest at 6% per annum, principal and interest payable in monthly installments of $44,408 over 35 months with a balloon payment of principal due in March 2007.  2,043,000  1,807,000 
Term note C in the principal amount of $529,539, interest at 6% per annum, principal and interest payable in monthly installments of $5,579 over 35 months with a balloon payment of principal due in March 2007.  459,000  501,000 
        
AmerisourceBergen Drug Corporation, unsecured note payable
       
Unsecured note in the principal amount of $750,000, interest at 6% per annum, principal and interest payable in monthly installments of $6,329 over 59 months with a balloon payment of principal of $576,000 due in March 2009.  693,000  726,000 
        
CPOC Acquisition Note payable to Kevin Hayes
       
Acquisition note in the principal amount of $6,900,000 due May 1, 2007, interest at Northern Trust Bank prime rate plus 0.5% (7.75% at December 31, 2005) payable monthly, principal payable quarterly from the Company's equity interest in the operating cashflow of CPOC and secured by the assets of CPOC.  6,182,000  6,900,000 
        
Capital lease obligations, secured by office equipment
  6,000  13,000 
        
Comerica Bank term note payable
       
Term note payable in the principal amount of $30,000, payable in 36 equal installments of $928 through April 2008, interest payable at the fixed rate of 7%, secured by all property and equipment of Ascendant Solutions, Inc.  23,000  - 
Unsecured term note payable in the principal amount of $225,000, interest only payable monthly at the Comerica Bank prime rate plus 1.00% (8.25% at December 31, 2005), principal due on February 1, 2006. Paid in full January 2006  225,000  - 
        
Insurance premium finance note payable
       
Term note payable in the principal amount of $86,250, payable in 9 equal installments of $9,804 through August 2006, interest payable at the fixed rate of 5.50%, secured by the Company's directors & officers insurance policies.  76,000  - 
   10,235,000  10,635,000 
Less current portion  (650,000) (457,000)
  $9,585,000 $10,178,000 


-59-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


The Term Note B
10.  
Notes Payable
Notes payable to Bank of Texas excludes $1,429,000 and $1,976,000 at December 31, 2005 and 2004, respectively, which has been allocated to the discontinued operations of Park InfusionCare. An allocated amountconsist of the notes payablefollowing:
  
December 31,
 
December 31,
 
  
2006
 
2005
 
Bank of Texas Credit Facility, secured by substantially all healthcare assets
     
Term note A in the principal amount of $1,000,000, interest at 6% per annum payable monthly, principal due in full in March 2007. Paid in full in February 2007. $659,000 $528,000 
Term note B in the principal amount of $4,000,000, interest at 6% per annum, principal and interest payable in monthly installments of $44,408 over 35 months with a balloon payment of principal due in March 2007. Paid in full in February 2007.  3,140,000  3,472,000 
Term note C in the principal amount of $529,539, interest at 6% per annum, principal and interest payable in monthly installments of $5,579 over 35 months with a balloon payment of principal due in March 2007. Paid in full in February 2007.  416,000  459,000 
AmerisourceBergen Drug Corporation, unsecured note payable
       
Unsecured note in the principal amount of $750,000, interest at 6% per annum, principal and interest payable in monthly installments of $6,329 over 59 months with a balloon payment of principal of $576,000 due in March 2009.  658,000  693,000 
CPOC Acquisition Note payable to Kevin Hayes
       
Acquisition note in the principal amount of $6,900,000 due May 1, 2007, interest at Northern Trust Bank prime rate plus 0.5% payable monthly, principal payable quarterly from the Company's equity interest in the operating cash flow of CPOC and secured by the assets of CPOC. Paid in full in May 2006.  -  6,182,000 
CPOC term note payable to First Republic Bank
       
Term note in the principal amount of $5.3 million, due June 1, 2009, interest at Bank of America prime rate minus 0.25% (8.50% at December 31, 2006) payable monthly, principal of $300,000 payable quarterly with a balloon payment of $1,700,000 due on June 1, 2009 and secured by the assets of CPOC.  4,400,000  - 
Capital lease obligations, secured by office equipment
  129,000  266,000 
Demand note payable to affiliate
       
Demand note payable to Ampco Partners, Ltd., interest at Bank of Texas prime rate plus 4.00% (12.25% at December 31, 2006), secured by the Company's distributions from and partnership interest in Ampco Partners, Ltd., principal and accrued interest due on demand.  440,000  - 
Comerica Bank term note payable
       
Term note payable in the principal amount of $30,000, payable in 36 equal installments of $928 through April 2008, interest payable at the fixed rate of 7.00%, secured by all property and equipment of Ascendant Solutions, Inc.  14,000  23,000 
Unsecured term note payable in the principal amount of $225,000, interest only payable monthly at the Comerica Bank prime rate plus 1.00% (8.25% at December 31, 2005), principal due on February 1, 2006. Paid in full January 2006  -  225,000 
Insurance premium finance notes payable
    
Term note payable in the principal amount of $86,250, payable in 9 equal installments of $9,804 through August 2006, interest payable at the fixed rate of 5.50%, secured by the Company's directors and officers insurance policies. - 76,000
Term note payable in the principal amount of $82,875, payable in 9 equal installments of $9,450 through August 2007, interest payable at the fixed rate of 6.25%, secured by the Company's directors and officers insurance policies. 74,000 -
  9,930,000 11,924,000
Less current portion (6,106,000) (1,049,000)
  $3,824,000 $10,875,000

-60-

ASCENDANT SOLUTIONS, INC.
Notes to Bank of Texas which are based on a borrowing base equal to 84% of eligible accounts receivable and 50% of eligible inventory, as further defined in the agreement with Bank of Texas, have been included in Liabilities Related to Assets Held Available For Sale on the accompanying condensed consolidated balance sheets. If the Company is successful in its attempt to sell Park InfusionCare, DHI will pay down the Bank of Texas notes payable in accordance with these borrowing base requirements. Capital lease obligations above also exclude capital leases for equipment specifically used by Park InfusionCare.Consolidated Financial Statements

The aggregate maturities of notes payable for the 12 months ended December 31 are as follows:

2006 $650,000 
2007  9,176,000  $6,106,000 
2008  32,000   1,243,000 
2009  377,000   2,581,000 
2010  - 
Thereafter  -   - 
 $10,235,000  $9,930,000 

The Bank of Texas credit facility containscontained a borrowing base formula with which the Company must comply. If the outstanding borrowings under the facility exceedexceeded the borrowing base, the Company iswas obligated to make additional principal payments to reduce the outstanding borrowings. As of December 31, 2005,2006, the Company was in compliance with this borrowing base requirement. During 2005, DHI failed to notify Bank of Texas, as required under its credit agreement, that it was changing the names of certain legal entities. This failure to notify Bank of Texas of the legal entity name changes constituted a technical breach of the credit agreement. This breach of the terms of the credit agreement has beenwas waived by Bank of Texas.

12.  
Income Taxes
In June 2006, ASDS entered into a credit agreement with First Republic Bank for a $5.3 million term note and CPOC entered into a $500,000 revolving line of credit. The proceeds from the term note were used to retire the outstanding balance owed to Kevin Hayes under the Acquisition Note pursuant to the acquisition of CPOC in 2004 by the Company (through ASDS). The Acquisition Note was retired at a discount of approximately $100,000 to its outstanding principal balance of $ 5,400,000.

Outstanding advances under the revolving line of credit will bear interest at the First Republic Bank prime rate minus 0.50% and is payable monthly. The provision (benefit) for income taxesrevolving line of credit is reconciledsecured by substantially all assets of CPOC and is cross-collateralized with the statutory rate forterm note. Both the years endedterm note and the revolving line of credit are subject to certain financial covenants including a minimum ratio of earnings before interest, taxes, depreciation and amortization to debt service and a limit on annual capital expenditures. As of December 31, 2005, 20042006, CPOC was in compliance with these covenants. The term note is being guaranteed by CPOC. The term note and 2003 as follows:the revolving line of credit are also being personally guaranteed, subject to certain limits, by certain officers and minority limited partners of CPOC. The Company is not paying any compensation to the individuals providing these guaranties. At December 31, 2006, there were no borrowings under the revolving line of credit.

  
2005
 
2004
 
2003
 
        
Provision (benefit) computed at federal statutory rate $104,000 $141,000 $(278,000)
State income taxes, net of federal tax effect  150,000  178,000  (24,000)
Other permanent differences  32,000  104,000  - 
Expiration of state net operating loss carryover  557,000  267,000  60,000 
Benefit of federal NOL utilization  (256,000) (300,000) - 
Benefit of state NOL utilization  -  (26,000) - 
Other changes in deferred tax assets valuation allowance  (350,000) (198,000) 191,000 
Other  4,000  -  51,000 
Current provision $241,000 $166,000 $- 
In June 2006, the Company entered into a term loan agreement with Ampco for a $500,000 demand note. The proceeds from the demand note were used for general working capital purposes. The demand note bears interest at the prime rate plus 4.00% per annum.  The Company’s quarterly partnership cash distributions from Ampco are being applied to the interest and principal balances owed on the demand note. The remaining outstanding balance of the demand note is due on the earlier of demand or June 13, 2009. The demand note is secured by the Company’s limited partnership interest in Ampco.


-60--61-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Subsequent Event

Subsequent to December 31, 2006, on February 20, 2007, Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP (collectively, the “Borrowers”), each a wholly-owned subsidiary of DHI, entered into a loan agreement with Amegy Bank National Association (the “Lender”) for a $2,000,000 revolving line of credit (the “Revolver”) and a $2,200,000 term loan (the “Term Loan”). Substantially all of the proceeds from the Revolver and the Term Loan were used to retire the outstanding balance owed to Bank of Texas, N.A. under an existing credit facility. The Term Loan and the Revolver are being guaranteed by the Company, DHI, Medicine Man, LP, Dougherty’s LP Holdings, Inc., Medicine Man GP, LLC, Alvin Medicine Man GP, LLC, Angleton Medicine Man GP, LLC and Santa Fe Medicine Man GP, LLC.

Outstanding advances under the Revolver will bear interest at the Lender’s prime rate. Accrued and unpaid interest on the Revolver is due monthly beginning on March 20, 2007. All outstanding principal under the Revolver plus all accrued and unpaid interest thereon is due and payable in full on February 20, 2009. On a monthly basis beginning on April 1, 2007, the Borrowers will pay to Lender a one-half percent per annum commitment fee on the average daily unused portion of the Revolver.

The Term Loan bears interest at the Lender’s prime rate plus 0.25%. Principal payments of $45,833.33 and accrued and unpaid interest on the Term Loan is due monthly beginning on March 20, 2007. All outstanding principal under the Term Loan plus all accrued and unpaid interest thereon is due and payable in full on February 20, 2011.

The Term Loan and the Revolver are secured by the accounts receivable, inventory and fixed assets of the Borrowers and the stock of Dougherty’s Pharmacy, Inc. The Term Loan and the Revolver are cross-collateralized and cross-defaulted.

Both the Term Loan and the Revolver are subject to certain financial covenants including, but not limited to, a cap on management fees, a limit on dividends and distributions except for dividends and distributions between Borrowers or any of the Borrowers’ subsidiaries, a limit on payments of subordinated debt to the Company and a limit on additional debt of the Borrowers. Furthermore, the loan agreement provides that the Borrowers will maintain a maximum ratio of funded debt to earnings before interest, taxes, depreciation and amortization plus certain non-recurring charges and fees (“Adjusted EBITDA”) and a minimum ratio of Adjusted EBITDA to current maturities of long term bank debt and interest. The Company is currently in compliance with these financial covenants.

11.  
Income Taxes

The provision for income taxes is reconciled with the statutory rate for the years ended December 31, 2006, 2005 and 2004 as follows:

  
2006
 
2005
 
2004
 
        
Provision computed at federal statutory rate $418,000 $104,000 $141,000 
State income taxes, net of federal tax effect  131,000  150,000  178,000 
Other permanent differences  55,000  32,000  104,000 
Expiration of state net operating loss carryover  552,000  557,000  267,000 
Other changes in deferred tax assets valuation allowance  (940,000) (606,000) (524,000)
Other  (11,000) 4,000  - 
Current provision $205,000 $241,000 $166,000 


-62-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Significant components of the deferred tax asset at December 31, 20052006 and 20042005 are as follows:


 
December 31,
 
December 31,
 
 
December 31, 2005
 
December 31, 2004
  
2006
 
2005
 
Current deferred income tax assets:
            
Allowance for doubtful accounts $203,000 $141,000  $108,000 $203,000 
Inventory reserves  13,000  -   7,000  13,000 
  216,000  141,000   115,000  216,000 
Current deferred income tax liabilities:
              
Equity in earnings of equity method investee  (61,000) -   -  (61,000)
Net current deferred income tax assets  155,000  141,000   115,000  155,000 
Valuation allowance  (155,000) (141,000)  (115,000) (155,000)
  $ $-    $- 
       
Non-current deferred income tax assets:
              
       
Net operating loss carryforward $17,043,000 $17,366,000 
State temporary differences  64,000  617,000 
Property and equipment  26,000  22,000 
Deferred rent $57,000 $-   39,000  57,000 
Property & equipment  22,000  0 
Net operating loss carryforward  17,366,000  17,812,000 
Equity in earnings of equity method investee  35,000  - 
Other  32,000  -   28,000  32,000 
  17,477,000  17,812,000   17,235,000  18,094,000 
Non-current deferred income tax liabilities:
              
       
Equity in earnings of equity method investee  (143,000) - 
Intangible assets  (179,000) -   (63,000) (179,000)
Property & equipment  -  (85,000)
Property and equipment  (17,000) - 
Other  (3,000) (31,000)  -  (3,000)
  (182,000) (116,000)  (223,000) (182,000)
              
Net non-current deferred income tax assets  17,295,000  17,696,000   17,012,000  17,912,000 
Valuation allowance  (17,295,000) (17,696,000)  (17,012,000) (17,912,000)
  $ $-   $- $- 

The Company’s total deferred tax assets have been fully reserved because of the uncertainty of future taxable income. Accordingly, no tax benefit has been recognized in the accompanying financial statements.

At December 31, 2005,2006, the Company had accumulated approximately $51 million of federal net operating loss carryforwards and $21available to offset future taxable income, which, if not utilized, will fully expire from 2018 to 2024. The Company anticipates utilization of approximately $940,000 of federal net operating losses during the year ended December 31, 2006. In addition, the Company had approximately $2.9 million of state net operating loss carryforwards which may be usedavailable to offset future taxable income, and reduce income taxes in future years.which, if not utilized, will fully expire from 2007 to 2009. The Company does not anticipate utilizing any significant portion of the state net operating losses during the year ended December 31, 2006. The use of these losses to reduce future income taxes will depend on the generation of sufficient taxable income prior to the expiration of the net operating loss carryforwards. The carryforwards, if not fully utilized, will expire from 2018 to 2024. Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”) imposes an annual limitation on the portion of the Company’s federal net operating loss carryforwards that may be used to offset taxable income.

-63-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



The Company believes that the issuance of shares of common stock pursuant to the initial public offering on November 15, 1999 caused an “ownership change” for purposes of Section 382 of the Code on such date. Consequently, the Company believes that utilization of the portion of the Company’s federal net operating loss carryforwards attributable to the period prior to November 16, 1999 is limited by Section 382 of the Code. If an “ownership change” is determined to have occurred at a date after November 15, 1999, additional federal net operating loss carryforwards would be limited by Section 382 of the Code. In addition, an “ownership change” may occur in the future as a result of future changes in the ownership of the Company’s stock, including the issuance by the Company of stock in connection with the acquisition of a business by the Company. A future “ownership change” would result in Code Section 382 limiting the Company’s deduction of federal operating loss carryforwards attributable to periods before the future ownership change.

-61-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



13.12.  
Stockholders’ Equity

Preferred Stock

The Company has authorized preferred stock as follows:

Number of
Shares
Series A convertible preferred stock, $.0001 par value1,111,111 shares
 1,111,111 
Series B redeemable preferred stock, $.0001 par value1,111,111 shares
 1,111,111 
Series C non-voting preferred stock, $.0001 par value3,200,000 shares
 3,200,000 
"Blank check”Check" preferred stock, $.0001 par value2,077,778 shares
 2,077,778 
Total7,500,000 shares

No preferred stock was outstanding at December 31, 20052006 or 2004.2005.

Common Stock Based Compensation

On July 24, 2001, James C. Leslie, Chairman of the Board, and CLB Partners, Ltd. purchased an aggregate of 5,000,000 shares ofUnder the Company’s common stock at $0.08 per share from Norman Charney (former Chairman and Chief Executive Officer) and CCLP, Ltd., a Texas limited partnership, of which David Charney (son of Norman Charney) was the sole general partner. This transaction resulted in an aggregate purchase price of $400,000. CLB Holdings LLC, a Texas limited liability company, is the general partner of CLB Partners, Ltd. Richard Bloch, a former director of the Company, and Will Cureton, a current director of the Company, are the managers of CLB Holdings LLC and the Richard and Nancy Bloch Family Trust and Will Cureton are the members of CLB Holdings LLC. On August 29, 2003, James C. Leslie and CLB Partners, Ltd. increased their ownership in the Company by purchasing an aggregate of 1,921,300, shares from a former shareholder of the Company in a negotiated transaction.

During the second quarter of 2002 the Company filed a registration statement on Form S-8, toEquity Incentive Plan, it can issue up to 2,000,000 shares of restricted stock under the 2002 Equity Incentive Plan.to employees and non-employee directors pursuant to restricted stock agreements. Under the restricted stock agreements, the restricted shares will vest annually over a three-year period, or such other restriction period as the Company’s Board of Directors may approve.

As of December 31, 2005,2006, the following shares had been issued under the 2002 Equity Incentive Plan:

 
Number of
     
Year of Issuance:
 
Number of Shares
 
Shares Vested at December 31, 2005
  
Shares
 
Shares Vested
 
Non-Vested
 
2002  435,000  435,000   435,000  435,000  - 
2003  -  -   -  -  - 
2004  67,500  22,500   67,500  65,069  2,431 
2005  47,500  22,500   47,500  36,389  11,111 
2006  127,270  115,603  11,667 
         677,270  652,061  25,209 
  550,000  480,000 

Deferred compensation equivalent to the market value of these restricted common shares at the date of issuance is reflected in stockholders’ equity and is being amortized to operating expense over three years or the vesting period if approved to be less than three years by the Company’s Board of Directors. Deferred compensation expense included in the accompanying consolidated statements of income amounted to $56,000, $81,000 and $40,000 for the years ended December 31, 2006, 2005 and 2004, respectively. The Company has not recognized any tax benefit related to this deferred compensation expense due to the existence of its federal tax net operating loss carryforward.

-62--64-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Deferred compensation equivalent
During the year ended December 31, 2006, the Company issued 99,770 shares of restricted common stock to the marketnon-employee directors in lieu of paying cash for directors’ fees. The fair value of these restricted common shares atwas approximately $51,000 based on the share price of the shares on the date of issuancegrant. This amount is reflected in Stockholders’ Equityalso equal to the cash amount that would have been paid for the director’s fees, and is being amortized on a straight line basis to operating expense over three years, or the vesting period if approved to be less than three years by the Company’s Board of Directors. Deferred compensation amortization expense included in the accompanying consolidated statement of operations amounted to $81,000, $40,000selling, general and $35,000administrative expense for the yearsyear ended December 31, 2005, 20042006. The Company has not deferred any of the compensation expense since the 3 month vesting period fully amortized these shares during 2006.

In September 2006, the Board of Directors of the Company elected to vest 43,334 of previously unvested shares of its former Chief Financial Officer in consideration for consulting services to be provided over the next year to advise on financial and 2003, respectively.accounting matters.

At December 31, 2005, the Company had warrants outstanding to purchase an aggregate of 800,000 shares of common stock at prices ranging from $1.00 to $3.00 per share related to the Company’s private placement offering in 1999. In September 2002, the Company’s Board of Directors authorized the extension of the maturity of the 800,000 warrants, which were held by Jonathan Bloch, one of its directors, from February 5, 2004 to February 5, 2006. These warrants expired unexercised on February 5, 2006.

14.  
Stock Option Plan

The Company’s Long-Term Incentive Plan (the “Plan”), approved in May 1999 and last amended in October 2000, provides for the issuance to qualified participants options to purchase up to 2,500,000 shares of common stock. As of December 31, 20052006 and 20042005 respectively, options to purchase 915,000460,000 and 1,140,000915,000 shares of common stock were outstanding under the Plan.

The exercise price of the options is determined by the administrators of the Plan, but cannot be less than the fair market value of the Company’s common stock on the date of the grant. Options vest ratably over periods of one to six years from the date of the grant. The options have a maximum life of ten years.

Following is a summary of the activity of the Plan:
   
Weighted
    
Weighted
 
 
Number of
 
Average Exercise
  
Number of
 
Average Exercise
 
 
Options
 
Price
  
Options
 
Price
 
          
Outstanding, January 1, 2003  1,340,000 $0.26   1,340,000 $0.26 
Granted in 2003  -  - 
Exercised in 2003  -  - 
Canceled in 2003  -  - 
       
Outstanding, December 31, 2003  1,340,000 $0.26 
Granted in 2004  -  -   -  - 
Exercised in 2004  (200,000) 0.24   (200,000) 0.24 
Canceled in 2004  -  -   -  - 
       
Outstanding, December 31, 2004  1,140,000 $0.26   1,140,000 $0.26 
Granted in 2005  -  -   -  - 
Exercised in 2005  (200,000) 0.24   (200,000) 0.24 
Canceled in 2005  (25,000) 0.24   (25,000) 0.24 
       
Outstanding, December 31, 2005  915,000 $0.26   915,000 $0.26 
Granted in 2006  -  - 
Exercised in 2006  (200,000) 0.24 
Canceled in 2006  (255,000) 0.33 
Outstanding, December 31, 2006  460,000 $0.24 


-63--65-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



Additional information regarding options outstanding as of December 31, 20052006 is as follows:

 
Options Outstanding
 
Options Exercisable
   
   
Weighted
       
   
Avg.
       
   
Remaining
   
Weighted
   
 
Options Outstanding
 
Options Exercisable
    
Contractual
   
Avg. Exercise
 
Intrinsic
 
Exercise Price
 
# Outstanding
 
Weighted Avg. Remaining Contractual Life (Yrs.)
 
# Exercisable
 
Weighted Avg. Exercise Price
  
# Outstanding
 
Life (Yrs)
 
# Exercisable
 
Price
 
Value
 
$1.00  30,000  3.20  30,000 $1.00 
           
$0.24  885,000  6.20  885,000 $0.24   460,000  5.20  460,000 $0.24 $59,800 
  915,000     915,000 $0.26 

On March 14, 2002, in an attempt to further align the interests of management and members of its Board of Directors with its stockholders, the Company granted an aggregate of 375,000 options, having an exercise price of $0.24 per share, to certain of its directors. In addition, the Company granted an aggregate of 1,000,000 performance-based options, 400,000 to its Chairman and 600,000 to its President and Chief Executive Officer. These management options, having an exercise price of $0.24 per share, are intended to incentivize management. The management options have a vesting period of six years which can be accelerated upon achievement of certain performance goals. In May 2004, these performance goals were achieved and the Company’s Board of Directors accelerated the vesting of the remaining 666,667 unvested options out of the 1,000,000 performance-based options issued in 2002.

Had compensation cost been recognized consistent with Statement 123R, the Company’s net income attributable to common stockholders and net income per share would have been adjusted to the pro forma amounts indicated below for the years ended December 31, 2005 and 2004:

  
2005
 
2004
 
Net income attributable to common stockholders as reported $65,000 $249,000 
Total stock-based employee compensation included in reported net income, net of related tax effects  -  18,000 
Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects  (10,000) (88,000)
        
Pro forma net income $55,000 $179,000 
        
Net income per share:       
Basic - as reported  * $0.01 
Basic - pro forma  * $0.01 
Diluted - as reported  * $0.01 
Diluted - pro forma  * $0.01 
        
* Less than $0.01 per share       

The Company used the Black-Scholes option-pricing model to determine the fair value of grants made during 2002. The following weighted average assumptions were applied in determining the pro forma compensation cost: risk free interest rate - 4.69%, expected option life in years - 6.00, expected stock price volatility - 1.837 and expected dividend yield - 0.00%.

-66-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



15.13.  
Employee Benefit Plan

Effective January 1, 2005, the Company established a new 401(k) plan to cover all of its employees, and it terminated the old 401(k) plans related to the acquired entities. The terms of the new plan are substantially the same as the terms of the 401(k) plans of its acquired subsidiaries, DHI and CPOC. Under the terms of the new plan, the Company has the option to match employee’s contributions, in an amount and at the discretion of the Company. During the year ended December 31, 2006 and 2005, the Company made matching contributions of $25,000 and $19,000 to the new 401(k) plan.

The Company’s employees (including employees of its acquired subsidiaries DHI and CPOC) participated in three 401(k) plans during 2004 and 2003.2004. Under two of the plans, the Company made matching contributions based on the amount of employee contributions. Total contributions by the Company under all three plans were $29,000 in 2004.

14.  
Computations of Basic and Diluted Net Income Per Common Share

Basic loss per common share is based on the net incomes divided by the weighted average number of common shares outstanding during the year. Diluted income per common share is based on the net income divided by the weighted average number of common shares including equivalent common shares of dilutive common stock options and $2,160warrants outstanding during the year. No effect has been given to outstanding options or warrants in the diluted computation for the years ended December 31, 2006 and 2005, respectively, as their effect would be anti-dilutive due to net income. The number of potentially dilutive stock options and warrants excluded from the computation for the years ended December 31, was approximately 265,909 in 2006 and 822,870 in 2005 and 296,989 in 2004, and 2003, respectively.

A reconciliation of basic and diluted loss per common share follows:

  
December 31,
 
December 31,
 
December 31,
 
  
2006
 
2005
 
2004
 
        
Income from continuing operations, net of taxes $793,000 $295,000 $249,000 
Income (loss) from discontinued operations, net of taxes  230,000  (230,000) - 
Net income $1,023,000 $65,000 $249,000 
           
Weighted average common shares outstanding-Basic  22,409,814  22,006,733  21,803,817 
Effect of dilutive stock options and warrants  265,908  870,971  585,450 
Weighted average common shares outstanding-Diluted  22,675,722  22,877,704  22,389,267 
           
Basic earnings per share from:          
Continuing operations $0.04 $0.01 $0.01 
Discontinued operations $0.01 $(0.01)$- 
Basic net income per share $0.05  * $0.01 
           
Diluted earnings per share from:          
Continuing operations $0.04 $0.01 $0.01 
Discontinued operations $0.01 $(0.01)$- 
Diluted net income per share $0.05  * $0.01 
           
* Less than $0.01 per share          


-64--67-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



16.  
Computations of Basic and Diluted Net Income (Loss) Per Common Share

  
Years Ended December 31,
 
  
2005
 
2004
 
2003
 
           
Income (loss) from continuing operations, net of taxes $718,000 $(87,000)$(818,000)
Income (loss) from discontinued operations, net of taxes  (653,000) 336,000  - 
Net income (loss) $65,000 $249,000 $(818,000)
           
Weighted average common shares outstanding-Basic  22,006,733  21,803,817  21,557,150 
Effect of dilutive stock options and warrants  870,971  585,450  - 
Weighted average common shares outstanding-Diluted  22,877,704  22,389,267  21,557,150 
           
Basic earnings per share from:          
Continuing operations $0.03  * $(0.04)
Discontinued operations $(0.03)$0.02 $- 
Basic net income (loss) per share $0.00 $0.01 $(0.04)
           
Diluted earnings per share from:          
Continuing operations $0.03  * $(0.04)
Discontinued operations $(0.03)$0.02 $- 
Diluted net income (loss) per share $0.00 $0.01 $(0.04)
           
* Less than $0.01 per share          

17.15.  
Commitments and Contingencies 

In connection with the acquisition of the Park Assets in 2004, DHI entered into a three year supply agreement with AmerisourceBergen Drug Corporation pursuant to which DHI and its newly acquired indirect subsidiaries agreed to purchase prescription and over-the-counter pharmaceuticals from AmerisourceBergen through March 2007. This supply agreement will also provideprovided DHI with pricing and payment terms that are improved from those previously provided by AmerisourceBergen to Park Pharmacy. In exchange for these improved terms, DHI has agreed to acquire 85% of its prescription pharmaceuticals and substantially all of its generic pharmaceutical products from AmerisourceBergen and agreed to minimum monthly purchases of $900,000 of all products in order to obtain new favorable pricing terms. For the yearyears ended December 31, 2006 and 2005 and the period from the date of acquisition through December 31, 2004, DHI purchased over $23,858,000, $23,159,000 and $17,250,000, respectively, of its pharmaceutical products from Amerisource Bergen,AmerisourceBergen.

As of which $3,484,000 relatesNovember 30, 2006, DHI entered into Amendment No. 1 (“Amendment”) to Park InfusionCare currently classified asthe supply agreement. The Amendment extends the supply agreement from March 24, 2007 to March 24, 2009. In addition, the Amendment (1) improves the pricing of goods purchased (2) changes the minimum order volume from $30,000,000 to $50,000,000 over the life of the agreement and (3) the percentage of generic drug purchases was changed from 2.50% to 6.0%. The Amendment also allows for the return of goods, in a discontinued operation.saleable condition, within 180 days of the invoice date without a restocking fee and provides for a termination fee if DHI terminates the supply agreement before the expiration of the term of the agreement. The termination fee is a maximum of $50,000 but is reduced for each full month from December 1, 2006 until the date of termination. However, there is no termination fee if the minimum order volume has been satisfied. At December 31, 2006, DHI believes it has satisfied the minimum order volume.

The Amendment also provides for a rebate in the amount of $150,000 representing a 15.0% volume discount off the price of goods for the first $1,000,000 of net purchases purchased in the period after November 1, 2006 providing that DHI makes net purchases in excess of $1 million after November 1, 2006. In December 2006, DHI satisfied the net purchase requirement and received the $150,000 rebate.

In January 2005, the Company agreed to provide a limited indemnification to its partners in the Fairways 03 New Jersey LP investment for any losses those partners may incur under their personal guaranties of the partnership’s bank indebtedness. The Company’s partners in this investment are the Fairways Members. The Company’s indemnification to the Fairways Members is limited to its 20% pro rata partnership interest of the $2.6 million in bank debt that was guaranteed by the individuals. In December 2005, this bank debt was paid in full by Fairways 03 New Jersey LP and the Company’s limited indemnification agreement was cancelled.

Operating Leases
The Company and its subsidiaries lease its pharmacy, real estate advisory service and corporate offices and certain pharmacy equipment under non-cancelable operating lease agreements. Certain leases contain renewal options and provide that the Company pay taxes, insurance, maintenance and other operating expenses. Total rent expense for operating leases was approximately $1,431,000, $1,375,000 and $974,000 for the years ended December 31, 2006, 2005 and 2004, respectively.

-65--68-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements


Certain leases contain renewal options and provide that the Company pay taxes, insurance, maintenance and other operating expenses. Total rent expense for operating leases was approximately $1,131,000, $974,000 and $45,000 for the years ended December 31, 2005, 2004 and 2003, respectively.

Minimum lease payments under all non-cancelable operating lease agreements for the years ended December 31, are as follows:

2006 $1,198,000 
Years ending December 31,
   
2007  1,025,000  $1,260,000 
2008  966,000   1,108,000 
2009  984,000   1,039,000 
2010  831,000   836,000 
2011  291,000 
Thereafter  2,292,000   2,007,000 
 $7,296,000  $6,541,000 

Legal Proceedings
On January 29, 2004, Bishopsgate Corp. and T.E. Millard filed a lawsuit in the 192nd District Court of Dallas County, Texas against us, ourthe Company, its officers and directors, and Park Pharmacy’s officers and directors claiming that wethe Company breached obligations to fund Bishopsgate’s proposed purchase of the Park Assets. Mr. Millard filed a Chapter 13 bankruptcy case in Dallas, Texas on August 15, 2003. Millard’s Chapter 13 bankruptcy case was converted to a Chapter 7 liquidation bankruptcy case on December 20, 2004. Upon the conversion of the bankruptcy case, Daniel J. Sherman was appointed Chapter 7 Trustee. In August 2005, the Company, its officers and directors and Park Pharmacy’s officers and directors entered into a compromise and settlement agreement, which was approved by the bankruptcy court, whereby the defendants collectively paid $80,000 to the bankruptcy Trustee in settlement of all claims. The Company’s insurance carrier provided the funds for the Company’s portion of the settlement amount, which was $55,000. In exchange for the settlement, and in satisfaction of the counterclaims filed against Millard and Bishopsgate Corp, the Company received all of the stock of Bishopsgate Corp. The stock has not been assigned any value in the Company’s financial statements and it is held by a newly-formed entity, DM-ASD Holding, Co.

Between January 23, 2001 and February 21, 2001, five putative class action lawsuits were filed in the United States District Court for the Northern District of Texas against us, certain of our directors, and a limited partnership of which a director is a partner. The five lawsuits assert causes of action under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, for an unspecified amount of damages on behalf of a putative class of individuals who purchased our common stock between various periods ranging from November 11, 1999 to January 24, 2000. The lawsuits claim that wethe Company and the individual defendants made misstatements and omissions concerning ourthe Company’s products and customers. 

In April 2001, the Court consolidated the lawsuits, and on July 26, 2002, plaintiffs filed a Consolidated Amended Complaint (“CAC”). WeThe Company filed a motion to dismiss the CAC on or about September 9, 2002. On July 22, 2003, the Court granted in part and denied in part defendants’ motion to dismiss. On September 2, 2003, defendants filed an answer to the CAC. Plaintiffs then commenced discovery. On September 12, 2003, plaintiffs filed a motion for class certification, and on February 17, 2004, wethe Company filed ourits opposition. On July 1, 2004, the Court denied plaintiffs’ motion for certification. On September 8, 2004, the Fifth Circuit granted plaintiffs’ petition for permission to appeal the denial of class certification. On August 23, 2005, the Fifth Circuit affirmed the district court’s denial of class certification. The Company settled the lead plaintiffs’ remaining individual claims for a confidential amount, which was paid by the Company’s directors and officersofficer’s insurance carrier. Accordingly, the district court entered a final judgment dismissing the claims with prejudice on February 24, 2006.

In April 2006, the Company was notified by the Internal Revenue Service (“IRS”) that its federal income tax return for the 2004 tax year had been selected for review. In addition, in September 2006 the Company was notified by the IRS that the federal partnership income tax return of CPOC for the 2004 tax year had been selected for review. The IRS is currently conducting its reviews. At this time, the Company can make no representations or give any guidance regarding the potential outcome of this review and the impact, if any, on its financial position. However, the Company is not aware of any potential issues that may cause adjustment to its filed tax returns.

-69-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



In September 2006, the Chapter 7 trustee for the bankruptcy estate of Quantum North America, Inc. sought to enforce two default judgments against the Company for alleged preferential and fraudulent transfers to the Company's predecessor, ASD Systems, Inc. in the aggregate amount of approximately $150,000, plus interest and attorneys fees. The transfers at issue occurred in 2000. The adversary proceedings filed in the bankruptcy case were styled: David Gottlieb Trustee v. ASD Systems, Inc.; Adv. Nos. 1:02-ap-02131-GM and 1:02-ap-01948. The Company took the position that the judgments were void based on defective service and neither Ascendant nor ASD were afforded the opportunity to defend the claims. The Company also disputed the underlying claims and was prepared to fully defend the Trustee's suit once the judgments were set aside. After presenting the Trustee with our defenses, the Company was able to settle the claims for a nominal payment of $5,000.00. The Company has a settlement in principle with the Trustee which is pending approval by the Bankruptcy Court.

The Company is also occasionally involved in other claims and proceedings, which are incidental to its business. The Company cannot determine what, if any, material affect these matters will have on its future financial position and results of operations.

18.16.  Related Party Transactions

During the fourth quarter of 2003, the Company entered into a participation agreement (the “Participation Agreement”) with Fairways Equities LLC (“Fairways”), an entity controlled by Jim Leslie, the Company’s Chairman, and Brant Bryan, Cathy Sweeney and David Stringfield who are principals of Capital Markets and shareholders of the Company (“Fairways Members”), pursuant to which the Company will receive up to 20% of the profits realized by Fairways in connection with all real estate acquisitions made by Fairways. Additionally, the Company will have an opportunity, but not the obligation, to invest in the transactions undertaken by Fairways. The Company’s profit participation with Fairways is subject to modification or termination by Fairways at the end of 2005 in the event that the aggregate level of cash flow (as defined in the Participation Agreement) generated by the acquired operating entities has not reached $2 million for the twelve months ended December 31, 2005. For the twelve months ended December 31, 2005, the Company did not meet this cash flow requirement and there has been no action taken by the Fairways Members to terminate the Participation Agreement. The Company is currently negotiating with the Fairways Members to modify the Participation Agreement, however, there can be no assurances that a mutually acceptable modification can be reached. The Company is unable to determine what real estate Fairways may acquire or the cost, type, location, or other specifics about such real estate.
There can be no assurances that the Company will be able to generate the required cash flow to continue in the Fairways Participation Agreement after 2005, or that Fairways will be able to acquire additional real estate assets, that the Company will choose to invest in such real estate acquisitions or that there will be profits realized by such real estate investments. The Company does not have an investment in Fairways, but rather a profits interest through its Participation Agreement. As of December 31, 2005, the Company held a profits interest in one real estate development transaction pursuant to the Participation Agreement. The Company has no investment in the transaction, is not a partner in the investment partnership and it has received no distributions.

During the year ended December 31, 2005, CRESA Capital Markets Group, LP, a subsidiary of the Company received approximately $108,000 in cash advances from the 4 members of Fairways Equities, which were used to pay general operating expenses. The 4 members of Fairways Equities who each own 25% of its membership interests include James C. Leslie, the Chairman and principal shareholder of the Company, and Cathy Sweeney, Brant Bryan and David Stringfield, who are each shareholders of the Company as well as principals of CRESA Capital Markets Group, LP, a subsidiary of the Company (the “Fairways Members”). These non-interest bearing advances were repaid in full in December 2005 from the receipt of revenues from Capital Markets real estate advisory transactions.

Mr. James C. Leslie, the Company’s Chairman, controls, and Mr. Will Cureton, one of ourthe Company’s directors, is indirectly a limited partner in the entity that owns the building in which the corporate office space is sub-leased by Ascendant and DHI.

Also, through August 2005, Capital Markets also paid rent for office space in the same building to an entity controlled by Mr. Leslie. The Company considers all of these leases to be at or below market terms for comparable space in the same building.

Beginning on March 16, 2005 and ending on October 13, 2006, Ascendant subleased space from an unrelated third party of approximately $7,000 per month. In October 2006, Ascendant began sharing office space with DHI. During the yearsyear ended December 31, 2006, DHI subleased space from an unrelated third party for $6,000 per month. In addition, Ascendant incurred certain shared office costs with an entity controlled by Mr. Leslie, which gives rise to reimbursements from the Company to that entity. These costs were approximately $9,000 in 2006.

-70-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements
During the year ended December 31, 2005 2004 and 2003,2004, Ascendant and Capital Markets paid aggregate rent of approximately $26,000 $67,200 and $45,000$67,200 directly to an entity controlled by Mr. Leslie. The remaining rent expense paid by Ascendant and DHI is paid under sublease agreements with an unrelated third party, and approximates $13,000 monthly. The Company also incursincurred certain shared office costs with an entity controlled by Mr. Leslie, which gives rise to reimbursements from the Company to that entity. These costs were approximately $24,300, $22,800$24,000 and $3,400$23,000 in 2005 2004 and 2003,2004, respectively.

During the years ended December 31, 2006, 2005 and 2004, the Company paid fees to its directors of $2,500, $8,750 and $11,000, respectively, in exchange for their roles as members of the board of directors and its related committees. During 2006, the Company issued 99,770 shares of restricted stock to a director in lieu of cash fees for his role as members of the board of directors and its related committees for the year ended December 31, 2006. These restricted shares vested ratably over the three month period after the date of issuance. In July 2006, the Company issue 7,500 share of restricted stock to a director, for his annual restricted stock grant, which vests ratably over a three year period from the date of issuance. In July 2006, the Company issued 10,000 share of restricted stock to a newly elected director as his initial grant of restricted stock. This initial grant of restricted stock also vests ratably over a three year period from the date of issuance. Additionally, in May 2005, the Company issued 22,500 shares of restricted stock to directors in lieu of cash fees for their roles as members of the board of directors and its related committees for the year ended December 31, 2005. These restricted shares vested ratably at the end of each quarter ending June, September and December 2005, respectively.

The Company acquired CPOC on May 1, 2004 and in connection with that acquisition, it assumed a $500,000 note payable to Kevin Hayes, who is currently the Chairman of CPOC, and it entered into the Acquisition Note with Mr. Hayes. During the period from January 1, 2006 to June 2006, CPOC paid approximately $1,108,000 to Mr. Hayes for principal and interest under the assumed note and the Acquisition Note. In June 2006, ASDS entered into a credit agreement with First Republic Bank for a $5.3 million term note. The proceeds from the term note were used to retire the outstanding balance owed to Kevin Hayes under the Acquisition Note pursuant to the acquisition of CPOC in 2004 by the Company (through ASDS). The Acquisition Note was retired at a discount of approximately $100,000 to its outstanding principal balance of $ 5,400,000. During the year ended December 31, 2005 and for the period from the acquisition date through December 31, 2004, CPOC paid approximately $1,198,000 and $720,000, respectively to Mr. Hayes for principal and interest under the assumed note and the Acquisition Note.

Mr. Leslie, the Company’s Chairman, also serves as an advisor to the Board of Directors of CRESA Partners, LLC, a national real estate services firm. Also, Kevin Hayes, the Chairman of CPOC servesserved as the Chief Executive Officer of CRESA Partners, LLC from October 2005 to September 2006.

In March 2006, CPOC purchased a minority interest of approximately 2.7% in CRESA Partners, LLC. The amount paid for this investment was $160,000 and is accounted for under the cost method of accounting for investments. CPOC is a licensee of CRESA Partners, LLC.

In April 2004, the Company invested approximately $97,000 through ASE Investments for a 24.75% interest in Fairways 36864, LP, (whose other partners also included the Fairways Members) that participated in the development of and leaseback of single tenant commercial properties. In August and October 2004, respectively, these properties were sold and the Company recognized investment income of $84,000 in addition to the return of its original investment of $97,000.

The Company made an investment in Fairways 03 New Jersey, LP in December 2003, along with the Fairways Members and on substantially the same terms as the other limited partners in Fairways 03 New Jersey, LP. As discussed in Note 17, theThe Company agreed to indemnify the other partners of Fairways 03 New Jersey, LP (who are also the Fairways Members) for its 20% pro rata partnership interest of a guarantee of bank indebtedness which the partners provided to a bank. The limit of the Company’s indemnification under this agreement is $520,000. In December 2005, this bank debt was paid in full by Fairways 03 New Jersey LP and the Company’s limited indemnification agreement was cancelled.

Effective September 1, 2005, Capital Markets entered into an advisory services agreement with Fairways Equities whereby Fairways Equities will provide all of the professional and administrative services required by Capital Markets. In exchange, Capital Markets will pay Fairways Equities an administrative fee of 25% of gross revenues and a compensation fee of 40% of gross revenues, as compensation to the principals working on the transaction that generated the corresponding revenues.
Under the terms of the agreement, Fairways Equities assumed all of the administrative expenses, including payroll, of CRESA Capital Markets. Fairways Equities will only receive payments under the agreement if the Fairways Members close a real estate capital markets advisory transaction that generates revenue for Capital Markets.  The impact of this agreement on Capital Markets is that it will have no administrative expenses or cash requirements unless it closes a revenue generating transaction. The principals in Capital Markets are also the four members of Fairways Equities. During the yearyears ended December 31, 2006 and 2005, Capital Markets paid compensation fees to Fairways Equities under the advisory services agreement of approximately $233,000.$262,000 and $233,000, respectively.

-67--71-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements
17.Unaudited Quarterly Financial Data for 2006 and 2005:

CONSOLIDATED QUARTERLY FINANCIAL DATA (UNAUDITED)
 
(In thousands except per share amounts)
 
            
  
Quarters Ended 2006
 
2006
 
  
March 31
 
June 30
 
Sept. 30
 
Dec. 31
 
YTD
 
      
(Restated)
     
Revenue $13,604 $12,889 $12,284 $16,640 $55,417 
Gross Profit  4,549  3,870  4,225  6,321  18,965 
Income (loss) from continuing operations  (142) (410) (8) 1,353  793 
Discontinued operations  -  230  -  -  230 
Net income (loss)  (142) (180) (8) 1,353  1,023 
                 
Basic income (loss) per share:
                
Continuing operations $(0.01)$(0.02) * $0.06 $0.04 
Discontinued operations $- $0.01 $- $- $0.01 
Net income (loss) per share, basic $(0.01)$(0.01) * $0.06 $0.05 
Diluted income (loss) per share:
                
Continuing operations $(0.01)$(0.02) * $0.06 $0.04 
Discontinued operations $- $0.01  - $- $0.01 
Net income (loss) per share, diluted $(0.01)$(0.01) * $0.06 $0.05 
                 
Weighted average shares, basic  22,258  22,418  22,455  22,508  22,410 
Weighted average shares, diluted  22,783  22,418  22,455  22,707  22,676 
  
Quarters Ended 2005
 
2005
 
  
March 31
 
June 30
 
Sept. 30
 
Dec. 31
 
YTD
 
            
Revenue $13,269 $12,576 $12,023 $15,099 $52,967 
Gross Profit  4,568  4,119  4,132  5,426  18,245 
Income (loss) from continuing operations  1  (439) (452) 1,185  295 
Discontinued operations  -  -  (230) -  (230)
Net income (loss)  1  (439) (682) 1,185  65 
                 
Basic income (loss) per share:
                
Continuing operations  * $(0.02)$(0.02)$0.05 $0.01 
Discontinued operations $-  -  (0.01) - $(0.01)
Net income (loss) per share, basic  * $(0.02)$(0.03)$0.05  * 
Diluted income (loss) per share:
                
Continuing operations  * $(0.02)$(0.02)$0.05 $0.01 
Discontinued operations $- $- $(0.01)$- $(0.01)
Net income (loss) per share, diluted  * $(0.02)$(0.03)$0.05  * 
                 
Weighted average shares, basic  21,933  21,965  22,014  22,114  22,007 
Weighted average shares, diluted  22,512  21,965  22,014  22,719  22,878 
* Less than $0.01 per share                
The quarterly earnings per share information will not tie across due to the different number of weighted average shares.

-72-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



As disclosed in a Current Report on Form 8-K filed on April 3, 2007, the Company identified an accounting error at our Park InfusionCare subsidiary where certain payments received from insurance companies during the year ended December 31, 2006 were incorrectly recorded as a liability. As a result, the Company will amend the previously filed Form 10-Q for the 3rd Quarter Financials with an aggregate impact of an increase to its previously reported revenue by $301,000 and will decrease its previously reported net loss by $179,000. As a result, the quarterly financial data for the quarter ended September 30, 2006 has been restated to reflect these adjustments.

As disclosed in a Current Report on Form 8-K filed on May 24, 2006, the board of directors decided to retain the operations of Park InfusionCare, which had previously been reported as a discontinued operation while the Company was pursuing a potential disposition or strategic transaction for its infusion therapy business. As a result of the board of director’s decision to retain the operations of Park InfusionCare, the Company has reported the operating results of Park InfusionCare as part of continuing operations. Consequently, the quarterly financial data for each quarter in 2005 have been adjusted to reflect Park InfusionCare as a part of continuing operations.

For the quarter ended March 31, 2005, these adjustments increased revenue by $2,388,000 and gross profit by $1,195,000. In addition, for the quarter ended June 30, 2005 these adjustments increased revenue by $2,461,000 and gross profit by $1,288,000. For the quarter ended September 30, 2005, these adjustments increased revenue by $2,261,000 and gross profit by $1,075,000. In addition, for the quarter ended December 31, 2005 these adjustments increased revenue by $1,961,000 and gross profit by $955,000. The Company also reclassified $108,000 in the quarter ended December 31, 2005 from other income to revenue as a result of the accounting error at Park InfusionCare. This reclassification entry was recorded to conform to the 2006 presentation. None of these adjustments had any effect on net income (loss) for any of the quarters.
 
19.Unaudited Quarterly Financial Data for 2005 and 2004:
CONSOLIDATED QUARTERLY FINANCIAL DATA (UNAUDITED)
 
(In thousands except per share amounts)
 
            
  
Quarters Ended 2005
 
2005
 
  
March 31
 
June 30
 
Sept. 30
 
Dec. 31
 
YTD
 
            
Revenue $10,881 $10,115 $9,762 $13,030 $43,788 
Gross Profit  3,373  2,831  3,057  4,363  13,624 
Income (loss) from continuing operations  (46) (450) (174) 1,388  718 
Discontinued operations  47  11  (508) (203) (653)
Net income (loss)  1  (439) (682) 1,185  65 
                 
Basic income (loss) per share:
                
Continuing operations  (0.00) (0.00) (0.10) 0.06  0.03 
Discontinued operations  0.00  0.00  (0.02) (0.01) (0.03)
Net income (loss) per share, basic  0.00  (0.02) (0.03) 0.05  0.00 
Diluted income (loss) per share:
                
Continuing operations  (0.00) (0.02) (0.01) 0.06  0.03 
Discontinued operations  0.00  0.00  (0.02) (0.01) (0.03)
Net income (loss) per share, diluted  0.00  (0.02) (0.03) 0.05  0.00 
                 
Weighted average shares, basic  21,933  21,965  22,014  22,114  22,007 
Weighted average shares, diluted  22,512  21,965  22,014  22,719  22,878 

  
Quarters Ended 2004
 
2004
 
  
March 31
 
June 30
 
Sept. 30
 
Dec. 31
 
YTD
 
            
Revenue $1,222 $9,497 $9,831 $11,075 $31,625 
Gross Profit  609  2,963  3,125  3,356  10,053 
Income (loss) from continuing operations  (111) 70  (39) (7) (87)
Discontinued operations  5  144  42  145  336 
Net loss  (106) 214  3  138  249 
                 
Basic income (loss) per share:
                
Continuing operations  (0.01) 0.00  (0.00) (0.00) (0.00)
Discontinued operations  0.00  0.01  0.00  0.01  0.02 
Net income (loss) per share, basic  (0.00) 0.01  0.00  0.01  0.01 
Diluted income (loss) per share:
                
Continuing operations  (0.01) 0.00  (0.00) (0.00) (0.00)
Discontinued operations  0.00  0.01  0.00  0.01  0.02 
Net income (loss) per share, diluted  (0.00) 0.01  0.00  0.01  0.01 
                 
Weighted average shares, basic  21,666  21,733  21,883  21,933  21,804 
Weighted average shares, diluted  21,666  21,925  22,419  22,600  22,389 
The quarterly earnings per share information will not tie across due to the different number of weighted average shares.

-68-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



20.18.  Subsequent Events

Subsequent to December 31, 2005, the Company settled class action securities litigationOn February 20, 2007, Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP), each a wholly-owned subsidiary of DHI, entered into a loan agreement with Amegy Bank National Association for a confidential amount, which was paid by$2,000,000 revolving line of credit and a $2,200,000 term loan. Substantially all of the Company’s directorsproceeds from the Revolver and officers insurance carrier. Accordingly, the district court entered a final judgment dismissingTerm Loan were used to retire the claims against the Company with prejudice on February 24, 2006.outstanding balance owed to Bank of Texas, N.A. under an existing credit facility. See Note 1710 for further information regarding this litigation matter.the new credit facility.

21.19.Segment Information

The Company is organized in three segments: (i) healthcare, (ii) real estate advisory services and (iii) corporate and other businesses. The healthcare segment consists of the operations of DHI, while the real estate advisory services segment consists of the operations of the CRESA Partners of Orange County LP and CRESA Capital Markets Group LP. Key measures used by the Company’s management to evaluate business segment performance include revenue, cost of sales, gross profit, investment income and EBITDA. EBITDA is calculated as net income before deducting interest, taxes, depreciation and amortization. Although EBITDA is not a measure of actual cash flow because it does not consider changes in assets and liabilities that may impact cash balances, the Company believes it is a useful metric to evaluate operating performance.

Statements of operations and balance sheet data for the Company’s principal business segments for the years ended December 31, 2005 and 2004 are as follows (000’s omitted):

-69--73-

ASCENDANT SOLUTIONS, INC.
Notes to Consolidated Financial Statements



  
Years Ended December 31,
 
                  
  
Healthcare
 
Real Estate Services
 
Corporate and Other
 
Consolidated
 
  
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
                  
Revenue $29,957 $21,866 $13,831 $9,759 $- $- $43,788 $31,625 
Cost of sales  21,959  16,185  8,205  5,387  -  -  30,164  21,572 
Gross profit  7,998  5,681  5,626  4,372  -  -  13,624  10,053 
Other income  9  19  -  -  64  -  73  19 
Equity in income (losses) of equity method investees  -  -  -  -  675  374  675  374 
Income (loss) from continuing operations $(422)$(635)$1,592 $1,435 $(452)$(887)$718 $(87)
Plus:                         
Interest Expense (Income)  225  182  444  247  (11) (24) 658  405 
Taxes  -  -  209  166  32  -  241  166 
Depreciation & Amortization  291  220  304  216  16  7  611  443 
                          
EBITDA from continuing operations
 
$
94
 
$
(233)
$
2,549
 
$
2,064
 
$
(415)
$
(904)
$
2,228
 
$
927
 

Statements of income and balance sheet data for the Company’s principal business segments for the years ended December 31, 2006 and 2005 are as follows (000’s omitted):
  
Years Ended December 31,
 
  
Healthcare
 
Real Estate Services
 
  
2006
 
2005
 
2006
 
2005
 
          
Revenue $41,062 $39,136 $14,355 $13,831 
Cost of sales  28,048  26,517  8,404  8,205 
Gross profit  13,014  12,619  5,951  5,626 
Other income  8  9  100  - 
Equity in income (losses) of equity method investees  -  -  -  - 
Discontinued operations  230  (230) -  - 
Net income (loss) $630 $(1,075)$1,956 $1,592 
Plus:             
Interest Expense (Income)  330  330  400  444 
Income tax provision  -  -  199  209 
Depreciation & Amortization  391  332  297  304 
Discontinued operations  (230) 230  -  - 
EBITDA from continuing operations
 
$
1,121
 
$
(183
)
$
2,852
 
$
2,549
 
              
Total Assets $7,483 $8,631 $12,363 $11,341 
              
 
  
Years Ended December 31,
 
  
Corporate & Other
 
Consolidated
 
  
2006
 
2005
 
2006
 
2005
 
          
Revenue $- $- $55,417 $52,967 
Cost of sales  -  -  36,452  34,722 
Gross profit  -  -  18,965  18,245 
Other income  47  64  155  73 
Equity in income (losses) of equity method investees  (356) 675  (356) 675 
Discontinued operations  -  -  230  (230)
Net income (loss) $(1,563)$(452)$1,023 $65 
Plus:             
Interest Expense (Income)  28  (11) 758  763 
Income tax provision  6  32  205  241 
Depreciation & Amortization  25  16  713  652 
Discontinued operations  -  -  (230) 230 
EBITDA from continuing operations
 
$
(1,504
)
$
(415
)
$
2,469
 
$
1,951
 
              
Total Assets $1,193 $2,026 $21,039 $21,998 

 
  
December 31,
 
  
Healthcare
 
Real Estate Services
 
Corporate and Other
 
Consolidated
 
  
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
2005
 
2004
 
                  
Total Assets $8,631 $8,811 $11,341 $10,971 $2,026 $971 $21,998 $20,753 








ITEMITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None

ITEMITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As required by rule 13a-15(b), the Company, including the Chief Executive OfficerWe maintain “disclosure controls and Chief Financial Officer, conducted an evaluationprocedures,” as such term is defined in Rules 13a-15(e) and 15d-15(e) of the endSecurities Exchange Act of 1934 (the “Exchange Act”), designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the period coveredtime periods specified by this report, of the effectiveness ofSEC and that such information is accumulated and communicated to our management, as appropriate, to allow for timely decisions regarding required disclosure.

In designing and evaluating the Company’s disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e). Based onmanagement recognizes that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosureany controls and procedures, were effective as of the end of the period covered by this report. As required by Rule 13a-15(d), the Company’s management, including the Chief Executive Officer also conducted an evaluation of the Company’s internal control over financial reporting to determine whether changes occurred during the fourth fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. Based on that evaluation, there has been no such change during the fourth fiscal quarter.

It should be noted that any system of controls, howevermatter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and not absolute, assurance thatmanagement is required to apply its judgment in evaluating the objectivescost-benefit relationship of the system will be met.possible controls and procedures. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.

However, dueDue to the limited size of the Company’s staff, there is inherently a lack of segregation of duties related to the authorization, recording, processing, and reporting of transactions. In October 2004, wethe Company added Gary Boyd as oura new Chief Financial Officer which will allow usallowed it to implement additional controls related, but not limited to segregation of duties. WeIn September 2006, that Chief Financial Officer resigned and was replaced by an Interim Chief Financial Officer. The Company will continue to periodically assess the cost versus benefit of adding the resources that would improve segregation of duties and currently,duties. Currently, with the concurrence of the board of directors, dothe Company does not consider the benefits to outweigh the costs of adding additional staff in light of the limited number of transactions related to the company’sCompany’s operations.

Management, including our Chief Executive Office and Interim Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as required by the Exchange Act Rules 13a-15(b) and 15d-15(b). Based upon that evaluation, our Chief Executive Officer and Interim Chief Financial Officer concluded that, as of December 31, 2006, our disclosure controls and procedures were ineffective, due to the identification of the material weakness in the revenue recognition process at its Park InfusionCare subsidiary as described below.

Notwithstanding the material weakness described below, management believes the consolidated financial statements included in this report fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented. The Company’s Chief Executive Officer and Interim Chief Financial Officer have certified that, to their knowledge, the Company’s consolidated financial statements included in this Annual Report on Form 10-K fairly present in all material respects the financial condition, results of operations and cash flows of the Company for the periods presented.

Changes in Internal ControlsMaterial Weakness Related to Revenue Recognition

There were no significant changes
A material weakness is a control deficiency, or combination of control deficiencies, that results in a more than remote likelihood that a material misstatement of the consolidated annual or interim financial statements will not be prevented or detected. In connection with the preparation of the Company’s 2006 consolidated financial statements, the Company has identified the following control deficiencies, which represent a material weakness in the Company’s internal controlsfinancial statement close and reporting process as of December 31, 2006.


The Company concluded that occurredits revenue recognition process for 2006 at its Park InfusionCare subsidiary was ineffective as a result of an identified material weakness. During 2006, variances from expected payments received from insurance companies were not investigated in a timely manner, and thus were incorrectly accounted for as liabilities rather than revenue. In March 2007, the Company identified an accounting error at its Park InfusionCare subsidiary where certain payments received from insurance companies during the last quarteryear ended December 31, 2006 were incorrectly recorded as a liability. The Company has evaluated these payments and, as a result of 2005this evaluation, has increased the 2006 revenue of Park InfusionCare in the amount of approximately $482,000. As a result, an adjustment of approximately $482,000 was recorded in order to increase the revenue and reduce the net loss of the Park InfusionCare subsidiary for the year-ended December 31, 2006.

The efficacy of the measures the Company implements in this regard will be subject to ongoing management review supported by confirmation and testing by management as well as audit committee oversight. As a result, the Company expects that materially affected, or are reasonably likelyadditional changes will be made to materially affect, the Company’s internal controls over financial reporting.its processes as time progresses.

ITEMPlan for Remediation of Material Weakness

In order to remediate this material weakness, the Company will review and document the processes relating to the recording, processing, reconciliation, recognition and reporting of revenue at our Park InfusionCare subsidiary. In addition, the Company will provide additional training, review and supervision of personnel responsible for the billing, collection and accounting of the Park InfusionCare revenue.

ITEM 9B. OTHER INFORMATION
None


 
 
 
 

 



PART III.

Certain information required by Part III is incorporated by reference in this Annual Report on Form 10-K from our definitive Proxy Statement forto be filed within 120 days of December 31, 2006 and delivered to our 2006stockholders in connection with our 2007 Annual Meeting of Stockholders, to be held on June 14, 2007, to be filed pursuant to Regulation 14A (the “Proxy Statement”).

ITEM 10IT.EM 10. DIRECTORS, AND EXECUTIVE OFFICERS OF THE REGISTRANTAND CORPORATE GOVERNANCE

The information required by this Item is incorporated by reference fromDirectors and Executive Officers
Information regarding our directors and executive officers may be found under the sectionscaptions “Election of Directors,” “Corporate Governance” and “Executive Officers” in the Proxy Statement captioned “Electionfor our 2007 Annual Meeting of Directors,”Stockholders. Such information is incorporated herein by reference.
Audit Committee
The Company has a separately-designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act. Additional information regarding the Audit Committee may be found under the captions “Committees of the Board of Directors; Meetings” and “Management—Executive Officers” and“Report of the Audit Committee” in the Proxy Statement for our 2007 Annual Meeting of Stockholders. Such information is incorporated herein by reference.
Audit Committee Financial Expert
The Board of Directors has determined that it has at least one “Audit Committee Financial Expert” (as defined by Item 401(h)(2) of Regulation S-K of the Exchange Act) on the Audit Committee of the Board of Directors, Anthony J. LeVecchio. The Board of Directors has further determined that Mr. LeVecchio is “independent” from management within the meaning of Item 7(d)(3)(iv) of Schedule 14A under the Exchange Act.
Section 16(a) Beneficial Ownership Reporting Compliance
Information regarding Section 16(a) Beneficial Ownership Reporting Compliance may be found under the caption “Section 16(a) Beneficial Ownership Reporting Compliance.”  Compliance” in the Proxy Statement for our 2007 Annual Meeting of Stockholders. Such information is incorporated herein by reference.
Code of Business Conduct and Ethics
The policies comprising the Company'sCompany has adopted a code of business conduct and ethics, arewhich applies to all of its officers, directors and employees, including its principal executive officer, principal financial officer, principal accounting officer and controller, or persons performing similar functions. The Company’s code of business conduct and ethics is set forth on the Company'sCompany’s website at http://www.ascendantsolutions.com/ascendant_codeofconduct.pdf.

ITEMITEM 11. EXECUTIVE COMPENSATION

The information required by this Item is incorporated by reference from the sections of the Proxy Statement captioned “Election of Directors,” “Management,” “Compensation Committee Report”Discussion and Analysis,” and “Performance Graph.”



ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Securities authorized for issuance under equity compensation plans at December 31, 20052006 are as follows:

Plan categoryNumber of securities to be issued upon exercise of outstanding options, warrants and rightsWeighted average exercise price of outstanding options, warrants and rightsNumber of securities remaining available for future issuance
Equity compensation plans approved by security holders
915,000(1)460,000 (1)
$0.26.24
2,610,000 (2)
Equity compensation plans not approved by security holders
800,000 (3)0
$1.70
0
Total
1,715,000460,000
 
2,610,000


(1)  As of December 31, 2005,2006, options to purchase 915,000 shares of common stock were outstanding under the 1999 Long Term Incentive Plan.
(2)  As of December 31, 2005,2006, 550,000 shares of restricted stock were issued under the 2002 Equity Incentive Plan. These shares are not included in the number of securities remaining available for future issuance.
(3)  This includes 800,000 warrants issued in February 1999, which were approved by the Board of Directors (we were not a public company at the time). In September 2002, our Board of Directors authorized the extension of the maturity of these warrants, which are held by Jonathan Bloch, one of our directors, from February 5, 2004 to February 5, 2006. The warrants have an exercise price ranging from $1.00-$3.00 per share. These warrants expired unexercised in February 2006.

Additional information required by this Item is incorporated by reference from the section of the Proxy Statement for our 2007 Annual Meeting of Stockholders captioned “Stock Ownership.”

ITEMITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

The information required by this Item is incorporated by reference from the section of the Proxy Statement for our 2007 Annual Meeting of Stockholders captioned “Management.”



ITEMM 14. PRINCIPAL ACCOUNTANTACCOUNTING FEES AND SERVICES

The information required by this Item is incorporated by reference from the section of the Proxy Statement for our 2007 Annual Meeting of Stockholders captioned “Independent Auditors.Public Accountants.
 
 
PART IV.

ITEMITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 1.
Financial Statements: See “Index to Consolidated Financial Statements and Supplementary Data” under Part II, Item 8 of this Annual Report on Form 10-K.

  
Unconsolidated subsidiaries

  The audited financial statements of Fairways Frisco, L.P. and Fairways 03 New Jersey, L.P. are filed hereto as Exhibits 99.8 and 99.9, respectively, pursuant to Rule 3-09 of Regulation S-X. The Company is not required to provide any other financial statements pursuant to Rule 3-09 of Regulation S-X.

 2.All other schedules are omitted because they are not applicable or the required information is included in the Company’s Consolidated Financial Statements or Notes thereto included in this Annual Report on Form 10-K.

 3.
Exhibits: The exhibits listed on the accompanying Index to Exhibits immediately following the certifications are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K.




 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on April 12, 2006.16, 2007.
 


 
ASCENDANT SOLUTIONS, INC.
   
   
 By:/s/ David E. Bowe
  David E. Bowe
  
President and Chief Executive Officer (Duly Authorized Officer and Principal Executive Officer)
   
   
 By:/s/ Gary W. BoydMichal L. Gayler
  Gary W. BoydMichal L. Gayler
  
Interim Vice President-Finance and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)



Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed on the 1216th day of April 2006,2007, below by the following persons on behalf of the registrant and in the capacities indicated.

Signature
 
 
Title
 
/s/ James C. Leslie
James C. Leslie
 
 
 
Chairman of the Board
/s/ David E. Bowe
David E. Bowe
 
 
 
Director, President and Chief Executive Officer,
/s/ Anthony J. LeVecchio
Anthony J. LeVecchio
 
 
 
Director, Audit Committee Chairman
/s/ Jonathan R. BlochCurt Nonomaque
Jonathan R. BlochCurt Nonomaque
 
 
 
Director
/s/ Will Cureton
Will Cureton
 
 
 
Director





INDEX TO EXHIBITS

Exhibit Number
 
Description
2.1
 Agreement and Plan of Merger by and between ASD Systems, Inc. d/b/a Ascendant Solutions, a Texas corporation, and Ascendant Solutions, Inc., a Delaware corporation (Exhibit 2.1) (1)
2.2
 Stock Purchase Agreement by and between ASDS of Orange County, Inc., a Delaware corporation f/k/a Orange County Acquisition Corp. and Kevin Hayes dated March 23, 2004 (Exhibit 2.1) (2)
2.3
 ASDS of Orange County, Inc. Promissory Note due May 1, 2007 (Exhibit 2.2) (2)
3.1
 Certificate of Incorporation of Ascendant Solutions, Inc. (Exhibit 3.1) (1)
3.2
 Bylaws of Ascendant Solutions, Inc. (Exhibit 3.2) (1)
4.1
 Specimen of Ascendant Solutions, Inc. Common Stock Certificate (Exhibit 4.1) (1)
4.2
 1999 Long-Term Incentive Plan for ASD Systems, Inc. (Exhibit 4.2) (3)
4.3
 Form of Stock Option Agreement under 1999 Long-Term Incentive Plan (Exhibit 4.3) (3)
10.1
 Form of Indemnification Agreement with directors (Exhibit 10.10) (3)
10.2
 Form of Warrant granted to affiliates of CKM Capital LLC (Exhibit 10.15) (3)
10.3
 Stock Option Agreement dated as of March 14, 2002 between Ascendant Solutions, Inc. and David E. Bowe (Exhibit 10.6) (4)
10.4
 Stock Option Agreement dated as of March 14, 2002 between Ascendant Solutions, Inc. and James C. Leslie (Exhibit 10.7) (4)
10.7
 Asset Purchase Agreement between Dougherty’s Holdings, Inc. and Park Pharmacy Corporation dated December 9, 2003 (Exhibit 2.1) (5)
10.8
 First Amendment to the Asset Purchase Agreement between Dougherty’s Holdings, Inc. and Park Pharmacy Corporation dated February 27, 2004 (Exhibit 2.2) (6)
10.9
 Amended Warrant Agreement dated as of July 21, 2003 between Ascendant Solutions, Inc. and affiliates of CKM Capital LLC (Exhibit 10.10) (7)
10.10
 Parent Guaranty dated as of May 1, 2004, by and among Ascendant Solutions, Inc., ASDS Orange County, Inc., a Delaware corporation, and the successor corporation of the merger of Orange County Acquisition Corp. and CRESA Partners of Orange County, Inc. (Exhibit 10.1) (8)
10.11
 Parent Pledge Agreement dated May 1, 2004, by and between Ascendant Solutions, Inc. and Kevin J. Hayes (Exhibit 10.2) (8)
10.12
 Subsidiary Guaranty dated as of May 1, 2004 by and among CRESA Partners of Orange County, LP, a Delaware limited partnership, ASDS Orange County, Inc., a Delaware corporation, and the successor corporation of the merger of Orange County Acquisition Corp. and CRESA Partners of Orange County, Inc. (Exhibit 10.3) (8)
10.13
 Amended Promissory Note of CRESA Partners of Orange County, Inc. dated August 12, 2004, payable to the order of Kevin J. Hayes (Exhibit 10.1) (9)
10.14
 Restricted Stock Agreement dated October 18, 2004, between Ascendant Solutions, Inc. and Gary W. Boyd (Exhibit 1.01) (10)
10.15
 Master Agreement Regarding Frisco Square Partnerships dated December 31, 2004 (Exhibit 10.1) (11)
10.16
 Participation Agreement between Ascendant Solutions, Inc. and Fairways Partners, LLC dated August 2003 (Exhibit 10.16) (12)
10.17
 Restricted Stock Agreement dated June 25, 2004, between Ascendant Solutions, Inc. and Anthony J. LeVecchio (Exhibit 10.17) (12)
10.18
 Amended and Restated Agreement of Limited Partnership of Fairways Frisco, L.P. effective December 30, 2004 (Exhibit 10.18) (12)
10.19
 Promissory note payable from Ascendant Solutions, Inc. to Comerica Bank dated April 11, 2005 (Exhibit 10.1) (14)
10.20
 Fee allocation agreement dated May 31, 2005 between Fairways Equities, LLC and Ascendant Solutions, Inc. (Exhibit 10.2) (14)




10.21 Advisory Services Agreement between CRESA Capital Markets Group, LP, Fairways Equities, LLC and Ascendant Solutions, Inc. dated September 1, 2005 (Exhibit 10.1)(15)
10.22 Form of Restricted Stock Agreement between Ascendant Solutions, Inc. and non-employee directors (Exhibit 1.01) (17)
10.23 Promissory note payable from Ascendant Solutions, Inc. to Comerica Bank dated September 13, 2005 (Exhibit 10.01) (18)
10.24Outline of Compensation Plan for Non-Employee Directors (21)
10.25Employment Agreement between Park InfusionCare, LP and Scott L. Holtmyer (Exhibit 10.1) (22).
10.26Loan Agreement (Term Loan) between ASDS of Orange County, Inc. and First Republic Bank dated June 8, 2006 (Exhibit 10.1) (23).
10.27Promissory Note (Term Loan) payable from Orange County, Inc. to First Republic Bank dated June 8, 2006 (Exhibit 10.2) (23).
10.28Security Agreement (Term Loan) between ASDS of Orange County, Inc. and First Republic Bank dated June 8, 2006 (Exhibit 10.3) (23).
10.29Continuing Guarantee of Payment and Performance by CRESA Partners of Orange County, LP for the benefit of First Republic Bank dated June 8, 2006 (Exhibit 10.4) (23).
10.30
Form of Limited Guaranty of the Obligations of ASDS of Orange County, Inc. for the benefit of First Republic Bank dated June 8, 2006 (Exhibit 10.5) (23).
10.31Loan Agreement (Line of Credit) between CRESA Partners of Orange County, LP and First Republic Bank dated June 8, 2006 (Exhibit 10.6) (23).
10.32Promissory Note (Line of Credit) payable from CRESA Partners of Orange County, LP to First Republic Bank dated June 8, 2006 (Exhibit 10.7) (23).
10.33Security Agreement (Line of Credit) between CRESA Partners of Orange County, LP and First Republic Bank dated June 8, 2006 (Exhibit 10.8) (23).
10.34
Form of Limited Guaranty of the Obligations of CRESA Partners of Orange County, LP for the benefit of First Republic Bank dated June 8, 2006 (Exhibit 10.9) (23).
10.35Promissory Note payable from Ascendant Solutions, Inc. to Ampco Partners, Ltd. dated June 14, 2006 (Exhibit 10.1) (24).
10.36Security Agreement between Ascendant Solutions, Inc. and Ampco Partners, Ltd. dated June 14, 2006 (Exhibit 10.2) (24).
10.37Letter Agreement between Ascendant Solutions, Inc. and Gary W. Boyd dated September 6, 2006 (Exhibit 10.1) (25).
10.38Letter Agreement between Ascendant Solutions, Inc. and GaylerSmith Group, LLC dated May 16, 2005 (Exhibit 10.2) (25).
10.39Loan Agreement between Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, Santa Fe Medicine Man, LP and Amegy Bank National Association dated February 20, 2007 (Exhibit 10.1) (26).
10.40Promissory Note (Term) payable from Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP to Amegy Bank National Association dated February 20, 2007 (Exhibit 10.2) (26).
10.41Promissory Note (Revolving) payable from Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP, and Santa Fe Medicine Man, LP to Amegy Bank National Association dated February 20, 2007 (Exhibit 10.3) (26).
10.42
Form of Security Agreement dated as of February 20, 2007 executed by Dougherty’s Pharmacy, Inc., Alvin Medicine Man, LP, Angleton Medicine Man, LP and Santa Fe Medicine Man, LP in favor of Amegy Bank National Association (Exhibit 10.4) (26).
10.43
Form of Unlimited Guaranty Agreement dated as of February 20, 2007 executed by Ascendant Solutions, Inc., Dougherty’s Holdings, Inc. Medicine Man, LP, Dougherty’s LP Holdings, Inc., Medicine Man GP, LLC, Alvin Medicine Man GP, LLC, Angleton Medicine Man GP, LLC and Santa Fe Medicine Man GP, LLC for the benefit of Amegy Bank National Association  (Exhibit 10.5) (26).
10.44Pledge Agreement between Dougherty’s Pharmacy, Inc. in favor of Amegy Bank National Association dated February 20, 2007 (Exhibit 10.6) (26).
21.1 Subsidiaries of Ascendant Solutions, Inc.*




23.1 Consent of Hein & Associates LLP *
23.2Consent of BDO Seidman, LLP *
31.1 Written Statement of President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2 Written Statement of Vice President-Finance and Interim Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1 Certification of Ascendant Solutions, Inc. Annual Report on Form 10-K for the period ended December 31, 2005,2006, by David E. Bowe as President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2 Certification of Ascendant Solutions, Inc. Annual Report on Form 10-K for the period ended December 31, 2005,2006, by Gary BoydMichal L. Gayler as Interim Vice President-Finance and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
99.1 Certificate of Incorporation for Orange County Acquisition Corp. (Exhibit 99.1) (8)
99.2 Certificate of Ownership and Merger of Staubach Company - West, Inc. into Orange Co. (Exhibit 99.2) (8)
99.3 Table reflecting certain ownership after giving effect to the transactions contemplated by the Master Agreement (Exhibit 99.1) (11)
99.4 Table reflecting certain ownership after giving effect to the termination of the Master Agreement and other changes (Exhibit 99.1) (16)
99.5 Office Building Sublease Agreement between Ascendant Solutions, Inc. and Holt Lunsford Commercial, Inc. dated March 16, 2005 (Exhibit 99.1) (14)
99.6 Press release dated November 3, 2005 (Exhibit 99.1) (18)
99.7 Press release dated January 3, 2006 (Exhibit 99.1) (19)
99.8 Audited consolidated financial statements of Fairways Frisco, L.P. and Subsidiaries for the yearyears ended December 31, 2006 and 2005 pursuant to Rule 3-09 of Regulation S-X*
99.9 Audited financial statements of Fairways 03 New Jersey, L.P. for the year ended December 31, 2005 pursuant to Rule 3-09 of Regulation S-X*
** Filed herewith




(1)
Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed October 23, 2000.
(2)
Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K/A filed July 21, 2004.
(3)
Incorporated by reference to the exhibits shown in parenthesis filed in our Registration Statement on Form S-1, File No. 333-85983.
(4)
Incorporated by reference to the exhibits shown in parenthesis filed in our annual report on Form 10-K for the fiscal year ended December 31, 2002.
(5)
Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed December 11, 2003.
(6)
Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed March 29, 2004.
(7)
Incorporated by reference to the exhibits shown in parenthesis filed in our annual report on Form 10-K for the fiscal year ended December 31, 2003.
(8)
Incorporated by reference to the exhibits shown in parenthesis filed in our quarterly report on Form 10-Q for the period ended June 30, 2004.




(9)
(9)Incorporated by reference to the exhibits shown in parenthesis filed in our quarterly report on Form 10-Q for the period ended September 30, 2004.
(10)
Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed October 19, 2004.
(11)
Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed January 7, 2005.
(12)
Incorporated by reference to the exhibits shown in parenthesis filed in our annual report on Form 10-K for the fiscal year ended December 31, 2004.
(13)
Incorporated herein by reference to the exhibits shown in parenthesis filed in our quarterly report on Form 10-Q for the quarterly period ended March 31, 2005
(14)
Incorporated herein by reference to the exhibits shown in parenthesis filed in our quarterly report on Form 10-Q for the quarterly period ended June 30, 2005.
(15)Incorporated herein by reference to the exhibits shown in parenthesis filed in our quarterly report on Form 10-Q for the quarterly period ended September 30, 2005.
(16)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed April 29, 2005.
(17)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed May 24, 2005.
(18)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed September 15, 2005.
(19)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed November 4, 2005.
(20)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed January 3, 2006.
(21)Incorporated by reference to Item 1.01 in our current report on Form 8-K filed May 16, 2006.
*(22)Filed herewithIncorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed May 24, 2006.
(23)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed June 13, 2006.
(24)Incorporated by reference to the exhibits shown in parenthesis filed in our quarterly report on Form 10-Q for the quarterly period ended June 20, 2006.
(25)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed September 8, 2006.
(26)Incorporated by reference to the exhibits shown in parenthesis filed in our current report on Form 8-K filed February 26, 2007.




Executive Compensation Plans and Arrangements

The following is a list of all executive compensation plans and arrangements required to be filed as an exhibit to this Form 10-K:

   
1.
 
1999 Long-Term Incentive Plan for ASD Systems, Inc. (filed as Exhibit 4.2 hereto and incorporated by reference to Exhibit 4.2 filed in our Registration Statement on Form S-1, File No. 333-85983)
2.
 
Form of Stock Option Agreement under 1999 Long-Term Incentive Plan (filed as Exhibit 4.3 hereto and incorporated by reference to Exhibit 4.3 filed in our Registration Statement on Form S-1, File No. 333-85983)
3.
 
Stock Option Agreement dated as of March 14, 2002 between Ascendant Solutions, Inc. and David E. Bowe (filed hereto as Exhibit 10.3 and incorporated by reference to Exhibit 10.6 filed in our annual report on Form 10-K for the fiscal year ended December 31, 2002)
4.
 
Stock Option Agreement dated as of March 14, 2002 between Ascendant Solutions, Inc. and James C. Leslie (filed hereto as Exhibit 10.4 and incorporated by reference to Exhibit 10.7 filed in our annual report on Form 10-K for the fiscal year ended December 31, 2002)
5.
 
Restricted Stock Agreement dated October 18, 2004, between Ascendant Solutions, Inc. and Gary W. Boyd (filed hereto as Exhibit 10.14 and incorporated by reference to Exhibit 1.01 filed in our current report on Form 8-K filed October 19, 2004)
6.
 
Restricted Stock Agreement dated June 25, 2004, between Ascendant Solutions, Inc. and Anthony J. LeVecchio (filed as Exhibit 10.17 hereto and Incorporated by reference to Exhibit10.17Exhibit 10.17 filed in our annual report on Form 10-K for the fiscal year ended December 31, 2004)
7.
 
Form of Restricted Stock Agreement between Ascendant Solutions, Inc. and non-employee directors (filed hereto as Exhibit 10.22 and incorporated by reference to the exhibits shown in parenthesisExhibit 1.01 filed in our current report on Form 8-K filed May 24, 2005)
8.
Outline of Compensation Plan for Non-Employee Directors (filed hereto as Exhibit 10.24 and incorporated by reference to Item 1.01 in our current report on Form 8-K filed May 16, 2006)
9.
Employment Agreement between Park InfusionCare, LP and Scott L. Holtmyer (filed hereto as Exhibit 10.25 and incorporated by reference to Exhibit 10.1 filed in our current report on Form 8-K filed May 24, 2006)
10.
Letter Agreement between Ascendant Solutions, Inc. and Gary W. Boyd dated September 6, 2006 (filed hereto as Exhibit 10.37 and incorporated by reference to Exhibit 10.1 filed in our current report on Form 8-K filed September 8, 2006)
11.
Letter Agreement between Ascendant Solutions, Inc. and GaylerSmith Group, LLC dated May 16, 2005 (filed hereto as Exhibit 10.38 and incorporated by reference to Exhibit 10.2 filed in our current report on Form 8-K filed September 8, 2006)

-77--85-